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Crystal  structure  assembly  is  a  subtle  compromise  between  geometrical  features,  a 
natural tendency to minimize the free, empty, volume, linked to the involvement of 
classical van der Waals forces, and the ability of particular complementary functional 
groups to form additional cohesive directional interactions. Depending on the system 
considered, each of these factors can have a more pronounced influence in determining 
the crystal packing. In order to develop a successful strategy to design new solid forms 
by  a  crystal  engineering  approach  a  complete  understanding  of  crystal  structure  is 
required.  It  involves  the  so  called  “retrosynthetic”  approach  which  allows  the 
identification  of  robust  assemblies.  However,  this  procedure  is  worthless  without  a 
systematic  approach  able  to  define  the structural consequences  deriving  from  small 
changes in the molecular skeleton of a given target molecule. 
 
In this thesis three families of substituted salicylic acid derivatives have been prepared 
and separately studied  in order to compare the crystal structures and determine whether 
the  substitution  and  the  associated  changes  in  shape  and  electrostatic  of  the  parent 
molecule introduce alternative intermolecular interactions or molecular patterns.  The 
first family is based on acetylsalicylic acid derivatives (aspirins) and contains 15 novel 
structures together with some substituted derivatives already present on the CSD. The 
second family contains 13 new structures of substituted salicylic acid and, as for aspirin 
derivatives, some already reported in  CSD. The last family contains 13 new crystal 
structures  of  molecular  salts  based  on  the  pair  4-aminopyridine-salicylic  acid 
derivatives. The families of compounds are those in which the parent molecules are 
substituted with small groups (Cl, Br, I, Me, NO2, MeO etc.) and in different positions. 
The only exception is given by the acetylamino derivatives, which were included in the 
analysis in order to verify if they can compete with the carboxylic group in forming 
particular  intermolecular  interactions  and  consequently  different  supramolecular 
synthons. 
 
The results in this work clearly showed that the substituent groups have an important 
role  in  generating  similarities  but,  also,  differences  within  the  family  under  study. 
Furthermore  the  analysis  has  shown  the  significant  involvement  of  both  weak 
intermolecular interactions and shape-related packing features in the crystal structure 
assembly. In the other hand, the analysis showed the importance of particular functional 
group in defining robust supramolecular synthons.  
The three families studied showed, apart from a small number of exceptions, predictable 
synthons (carboxylic dimers for the aspirins and the salicylic acids and the well known 
pyridine-carboxylate synthon for the salts) observed in the majority of the structures. 
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CHAPTER 1: CRYSTALLINE ORGANIC SOLID STATE. 
In  this  chapter  the  crystalline  organic  solid  state,  intermolecular  interactions  and 
related topics such as polymorphism, supramolecular chemistry, crystal engineering 
are discussed. 
 
1.1. Introduction. 
Organic  crystals  consist  of  discrete  molecules  or  molecular  ions  held  together  in  a 
periodic arrangement by medium and long-range non-covalent interactions, to form a 
highly ordered macroscopic product, which has determined physical properties. 
Crystal packing is a compromise between “the necessity to fill the empty spaces”, the 
influence  of  geometrical  features  and  the  tendency  of  particular  pairs  of  atoms  or 
functional groups to form stable interactions. The forces involved in a crystal include 
directional hydrogen bonds and dipole-dipole and isotropic van der Waals interactions. 
In the last two decades, hydrogen bonds have received the most attention as descriptors 
for intermolecular interactions in crystal structure analysis. Hydrogen bonds are often 
involved in promoting recurrent molecular arrangements (e.g. homomeric motifs such 
as  carboxylic  dimers  or  catemers,  heteromeric  motifs  like  pyridine-carboxylic  acid, 
etc.),  defined  in  crystal  engineering  as  supramolecular  synthons.  However  the 
observation of similar geometrical arrangements (chains, tapes, columns, etc.) involving 
structures with different associations, suggests that isotropic van der Waals interactions 
and weak interactions in general could have a role as well in defining crystal packing 
geometry.  This  thesis  is  concerned  with  the  identification  of  such  assemblies  for 
different families of compounds, which include single- and multi-component systems, 
by taking a systematic approach to gain a detailed assessment of the overall crystal 
packing features. Before discussing these, however, it is important to describe the main 
phenomena and the nature of the interactions involved, that characterize organic solid 
forms. 
 
1.2. Intermolecular Forces and Interactions. 
Intermolecular interactions are generally classified in two main types: short range forces 
and long range forces. The criteria for their classification are the distance dependence 
and the directionality.  Intermolecular forces can be attractive or repulsive and  their 
energy is proportional to r
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usually  considered  as  a  positive  integer,  different  for  the  types  of  interaction  (see 
below).  
The  potential  energy  of  a  structure is  given  by  the  sum  of these two  contributions 
(attractive  forces  and  repulsive  forces)  and  a  crystal  structure  is  a  result  of  the 
equilibrium between these forces.  
Short  range  forces  are  generally  repulsive  and  the  energy  associated  decreases 
exponentially with the distance. At short intermolecular distances the electrons tend to 
avoid the overlap region and the nuclear charge is no longer screened so effectively, 
determining  an  effective  Coulombic  repulsion  between  the  nuclei  of  two  adjacent 
molecules.  Repulsive  forces  are  responsible  for  the  shape  and  conformations  of 
molecules and for  phenomena such as steric hindrance. The energy associated with 
these  forces  increases  rapidly  at  shorter  intermolecular  separations,  varying 
approximately as r
-12. 
Long range forces are attractive and may be classified into electrostatic, induction and 
dispersion forces. Depending on the differences in electronegativities of the atoms in a 
molecule, the permanent charge distribution of molecules are often not uniform and this 
non-homogeneous  charge  distribution  can  be  described  as  a  series  of  multipole 
moments.  
The electrostatic or Coulomb energy can be expressed in terms of a series of different 
components with a different distance dependency: charge-charge (r
-1), charge-dipole (r
-
2), dipole-dipole (r
-3), quadrupole-quadrupole (r
-5) etc.  
A  permanent  dipole  can  also  interact  with  a  polarizable  atom  or  group  of  atoms, 
inducing  a  charge  separation  (induced  dipole).  Induction  energies  have  a  distance 
dependency proportional to r
-6. 
Even if molecules are not polar, weak forces exist between them. In fact interactions 
between dipoles and charges are not sufficient to explain the stabilization energies of 
crystals  of  non-polar  molecules.  The  first  explanation  of  dispersion  forces  was 
suggested by London
[1] describing them as  forces of electrical nature. The movement of 
the  valence  electrons  create,  at  any  given  instant,  a  fluctuating  multipole  moments 
which can induce dipole moments in adjacent molecules. The interaction between the 
transient multipole moment and the induced multipole results in a weak, short-range 
attractive force defined as London dispersion force. The dispersion energy drops off 
with the distance, decreasing as a function of r
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Hydrogen Bonding. 
Among the directional intermolecular interactions, the hydrogen bond is surely the most 
important,  not  only  for  its  key  role  in  many  aspects  of  the  liquid  and  solid  state 
chemistry  but  also  for  the  uniqueness  of  the  phenomenon.  Its  classical  description 
derives from Pauling‟s work 
[2] which defines a hydrogen bond as a stable interaction 
between two  electronegative  atoms,  X  (the  donor)  and  A  (the  acceptor),  where  the 
hydrogen atom is attracted to both atoms and thus acts as a bridge or a bond X-H···A 
between them (where X and A are atoms such as N, O, S and N, O, F, Cl, Br and I). 
Because of the electronegativity of the X atom, the electron of the H atom is located 
between X and H, generating a charge separation X
ʴ--H
ʴ+. It can interact with the lone-
pair on the electronegative acceptor A, forming an interaction with energies in the range 
15-40  kJ  mol
-1.  The  H···A  interatomic distance  of  conventional  hydrogen  bonds  is 
generally shorter than the sum of the van der Waals radii (2.6 Å). Conventionally this 
hydrogen bond model relates only to very electronegative atoms and does not take in 
account all those intermolecular interactions such as C-H···X (X = O, F, π, etc) or O-
H···π, recently defined as weak hydrogen bonds 
[3] (interaction energies in the range 2-4 
kJ mol
-1), recognised to make decisive contributions to the cohesion in the structure. 
[4] 
As stated by Desiraju and Steiner 
[3] there is no experimental evidence that at a critical 
distance the nature of X-H···A interactions is switched from hydrogen bonding to van 
der Waals type. 
A broader definition 
[5] describes the hydrogen bond as any cohesive interaction X-
H···A where H carries a positive charge and A a partial or full negative charge and the 
charge on X is more negative than on H.  
Jeffrey and Saenger have classified hydrogen bonds in two categories: weak and strong 
[6]. Further classifications 
[3] divide hydrogen bonds into three types which depend on 
the strength of the interaction: weak (2-4 kcal mol
-1), strong (4-15 kcal mol
-1), and very 
strong (above 15 kcal mol
-1). 
Hydrogen bonds have a strong electrostatic nature, however they can be considered as 
components of a more complex system. The total energy of the hydrogen bond can be 
subdivided into at least four component interaction types: electrostatic, charge transfer, 
dispersion, exchange repulsion and polarization. Apart from the dispersion term which 
is  repulsive,  the  remaining  components  are  attractive  and  can  have  more  or  less 
importance  depending  on  the  type  of  hydrogen  bond  considered:  strong  (most Chapter 1                                                                                                       Crystalline Organic Solid State 
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electrostatic), weak (electrostatic) and very strong (most covalent). For example, very 
strong hydrogen bonds have a large charge transfer contribution and can be considered 
as  quasi  covalent  interactions 
[7]  and  very  weak  hydrogen  bonds  (in  which  the 
electrostatic contribution can be comparable to the dispersion term 
[6, 8] or even smaller) 
cannot be easily distinguished from van der Waals interactions.  
Hydrogen bonds are often rationalised in terms of geometrical parameters 
[9] such as 
bond angles and X-A or H-A distances (Figure 1.1). In a classical hydrogen bond the 
donor interacts with one acceptor forming a linear interaction (although experimentally, 
θ is normally smaller than 180°).  
 
 
Figure 1.1. Representation of hydrogen bond parameters d, D, θ. 
 
However  a  donor  can  interact  simultaneously  with  two  or  three  acceptors  forming 
bifurcated (three-centre) 
[6] and trifurcated (four centre) hydrogen bonds.  
Hydrogen  bonds  are  important  tools  in  crystal  engineering  and  have  profound 
influences in crystal structures.  
In 1984 Kennard 
[9] recognised the necessity to rationalise, or even predict, hydrogen-
bonding patterns in crystal structures, observing, for example, that it is unusual for an 
O-H or N-H group not to be hydrogen bonded if an acceptor atom is available in the 
crystal structure. 
General rules were finally defined by Etter in 1990 
[10]. These rules apply equally to 
both strong donors and acceptors and correlate functional groups in neutral organic 
molecules  with  hydrogen  bonded  motifs  in  crystal  structures.  The  rules  can  be 
summarized as follows:- 
 
All good hydrogen bond donors and acceptors are used in forming this interaction. 
Hydrogen  bonds  forming  six-membered  intramolecular  rings  are  preferred  to 
intermolecular hydrogen bonds. Chapter 1                                                                                                       Crystalline Organic Solid State 
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The remaining donors and acceptors after intramolecular hydrogen bond formation will 
form intermolecular hydrogen bonds. 
Additional rules for specific classes of functional groups (e.g. nitroanilines, cocrystals 
between carboxylic acids and aminopyridines, etc.) are also given. 
However, though these rules are followed in the majority of the cases, it is worth noting 
that some exceptions may be observed 
[11].  
 
Other Interactions. 
In an analogous way, halogen bonds are directional D∙∙∙X-Y intermolecular interactions  
with D = N or O or in general any Lewis base, X = Cl, Br and I and Y = carbon, halogen 
etc. 
[12] . This type of interaction has recently been the focus of much interest in the area 
of  organic  solid  state  chemistry  including  crystal  engineering  and  biomolecular 
engineering 
[13].  
Halogens Cl, Br, and I are also involved in forming short non-bonded interactions such 
as X∙∙∙X and X∙∙∙Y (where X and Y indicate two different halogens). The nature of these 
interactions is not completely clear and is still debated. An example is given by the 
crystal  structure  of  chlorine  (orthorhombic  S.G.  Cmca)  which  shows  unusual  short 
Cl···Cl contacts (3.271 Å). Some authors 
[14] suggest that this is the result of a decreased 
repulsion  in  the  direction  of  the  short  contact  due  to  the  elliptically  shaped  atoms 
(anisotropy), whilst others 
[15] claim that there are specific attractive forces between 
halogen atoms in crystals. 
π∙∙∙π  interaction  is  another  important  cohesive  force  responsible  for  directing  the 
packing of aromatic molecules 
[16]. These forces arise from the polarizable π-electron 
density  that  enhances  the  stabilizing  dispersion  interactions  between  the  aromatic 
molecules.  π∙∙∙π  interactions  can adopt  two  different  geometries:  parallel  stacked  or 
parallel displaced (Figure 1.2) 
 
 
Figure  1.2.  Aromatic-aromatic  interactions:  a)  face-to-face  parallel  stacked;  b)  face-to-face  parallel 
displaced; c) edge-to-face. Chapter 1                                                                                                       Crystalline Organic Solid State 
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However parallel stacked is a rare phenomenon and generally offset stacking is more 
common 
[17]. The stability order of stacking interactions in polarized aromatic π-systems 
is π-deficient–π-deficient > π-deficient–π-rich > π-rich–π-rich 
[18]. The concept of the 
π∙∙∙π interaction is often used erroneously to describe aromatic-aromatic interactions in 
which there is no substantial overlap of the aromatic rings. The resulting geometry is a 
T-shaped  arrangement  defined  as  edge-to-face  motif  (Figure  1.2  c).  Phenyl  rings 
generally  prefer  this  geometry  which  is  enthalpically  favorable 
[19].  This  can  be 
expained on the basis of the quadrupole-quadrupole interactions, in which the energy 
term is repulsive for the parallel stacked arrangements and attractive for the T-shaped 
arrangement 
[20]. 
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1.3. Organic Solid Forms. 
Organic crystalline materials play a central role in fine chemicals as well as in many 
area of industry such as pigments, explosives, food and, above all, in the pharmaceutical 
industry 
[21].  Because  of  their  direct  relevance  to  products  of  commerce,  which 
necessitate  regulatory  controls 
[22],  interests  in  the  solid  state  properties  has  grown 
exponentially in the last few decades.  
Depending on their features (e.g. conformational flexibility, hydrogen bonding sites, 
etc.), organic molecules can often exist in more than one solid form, each characterized 
by different molecular arrangements and, consequently different inter- or intramolecular 
interactions which lead to different physical and chemical properties such as melting 
point, solubility, chemical stability etc.  
Particularly in the last two decades the attention has been focused on molecules of 
pharmaceutical importance. The development of a particular formulation is a complex 
process  involving  the  production  of  the  active  ingredient  and  its  conversion  into  a 
product  suitable  for  administration.  Properties  such  as  solubility,  rate  of  dissolution 
have  a  high  importance  in  contributing  on  the  bioavailability  of  particular  drug 
substances. The stability of a given crystalline form is another crucial property that 
should be investigated during the manufacturing processes of an Active Pharmaceutical 
Ingredient (API).  
The ultimate goal of solid form screening is to identify and to select or design the 
optimal solid form  for  the intended use in order to ensure a reliable and a robust 
process, avoiding problems such as tablet failure (e.g. tablets cracking, polymorphic 
transitions  under  mechanical  treatment) 
[23]  precipitation  from  solutions,  chemical 
production problems like filterability 
[24].  
In relation to these concepts, topics such as polymorphism, co-crystals and in general 
multiple component systems have in recent years gained in importance 
[25].  
The  approaches  to  enhance  solubility,  dissolution  rate  and,  generally,  physical 
properties of solids involve altering the molecular networks follow two main routes:  
 
By producing different polymorphs  
By designing multi-component systems (e.g. cocrystals, solvates, salts). 
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Polymorphism  is  generally  defined  as  the  ability  of  a  given  compound  to  exist  in 
different molecular arrangements and/or different conformations 
[26].  
API`s, which typically exhibit hydrogen bonding sites and conformational flexibility, 
are ideal candidates to crystallize in different polymorphic forms.  
Multi-component  systems  are  generally  prepared  by  means  of  hydrogen  bonded 
assemblies between API`s and other components such as solvent or other molecules.  
Salt  and  hydrate  formation  are  often  used  in  pharmaceutical  industry  to  improve 
properties  such  as  hygroscopicity,  toxicity,  solubility  and  stability  of  many  drug 
compounds 
[27].  
Cocrystals  are  currently  studied  as  potentially  useful  tools  in  pharmaceutical  field. 
Figure 1.3 reports a schematic representation of the solid state phenomena described in 
this chapter. 
 
 
Figure  1.3.  Schematic  representation  of  solid  state  phenomena.  a)  Polymorphism:  crystallization  of 
metastable form (2) which converts in the stable form (1). b) Cocrystal formation. c) Salt formation. d) 
Solvate formation. 
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Polymorphism. 
Although its first modern definition was given by McCrone in 1965 
[24], polymorphism 
is a concept known since 1821, when Mitscherlich coined this term to describe the 
tendency  of  some  inorganic  compounds  to  crystallise  in  more  than  one  form. 
Polymorphism is currently defined as “a phenomenon that involves different packing 
arrangements of the same molecule in the solid state” 
[21].  
It is in recent years that polymorphism has been subject of a growing interest, especially 
for its implications in many areas of the industry, particularly in the pharmaceutical 
field. However, although a large number of works on this topic is available (about the 
frequency  of  its  occurrence,  its  rational  control,  nomenclature  and  other  aspects 
concerning  this  phenomenon) 
[21]  it  remains  poorly  understood  and  still  difficult  to 
control. 
Many factors influence crystallization of different polymorphs such as chemical features 
of  the  organic  molecule  (hydrogen  bond  sites,  conformational  flexibility),  solvents, 
concentrations,  thermodynamic  and  kinetic  factors,  impurities  etc.  Because  the 
complexity  of  this  phenomenon,  the  experiments  reported  in  the  literature  for 
crystallization of polymorphs are frequently unrepeatable 
[28].  
Kuhnert-Brandstaetter  stated  that  “probably  every  substance  is  potentially 
polymorphous.  The  only  question  is,  whether  it  is  possible  to  adjust  the  external 
conditions in such a way that polymorphism can be realised or not” 
[29].  
Sarma and Desiraju 
[30] demonstrated that the frequency of occurence of polymorphism 
is not uniform in all categories of compounds but  it is probably more common with 
molecules  with  hydrogen  bonds  donor  or  acceptor  and/or  molecules  with 
conformational flexibility.  
As emphasised in some works 
[31], the solvent can have significant role in promoting  
the crystallization of a particular polymorphic form rather than another, however it is 
not the unique determinant of the polymorphic outcome 
[28].  
Crystallization  (from  solutions,  melts  etc.)  is  a  complex  process  governed  by  a 
combination  of  thermodynamic  and  kinetic  factors.  At  a  given  temperature  and 
pressure, only one polymorphic form of a given compound is thermodynamically stable, 
all other forms under these conditions are defined as metastable. A metastable form is a 
thermodynamically unstable form which may have a finite existence as a result of a 
slow rate of transformation. Chapter 1                                                                                                       Crystalline Organic Solid State 
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From  a  thermodynamic  point  of  view,  at  a  given  temperature  and  pressure,  the 
crystallization determines a decrease of the free energy of the system and the resulting 
crystal structure it is assumed to have the greater negative free lattice energy. However, 
kinetic factors also play an important role in the crystallization process and can promote 
the crystallization of a metastable form.  
Nucleation  is  a  crucial  process  in  the  development  and  growth  of  the  macroscopic 
crystal  from  a  melt,  solution  or  vapour.  The  nucleation  rate  depends  to  the 
supersaturation, the Gibbs free energy of activation, and the surface energy, which can 
be  different  for  polymorphs  of  the  same  substance.  Under  specific  experimental 
conditions nuclei of all possible polymorphs can exist and the metastable form can 
nucleate at a faster rate than the stable form. This is is summarised in the well known 
Ostwald‟s Rule of Stages 
[32].  
If the rate of transformation of metastable polymorphs to the stable one is slow, it is 
possible  to  isolate  more  than  one  polymorphic  form  of  a  single  compound  under 
particular  set  of  conditions.  As  stated  by  some  authors,  the  very  existence  of  a 
metastable polymorph is due to the “triumph of kinetics over thermodynamics” 
[33].  
 
For two polymorphic forms of a given compound at constant pressure, two behaviours 
generally can be observed: monotropism and enantiotropism 
[34].  
 
 
Figure  1.4.  Schematic  Energy-Temperature  diagrams  for  a  dimorphic  system.  a)  Monotropism;  b) 
Enantiotropism. 
 
Two forms are monotropically related if one polymorph is always more stable below the 
melting points of both polymorphs. The transition is not reversible because the free 
energy of one form is always lower with respect to that of the other form (Figure 1.4 a). Chapter 1                                                                                                       Crystalline Organic Solid State 
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Two  polymorphs  of  the  same  compound  are  enantiotropically  related  if  there  is  a 
transition  temperature  (Tt),  at  which  the  Gibbs  energy  of  both  forms  is  equal  and 
transformation can, in principle, occur if the compound is heated above or cooled below 
such temperature (Figure 1.4 b). The presence of extraneous molecules such as additives 
or impurities can promote polymorphism. 
[35] The first identification of elusive form II 
of aspirin was obtained in the presence of either levetiracetam or acetamide 
[36].  Bond et 
al. 
[37] claimed that the presence of additives is not an important factor for the outcome 
of the  polymorph II of aspirin, but a recent paper from some of these authors describes 
the  isolation  of    pure  polymorph  II  by  crystallization  in  the  presence  of  aspirin 
anhydride 
[38]. 
 
Solvates, Cocrystals and Salts. 
Multi-component  systems  are  generally  realized  by  means  of  hydrogen  bonded 
assemblies between a given molecule and other components such as solvent, excipients 
or other molecules.  
Solvates  are  a  common  example  of  multi-component  systems  in  which  solvent 
molecules are incorporated in the lattice. “Pseudopolymorphism” is often used to define 
solvate forms of a given compound although it is going out of favor. Hydrate is used to 
define solvate forms in which the solvent is water. The ability of a given compound to 
form solvate forms is related to the molecular structure and in particular to the ability of 
the  solvent  molecules  to  give  strong  and  weak  hydrogen  bonds  with  the  solute 
molecules 
[39]. As suggested by Desiraju 
[40], solvents can be incorporated into crystal 
structures to balance an eventual disproportion in the number of hydrogen bond donors 
and acceptor in the solute molecules.  
Cocrystals  are  generally  obtained  by  interaction  between  a  given  compound  and  a 
secondary  molecule  defined  as  cocrystallizing  agent  (CA).  The  field  of  crystal 
engineering  uses  these  concepts  to  design  new  solid  state  forms  with  predictable 
stoichiometry and architecture and with desired chemical and physical properties 
[41]. 
The  assembly  of  crystalline  materials  that  contains  both  an  API  and  a  biologically 
passive  component  by  cocrystallization  may  permit  an  adjustment  of  fundamental 
physical properties such as solubility,  melting point or crystal stability, maintaining 
intact the activity of the drug molecule 
[42]. The choice of a cocrystallizing agents is 
critical. In effect, the probability to have intermolecular interactions API-CA should be Chapter 1                                                                                                       Crystalline Organic Solid State 
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more favorable than the interactions between API-API and CA-CA 
[43]. CA should also 
be  biologically  and  environmentally  passive.  In  terms  of  both  directionality  and 
strength, hydrogen bonds often play a central role in cocrystal design. In general, it is 
observed that the best hydrogen bond donor tends to interact with the best hydrogen 
bond acceptor 
[10a].  
Salts  formation  is  a  widely  used  strategy  to  modify  physical  properties  such  as 
solubility,  bioavailability  and  stability  of  a  given  drug  compound.  The  protonation 
/deprotonation of a basic/acidic site of a given organic compound results in a new solid 
form  with  a  different  crystalline  structure  and,  as  consequence,  different  physical 
properties. Many drugs compounds are marketed as salts. Mineral acids such as HCl are 
often used to prepare stable salt of pharmaceutical bases. Salt formation is strongly 
dependent on the pKa differences between the acid/base pair. To form a stable salt the 
pKa difference should differ approximately by more than three units. Molecular salt is, 
currently, used to distinguish salts in which both ionic components are neutral organic 
molecules prior to proton or electron transfer to salts in which one or both components 
are simple counterions (e.g. Cl
- or Na
+) 
[44].  If the pKa difference is less than zero, the 
acid-base pair can interact without proton transfer and the resulting solid form is defined 
as a cocrystal 
[45]. However when the pKa difference is between 0 and 3, the occurrence 
of  salts  or  cocrystals  is  not  predictable.  As  suggested  by  Stahly 
[46],  for  acid-base 
complexes  in  the  range  0<  ΔpKa  <3  there  exists  a  continuum  between  the  two 
categories, in which the crystalline environment determines the location of the proton. 
From a structural point of view these two classes of compounds differ only in the proton 
location. For this reason molecular salts are often described using tools and definition 
normally applied for cocrystals. The same confusion can be extended to solvate forms 
(the  distinction  between  pyridine  solvate  forms  of  carboxylic  acids  and  pyridine-
carboxylic acid cocrystals can be ambiguous).  
A universal accordance of what actually constitutes a cocrystal (or co-crystal) is still 
unavailable and recently many authors proposed various definitions 
[25a, 47].  
Dunitz, 
[47g]  argues  that  the  term  cocrystal  (co-crystal)  should  include  molecular 
compounds, molecular complexes, solvates, inclusion compounds and other types of 
multi-component crystals or, in other words 
[47f], should be used as synonym for multi-
component crystal.   Chapter 1                                                                                                       Crystalline Organic Solid State 
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1.4. Supramolecular Synthon. 
Since  the  initial  definition  given  by  Lehn,  supramolecular  chemistry  (“a  chemistry 
beyond the molecule”) 
[48] has influenced enormously different fields of chemistry. To 
summarize,  a  supramolecule  is  a  highly  organized  system,  obtained  as  result  of 
molecular  recognition  events  within  polymolecular  systems,  held  together  by  non-
covalent interactions. In this context crystals might be considered in a supramolecular 
sense as examples of supramolecular assemblies, “supermolecule(s) par excellence” 
[49]. 
As stated by Lehn “supermolecules are to molecules and the intermolecular bond as 
molecules  are  to  atoms  and  the  covalent  bond”.  From  this  sentence  the  analogy 
between  crystal  formation  and  organic  synthesis  is  a  natural  consequence  (e.g. 
polymorphs can be regarded as supramolecular equivalents of structural isomers, phase 
transitions as molecular isomerization) 
[50].  
Intimately related to this analogy is the term crystal engineering, appeared for the first 
time in a paper written by Schmidt titled “Photodimerization in the solid state”. This 
concept was subsequently described by Desiraju, which define the crystal engineering 
as the rational design of functional molecular solids 
[51]. Going back to the analogy 
between crystals and supermolecules, crystal engineering can be considered as a proper 
synthetic discipline (in a supermolecular sense) which uses intermolecular interactions 
as main tools to design and isolate solid forms with desired properties exactly in the 
same way as synthetic chemists design and functionalizes molecules.  
However, crystals are more complex systems than molecules. As described in the next 
section, crystals are the result of a complex balance between forces, which possess 
different strength, distance dependence and directionality 
[52], and geometrical factors. A 
directed  synthetic approach  requires  a  complete control  of these  factors  in  order  to 
create predetermined 3-D architectures.  
The simplification of crystal structures into smaller units, in a so called “retrosynthetic 
process” permits the identification of particular recurrent interactions which may be 
robust enough to be predicted and used in a synthetic approach.  
In this scenario, the “supramolecular synthon philosophy” has undergone a rapid growth 
in the last years. 
The term Synthon was introduced in synthetic chemistry by Corey in 1967 to define 
“structural units within molecules which can be formed and/or assembled by known or 
conceivable  synthetic  operations” 
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recently introduced in a supramolecular sense by Desiraju 
[50]. Supramolecular synthons 
are structural units within supermolecules which can be formed and/or assembled by 
known  or  conceivable  synthetic  operations  or  conceivable  synthetic  operations 
involving intermolecular interactions”. A supramolecular synthon is “a structural unit 
which ideally expresses the kernel of a crystal structure” 
[51b].  
Figure 1.5 reports some of the most common synthons identified. 
 
Figure 1.5. Selection of representative synthons. 
 
A supramolecular synthon derives from designed combination of interactions that can 
involve one (e.g 1-3 in Figure 1.5) or more functional groups (4 or 6 in Figure 1.5).  
Supramolecular  synthons  can  be  divided  in  two  distinct  categories:  supramolecular 
homosynthons (1-3 in Figure 1.5):  composed of the same functional groups (e.g. same 
functional group behaving as hydrogen bond donor and acceptor in a self-assembly 
process to form the supramolecular motif); the supramolecular heterosynthon (4-7 in 
Figure 1.5): composed of different but complementary functional groups.  
In case of heterosynthons formed between acid and base functionalities, if the donor and 
the acceptor are strong enough and the pKa is reasonable 
[54],  a proton transfer can 
occur  forming  an  organic  salt  and  the  resulting  motifs  can  be  defined  as  “ionic 
supramolecular synthons”. These synthons are generally more robust and more easily 
predicted than those in neutral systems 
[55].  
Although the definition of synthon includes all types of molecular recognition 
[51b] (in 
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herringbone  and  alkyl···alkyl  stacking)
  [50];  those  involving  hydrogen  bonds  are  the 
most common 
[56].  
Among  the  various  functional  groups  often  involved  in  hydrogen  bonds  formation, 
carboxylic  acid  is  one  of  the  most  studied.  It  can  self-associate  generating  a 
centrosymmetric dimer or catemers (or even both in the same structure) 
[57] forming 
supramolecular homosynthons and, in presence of alternative functional groups, they 
can also form heterosynthons.  
Although the synthon is intimately related to the chemical feature of the molecules 
(functional groups), it also takes in account the resulting geometry of the object deriving 
from  the  intermolecular  interaction.  1  and  3  in  figure  5,  which  involve  different 
functionalities  and  are  defined  as  different  synthons,  adopt  an  analogous  geometry 
which can generate similar crystal packing. From this follows the concept of  “Synthon 
Interchangeability” 
[58], used to describe similarity between structures of molecules with 
widely differing functionalities. 
Supramolecular Synthon is a widely accepted concept not only because it is an elegant 
way  to  simplify  crystal  structures  into  smaller  units  but  also  because,  in  cases  of 
synthon involving strong interactions, it could be considered a sort of “trait d‟union” 
between  the  liquid  state  and  the  solid  state  during  a  crystallization  experiment.    A 
crystallization from solvent, for example, can be regarded as a process which begins 
with  solvated  molecules  which  interacts  by  molecular  recognition  events  (e.g. 
supramolecular  synthon  formation)  and  through  molecular  assembly  processes  and 
nucleation  leading  to  the  crystal  formation 
[59].  This  is  supported  by  the  fact  that 
recurrent 0-D molecular arrangements promoted by hydrogen bonds (e.g. carboxylic 
dimers) can be observed in solution prior to the nucleation process 
[60].  
 
1.5. Rationalizing Crystal Packing: Crystal Structure Analysis. 
As described in section 1.1 crystal structure assembly is a subtle compromise between 
geometrical  features  of  the  contributing  components 
[16,  61],  a  natural  tendency  to 
minimize the free, empty, volume 
[62], linked to the involvement of classical van der 
Waals forces, and the ability of particular complementary functional groups to form 
additional cohesive interactions, which can vary considerably in strength. Each of these 
factors  can  have  a  more  pronounced  influence  in  determining  the  crystal  packing 
depending on the system considered. This description is the result of the seminal work Chapter 1                                                                                                       Crystalline Organic Solid State 
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of Kitaigorodskii (which is mainly based on geometry) and Etter (which defined the 
rules on hydrogen bonding) 
[10a].  
In  his  book 
[62],    Kitaigorodskii  defines  an  isotropic  model,  in  which  the  possible 
interactions  between  molecules  are  weak  and  lacking  in  directionality  with  the 
consequence  that  the  driving  force  for  the  crystal  structure  formation  is  the  close 
packing.  Desiraju describes this principle as a natural consequence of the atom-atom 
potential  method,  in  which  the  molecules  in  a  crystal  tend  to  assume  equilibrium 
positions in order to minimize the potential energy of the system 
[51a].  
The  need  to  achieve  a  close  packed  arrangement  determines  a  maximization  of 
favourable isotropic van der Waals interactions. Kitaigorodskii also observes that some 
space groups permit close packing much more readily than others. 
Although  many  structures  deviate  from  this  model,  it  is  not  uncommon  in  organic 
crystals to observe recurrent 1-D or 2-D periodic fragments, which may or not involve 
directional  interactions.  This  behaviour  is  an  evidence  of  the  tendency  of  certain 
molecules to pack choosing particular arrangements over alternative motifs 
[63] and it 
may be an indication that there are structures in which geometrical features rather than 
specific interactions seems to be the critical determinant 
[11, 64].  
A good example is the structure of alloxan 
[11] which shows a close structural similarity 
to fluorobenzene; interestingly the two molecules have a similar shape but different 
functionalities (Figure 1.6). 
 
Figure 1.6. Isostructurality of a) alloxane, b) fluorobenzene. 
The second model is based on directional forces such as hydrogen bonding and derives 
from Etter‟s rules described in section 1.2.2. The donor and acceptor pairs interact with 
each other following a particular hierarchy based on the strength of the interaction and a 
crystal structure can be explained on this basis. However, hydrogen bond is not the only 
interaction  available  for  crystal  packing.  In  Etter‟s  model  other  intermolecular Chapter 1                                                                                                       Crystalline Organic Solid State 
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interactions  may  also  be  employed  for  “intermolecular  synthesis”  when  they  are 
sufficiently  strong  and  directional  to  give  rise  reproducible  and  recurrent  molecular 
assemblies. As observed by Burgi and Dunitz 
[65], very weak electrostatic interactions 
sometimes  give  predictable  molecular  patterns  and  van  der  Waals  interactions 
[66], 
charge-transfer interactions 
[67], and halogen-halogen 
[68] interactions can also be used.  
Since the introduction of the concept that a crystal is a “supermolecule” among the 
various non-covalent interactions involved in a crystal structure, directional forces and 
in particular hydrogen bonds have been considered as of prime importance.  
This  is  reflected,  as  described  above,  in  the  current  tendency  to  associate the term 
“supramolecular synthon” 
[50] specifically with such interactions, although the original 
intention implied a more general approach 
[51b].  
Supramolecular synthon contains both geometrical and chemical recognition concepts 
and in this regard can be considered as a good compromise between the two approaches 
described above 
[51b].  
Following  the  considerations  reported  above  it  is  clear  that  in  order  to  develop  a 
successful  strategy  to  design  new  solid  forms  by  a  crystal  engineering  approach  a 
complete understanding of crystal structure is required. It involves a retro-synthetic 
approach  able  to  identify  robust  assemblies.  However,  this  procedure  is  worthless 
without a systematic approach able to define the structural consequences deriving from 
small changes in the molecular skeleton of a given target molecule. 
This is the driving force for the study being undertaken in our Group. 
 
The Supramolecular Construct (SC) 
[69] represents an alternative approach to rationalize 
a crystal structure. This term defines any geometrically similar assemblies of molecules 
occurring  in  two  or  more  structures  and  invites  identification,  not  only  of  directed 
interactions but also of components that may reflect the influence of the more diffuse 
interactions, assemblies that are mainly the result of close packing or even directional 
interactions.  
SCs  may  have  different  dimensionalities:  0-D  (discrete  molecular  assemblies),  1-D 
(similar stacks or rows of molecules bundled differently), 2-D (similar sheets, packed 
differently and 3-D (isostructurality, isomorphism and pseudo-isostructurality) 
[70]. The 
approach, based on molecular shape which characterises SCs, permits comparison of 
structures with different functionalities such as single or multiple component systems. Chapter 1                                                                                                       Crystalline Organic Solid State 
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1.6. Aims of the Research. 
The  identification  of  recurrent  SCs  in  a  given  set  of  structures  may  represent  an 
indication  of  particular  preferences  in  the  processes  of  both  nucleation  and  crystal 
growth. A systematic search of SCs for given set of structures can be a useful approach 
aimed to gain more information on the assembly of molecules in the solid state. This 
idea  is  part  of  the  strategy  adopted  in  our  laboratory  for  the  systematic  search  of 
similarity in crystal structures. The XPac software 
[69], has been developed to enable the  
search for SCs in molecular crystals (Chapter 2, Section 2.4). 
In this vein three families of substituted salicylic acid derivatives were prepared and 
studied    in  order  to  compare  the  crystal  structures  and  determine  whether  the 
substitution and the associated changes in shape and electrostatic of the parent molecule 
introduce alternative intermolecular interactions or molecular patterns. The families of 
compounds are those in which the parent molecules are substituted with small groups 
(Cl, Br, I, Me, NO2, MeO etc.) and in different positions. The only exception is given by 
the acetylamino derivatives, which were included in the analysis in order to verify if 
they  can  compete  with  the  carboxylic  group  in  forming  particular  intermolecular 
interactions and consequently different supramolecular synthons. 
The first set of compounds is based on acetylsalicylic acid (aspirin), which recently has 
been object of growing interest following the identification of a polymorph
[36-37, 71]. This 
is discussed in Chapter 3, in which the common molecular arrangements within the 
various  substituted  derivatives  and,  consequently,  the  importance  of  particular 
functionality in defining the similarities will be described.  
The second set is based on 2-hydroxobenzoic acids derivatives (salicylic acids) and is 
described in Chapter 4. In this analysis the role of the rigid molecular conformation and 
the effect of the various substituents are discussed in detail. 
The last set of compound is described in Chapter 5. For this analysis a set of molecular 
salts  based  on  4-aminopyridine  and  2-hydroxobenzoic  acid  derivatives  is  chosen  in 
order to study the effect on the crystal packing deriving from the introduction of a 
cocrystallizing agent. 
Figure 1.7 a, b and c the three families under study are shown. Chapter 1                                                                                                       Crystalline Organic Solid State 
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Figure 1.7. Family of salicylic acid derivatives chosen for this study. 
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CHAPTER 2: GENERAL PROCEDURES. 
In this chapter the analytical techniques and the general procedures are described. 
Particular attention is given to the single crystal X-Ray diffraction technique and the 
XPac procedure.    
 
2.1. Introduction. 
As described in the previous chapter (Chapter 1, Section 1.6) the work presented in this 
thesis focusses on the structural analysis of three families of salicylic derivatives. The 
experimental  results  are  divided  into  three  separate  chapters,  each  dedicated  to  a 
particular family of compounds: acetylsalicylic acid derivatives (Chapter 3), salicylic 
acid  derivatives  (Chapter  4)  and  multiple  component  crystals  based  on  4-
aminopyridine-salicylic acid derivatives (Chapter 5). The analyses, mainly based on the 
single  crystal  X-ray  diffraction  technique,  can  be  divided  into  three  steps:  crystal 
growing (which in case of acetylsalicylic acid derivatives follows the synthesis starting 
from the salicylic acid precursors), structure determination and structural comparison. 
This last step is carried out following the XPac procedure 
[1] developed in our group. 
In the case of identification of possible polymorphic forms (see Chapter 3, Section 3.4) 
the analysis also involves solvent screening, and analytical techniques such as Fourier 
Transform Infrared Spectroscopy (FT-IR) and thermal analysis by Differential Scanning 
Calorimetry (DSC) and Hot-Stage Microscopy (HSM). 
 
This chapter reports a brief summary of the basic knowledge for the techniques applied 
in the analysis such as crystallization methods, single crystal X-ray diffraction and, also, 
a description of the XPac procedure. Furthermore, starting materials and a description of 
the instrumentation is provided. Details such as synthesis, crystallization experiments, 
thermal analysis conditions are given in each chapter in specific experimental sections.  
 
2.2. Crystallization Techniques. 
Crystallization is a very popular technique, often used as a separation and purification 
procedure in many field of both research and industry. This process also represents a 
critical step in a single crystal X-ray diffraction experiment since the quality of the 
crystal might significantly affect the resulting quality of the diffraction data.  Chapter 2                                                                                                                         General Procedures 
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Within the various method of crystallization, those from solution are the most popular. 
However, crystallizations by sublimation and from melts are useful alternative ways to 
produce crystals. Crystallization can be regarded as a phenomenon which consists of 
two critical steps: nucleation and crystal growth.  
 
Nucleation is generally defined as the starting point of the formation of a new phase in      
another
[2].    In  the  case  of  crystallization  processes,  nucleation  describes  the  initial 
formation of nanoscopic clusters of the new crystalline phase into another phase (such 
as liquid, gas and melt) which, under particular conditions, can spontaneously grow to 
form a macroscopic crystal. This is achieved under supersaturation conditions which is 
one of the most significant requirements for the crystallization process. 
A solution is defined as supersaturated when the concentration of the solute exceeds the 
saturation value. Figure 2.1 shows a typical solubility diagram.  
 
 
Figure  2.  1.  Typical  solubility  diagram  for  a  given  solute  reported  as  a  function  of  an  arbitrary 
crystallization variable. 
 
When  the  concentration  values  are  in  the  region  above  the  solubility  curve 
(supersaturated  conditions  [C]  >  [Cs]),  thermodynamics  states  that  the  system  must 
return to equilibrium by precipitating a solid phase until the equilibrium is achieved ([C] 
=  [Cs]) 
[3].  However,  a  solution  may  be  supersaturated  over  a  concentration  range 
(metastable zone) for a certain period without forming any new phase. This can be 
explained considering that the nucleation is an activated process and the free energy 
barrier depends on the size of the cluster formed 
[4]. When a number of molecules 
assemble forming a nucleus, there is a balance between the cohesion forces that hold the Chapter 2                                                                                                                         General Procedures 
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molecules  together  and  the  solvent-solute  interactions,  which  tend  to  pull  apart  the 
growth unit. For a given value of supersaturation there is a critical size of the nucleus 
below  which  the  solvent-solute  interactions  are  more  important  and  determine  the 
dissolution and above which the cohesion forces have a greater contribution and the 
nanocluster can grow spontaneously.  
This  description  derives  from  the  classical  theory  of  homogeneous  nucleation 
[5], 
described for the case of the condensation of a drop from its vapour phase and based on 
the Gibbs-Thompson expression (Equation 2.1, see also Figure 2.2).  
 
   
3
2
4
3 ln 4
r
G kT S r
v

                                                                 Equation 2.1. 
 
Where v is the molar volume occupied by a growth unit, S is the supersaturation and  
represent the surface energy. 
 
Figure 2. 2. Free energy of a  nucleus as a  function of the radius. The surface area and the  volume 
contributions of the Equation 2.1 are indicated as grey curves.   
 
 This equation, applied to the ideal case of spherical nuclei, contains two terms both 
depending on the radius of the growth  unit. The first term, which is related to the 
volume  of  the  nucleus,  takes  into  account  the  internal  cohesion  forces  which  hold 
together the molecules in the cluster; the second term, due to the surface area, is related 
to the surface forces such as solvent-solute interactions which tend to pull apart the 
growth units.  When the radius of the assembly increases, the surface area term, which Chapter 2                                                                                                                         General Procedures 
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increases with radius squared, become less important than the cubic term relative to the 
internal cohesion forces and the crystal grows spontaneously. 
Increasing the supersaturation the critical size and the activation barrier decrease and 
consequently  more  crystals  will  be  formed.  However,  for  very  high  values  of 
supersaturation the new phase can result in oils or amorphous materials 
[6].  
 
In order to grow crystal of suitable quality and size for single crystal X-ray diffraction 
analysis,  the  crystallization  procedure  must  be  developed  carefully.  Ideally  all  the 
factors which can affect the size and the quality of the crystal (e.g. mechanical stirring, 
impurities or dust in the vessel etc.) should be eliminated. In general a crystal should be 
grown  slowly,  in  order  to  avoid  phenomena  such  as  twinning  or  disorder.  The 
crystallization rate can be controlled with a correct choice of the solvent and the shape 
of the vessel. A high growth rate corresponds to less time for the molecules approaching 
the surface to the nucleus to orient themselves consistently to molecules already there. 
Impurities such as dust particles increase the number of sites of nucleation affecting the 
corresponding size of the crystals. The choice of the solvent is another crucial parameter 
which should be considered during a crystallization experiment. In general the solute 
should be moderately soluble in the solvent chosen. Depending on the crystallization 
experiment design the volatility of the solvent must also be considered carefully. As 
described above, the supersaturation plays a key role for a successful experiment and 
can  be  achieved  following  different  routes  corresponding  to  different  crystallization 
techniques. Figure 2.3 shows three main cases used in this thesis work.  
 
 
Figure  2.  3.  Typical  solubility  diagrams  describing  three  different  crystallization  experiments:  a) 
crystallization by slow evaporation, b) crystallization by slow cooling, c) Crystallization by using mixed 
solvent (drop-wise mixing of an anti-solvent, solvent diffusion, vapour diffusion).   
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Crystallization by Slow Evaporation. 
This is the most common and intuitive procedure to grow crystals (Figure 2.3 a). It 
consists of the preparation of a saturated or nearly saturated solution and allowing the 
solvent to evaporate. In order to control the crystallization rate, a moderately volatile 
solvent  can  be  used.  Alternatively  the  vial  can  be  covered  by  parafilm  in  which  a 
desired number of holes are made. 
 
Crystallization by Slow Cooling. 
This method is carried out by preparing a saturated solution at one temperature and 
allows  the  solution  to  cool  down  slowly  (Figure  2.3  b).  In  order  to  control  the 
crystallization rate a water bath in an isolated vessel (e.g. a dewar) can be used. To 
avoid the evaporation of the solvent the system must be closed by covering the vessel 
with a cap or parafilm.  
 
Crystallization by Mixture of Solvents. 
This  method  involves  two  solvents,  one  in  which  the  solute  is  moderately  soluble 
(solvent 1) and the second, defined as anti-solvent, in which the solute is insoluble 
(solvent 2). The substance is dissolved in solvent 1 and the anti-solvent is slowly added 
drop-wise in order to decrease the solubility of the solute (Figure 3.2 c).  
Strictly related to this method is the so called crystallization by solvent diffusion. This 
procedure  is  based  on  the  fact  that  solvent  with  different  densities  mix  slowly  in 
absence of any mechanical stirring. Similarly to the previous case the solute is dissolved 
in the solvent 1 and a layer of the anti-solvent is added using a syringe fitted with a fine 
needle. This creates an interface between the two solvents in which the crystals grow. 
An alternative method is the so called crystallization by vapour diffusion (also defined 
as isothermal distillation) which consists of a diffusion of vapours of the anti-solvent 
(which must be moderately volatile) into the solution with the solvent 1.  
The  mixed  solvents  method  can  also  be  used  in  conjunction  with  the  method 
represented in  Figure 2.3 a. After the solvent 1 and the anti-solvent are mixed, the 
system  can  be  allowed  to  evaporate  the  solvent  1  (which  should  also  be  the  most 
volatile). Referring to the diagram reported above, this case can be described imagining 
the arrow oriented along the diagonal of the two axes in Figure 2.3 c. 
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2.3. Structure Determination. 
Crystal Structure. 
The description of crystal structure given so far (in particular see section 1.5), was 
mainly based on concepts such as geometrical features and intermolecular interactions. 
However,  in  order  to  develop  the  basic  concepts  of  crystallographic  structure,  a 
description based on symmetry must be given.  
A  crystal  structure  can  be  defined  as  an  ordered  arrangement  of  atoms,  ions  or 
molecules, repeated in all directions. This arrangement may comprise one, but usually 
more, chemical units (hereafter described as molecules, for convenience). In the case of 
such clusters of molecules, these are usually related by point symmetry elements such 
as  rotation,  reflection  and  inversion,  plus  relationships  which  contain  elements  of 
translation. Translation symmetry is a necessary requisite to generate a crystal structure 
and a convenient description of a crystal structure can be than made considering a 
representative  repeat  structural  unit,  which  may  contain  a  number  of  molecules  in 
different,  symmetry  related,  orientations,  and  defining  how  this  composite  unit  is 
repeated  in  the  three  dimensions  by  translation  symmetry.  This  can  be  made  by 
considering the molecules in the repeated structural unit, selecting one molecule and its 
exact equivalent in all repeating units, and representing each molecule by an identical 
point (e.g. choosing one atom in each molecule). The translations of this point in the 
three non-coplanar directions result in an infinite three dimensional array of points. This 
collection  of  regular  and  infinite  points,  equivalent  to  each  other  by  translation 
symmetry, is defined as a lattice. The lattice is independent to the choice of the point, 
choosing different points within the same representative molecule results in the same 
lattice. If an arbitrary lattice point is defined as the origin, the translation from any 
lattice point to another can be defined by a vector t such that:  
 
u v w    t a b c                                                                                               Equation 2.2 
 
where a, b and c are the three unit vectors, connecting the origin with the three nearest, 
non-coplanar lattice points, and  u, v and w  are integers. Considering the length a, b 
and c of these vectors and the angle formed by each pair of them, ,  and  (where  is 
the angle between b and c,  the angle between a and c and  the angle between a and b) 
a parallelepiped defined by eight lattice points can be drawn (Figure 2.4). This is called Chapter 2                                                                                                                         General Procedures 
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the  unit  cell  and  represents  the  smallest  group  of  molecules,  or  other  chemical 
components, which has the overall symmetry of a crystal structure. The three lengths 
and the three angles represent the unit cell parameters. Each of the lattice points at the 
corners of the unit cell is shared with other eight unit cells for a total of one lattice point 
per unit cell. This is by convention defined as the primitive cell (P). For a given lattice 
different unit cells can be defined simply choosing different vector lengths and different 
angles. However there are some conventions which rule this choice. In general,  the 
conventional cell should have lengths that are as short as possible and angles close to 
90. 
 
 
Figure 2. 4. Unit cell and unit cell parameters. 
 
As described above, the unit cell should be the smallest representative repeat unit and 
some crystal structures might also contain other symmetry elements such as rotation, 
reflection which impose constraints on the shape of the representative unit cell. As 
consequence of these restrictions, seven types of unit cell, identifying the seven crystal 
systems can be defined. These are listed in Table 2.1. Note that the shape of trigonal and 
hexagonal  unit  cells  are  actually  identical,  with  a  rhombus  base,  but  they  generate 
fundamentally different crystal structure types as a result of the different symmetry. The 
angle for the hexagonal case is given as 60
o to emphasise this point. 
 
Crystal System  Unit Cell Restrictions  Essential Symmetry 
Triclinic  -  - 
Monoclinic   =  = 90  One 2-fold axis and/or mirror plane 
Orthorhombic   =  =  = 90  Three 2-fold axes and/or mirror planes 
Tetragonal   =  =  = 90, a = b  One 4-fold axis 
Trigonal   =  = 90,  = 120, a = b  One 3-fold axis 
Hexagonal   =  = 90,  = 60, a = b  One 6-fold axis 
Cubic   =  =  = 90, a = b = c  Four 3-fold axes 
Table 2. 1. The seven crystal systems with their cell parameters and constraints. Chapter 2                                                                                                                         General Procedures 
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In presence of some symmetry elements it is more convenient to increases the unit cell 
size to include more than one lattice point, in order to fully represent the full symmetry 
in the structure. This choice results in so called centred cells.  
There are six different types of centred cells depending on the position of the lattice 
points. These can be located on the centre of opposite faces of the parallelepiped (type 
A, B or C consistent with which faces are centred), or at the body centre (type I), for a 
total of two lattice points; further types contain the lattice on the centre of all faces (type 
F) for a total of four lattice points or the special case of the trigonal rhombohedral 
centred unit cells (type R) which contain three lattice points. 
The combination of the seven crystal systems with all the possible types of cell centring 
described above (P, A, B, C, I, F, R) allows fourteen unique crystal lattices (since the 
trigonal primitive and hexagonal are geometrically equivalent), which are defined as 
Bravais lattices. These are shown in Figure 2.5. The primitive trigonal lattice is included 
in this figure to highlight the fact that real structures can form with such a lattice. 
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A  single  molecule  can  show  a  degree  of  symmetry  such  that  if  a  given  symmetry 
operation  (inversion,  rotation  or  reflection)  is  applied  through  a  symmetry  element 
(point, line or plane), its appearance remains identical. The symmetry elements for a 
single molecule must pass through a common point and the collection of all symmetry 
operations constitute a group called point group. All the symmetry operations can be 
divided  in  two  categories  (Schoenflies  convention)  defined  respectively  as  proper 
rotations (for example any rotation of a certain fraction of 360) and improper rotations 
(the combination of a rotation and the reflection in a perpendicular plane through a point 
at the centre of the molecule). Crystallographers define improper rotation as a rotation 
followed  by  an  inversion  through  a  point  at  the  centre  of  the  molecule  (Hermann-
Maugin convention). This difference relates to the importance of the centre of inversion 
in crystallographic symmetry. Table 2.2 lists the symbols used in the two conventions 
for symmetry elements and operations relevant to crystallography. 
 
  Proper Rotations    Improper Rotations 
Hermann-Maugin  1  2  3  4  6         (or m)          
Schoenflies  C1 (or E)  C2  C3  C4  C6    C2 (= i)  S1 (= )  S6  S4  S3 
 Table  2.  2.  Symmetry  elements  and  operation  notations  in  the  Hermann-Maugin  and  Schoenflies 
conventions. 
As mentioned above the translation symmetry is a necessary requisite to generate a 
crystal.  For a molecule in a crystal not all types of symmetry are permitted. In fact the 
combination  of  the  symmetry  elements  for  a  single  molecule  with  the  translation 
symmetry  generates  some  restrictions  due  to  the  incompatibility  of  some  order  of 
rotation with the repeat nature of the lattice. The only orders possible are those reported 
in table 2.2. However the combination of the symmetry operations discussed so far with 
the translation generates other types of symmetry operations which can be divided in 
two types defined respectively screw axes (proper rotations followed by translation by a 
fraction of the unit cell vector) and glide planes (reflections followed by translation by a 
fraction of the unit cell vector). These symmetry operations are such that, similarly to 
the  case  of  a  single  molecule  (in  which  repeated  operations  leaves  its  appearance 
identical), a repeated application of the operation places the molecule in an equivalent 
position in the next unit cell along the translation vector. The possible types of screw 
axes and glide planes and the conventional symbols used to classify these symmetry 
operations are reported in Table 2.3. 
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Screw Axes  Glide Planes 
Order  Notation  Translation vector  Notation 
2-fold  21  Parallel to the cell axis  a b c 
3-fold  31 32  Parallel to diagonals  n 
4-fold  41 42 43  Between corner and centred lattice 
points 
d 
6-fold  61 62 63 64 65 
Table 2. 3. Possible types of screw axes and glide planes. 
Similarly  to  the  case  of  a  single  molecule,  in  which  the  symmetry  operations  are 
combined in a point group, in the case of a crystal the symmetry elements are arranged 
in space and constitute a group defined as space group. Each space group defines a 
particular  combination  of  point  and  space  symmetry  elements  compatible  with  the 
geometrical requirement of the lattice. There are 230 possible combinations and these 
are listed in the International Table for Crystallography 
[7]. 
 
Single Crystal X-ray Diffraction. 
X-rays,  discovered  in  1895  by  Wilhelm  Röntgen 
[8],  are  a  form  of  electromagnetic 
radiation with a wavelength (in the range 0.1-100Å) lying between the ultra violet and 
the gamma ray wavelengths in the electromagnetic spectrum. X-rays can be generated 
by  bombarding  a  metal  target,  such  as  molybdenum  or  copper,  with  a  beam  of 
accelerated electrons. The electrons are produced by a tungsten filament (cathode) and 
accelerated  toward  the  metal  target  (anode).  The  resulting  collision  of  the  photo-
electrons and the target produces the emission of a continuous range of wavelengths 
known as Bremsstrahlung. The process also causes the emission of the characteristic 
radiation which consists of X-ray photons with specific wavelengths dependent on the 
metal target. The desired wavelength can be selected by passing the radiation through a 
monochromator  such  as  a  graphite  crystal.  In  recent  years,  X-rays  generated  at  a 
synchrotron source have also been used for diffraction experiments to very good effect. 
 
Due the order of magnitude of their wavelengths, which is comparable to the inter-
atomic distances in crystals, X-rays can be diffracted by crystals. This was recognised 
by Max von Laue in 1912 who derived three equations to describe the conditions for 
constructive interference of X-rays diffracted by crystals. 
Following von Laue‟s work, in 1913 W. H and W. L Bragg developed an easier model 
to describe  the diffraction of X-rays by crystals 
[9]. W. H. Bragg and his son showed 
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a semi-transparent mirror (Figure 2.6) in which the angle formed between the incident 
X-ray beam and the reflected beam have the same value .  
 
Figure 2. 6. Derivation of Bragg‟s Law. 
The Bragg equation (Equation 2.3) describes the conditions for constructive interference 
to occur between lattice planes.  
 
2 sin hkl nd                                                                                                 Equation 2.3. 
 
Where n is an integer,  the X-ray wavelength, dhkl the lattice plane spacing,   the 
Bragg‟s angle.  
The equation can be simplified setting the value of n to one (Equation 2.4) because 
reflections of the n
th order from a set of planes dhkl are geometrically equivalent to 
reflections with n = 1 from planes nh, nk, nl with spacing dhkl/n. 
 
2 sin hkl d                                                                                                   Equation 2.4. 
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Structure Factors and Phase Problem. 
The scattering of X-rays by a crystal structure is due to the electron clouds of each atom 
and increases as the number of the electrons or, in general, the atomic number increases. 
For this reason X-ray are not very sensitive to atoms such as hydrogen. The individual 
contribution of the atoms to X-ray scattering is defined as atomic scattering factor (f) 
and depends on the electron density distribution of the atom and on the Bragg‟s angle 
(). When  = 0, all the electrons in an atom scatter in phase and the atomic scattering 
factor corresponds to the atomic number of the atom. For greater scattering angles, f 
decreases since the scattered waves from different regions of the electron cloud become 
out of phase with each other. In the case of the diffraction from a crystal, the scattering 
of all the atoms must be taken into account. Similarly to the case of a single atom, the 
scattering of a group of atoms for a reflection h, k, l is defined by the structure factor 
Fhkl and is a complex number with amplitude an phase: 
 
  1 exp 2 )
N
hkl j j j j j F f i hx ky lz 
                                                             Equation 2.5. 
 
where fj is the atomic scattering factor for the j
th atom in the unit cell, with fractional 
coordinates xj, yj and zj. In other words the diffraction pattern is the Fourier transform of 
the crystal structure in which each reflection is a wave resulting from the sum of the 
waves scattered by each atom depending on its electron density distribution.  
In a similar way the crystal structure (considered as the electron density distribution of 
the unit cell) is the Fourier transform of the diffraction pattern and can, in principle, be 
calculated as follow:  
 
   
1
exp 2 hkl j j j hkl xyz F i hx ky lz
v
                                                      Equation 2.6. 
 
where (xyz) is the electron density at any point with coordinates x, y, z and V is the unit 
cell volume. 
However,  since  the  structure  factors  F(hkl)  reported  in  Equation  2.6  are  complex 
numbers, with an amplitude and a phase and only their magnitude is available, the 
crystal  structure    cannot  be  directly  solved  unless  the  lost  phase  information  is 
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is known as the phase problem. The Equation 2.6 can be rearranged in order to isolate 
the phase angle from the electron density (Equation 2.7).  
 
   
1
exp 2 ( ) hkl j j j hkl xyz F i hx ky lz hkl
v
                                      Equation 2.7. 
 
Two main techniques are used for this called respectively direct method and Patterson 
synthesis. 
The direct method, mainly used for structures containing atoms of approximately equal 
atomic  number  (such  as  C,  N,  O),  use  mathematical  relationships  to  estimate  the 
structure factor phases directly from the observed intensities in the diffraction pattern.  
The  Patterson  method  is  generally  used  for  structures  with  few  heavy  atoms  such  as 
organo-metallic compounds.  
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Refinements. 
This is an iterative process aimed to improve the model generated from the structure 
solution. During the refinement process the parameter of the model are systematically 
varied in order to obtain the best least square fit between the observed |F(hkl)| values  
(|Fo|)  and  the  calculated  (|Fc|).  Each  atom  is  initially  refined  considering  its  three 
positional coordinates x, y, z and a displacement parameter U. This last parameter is 
relative to the isotropic displacement due to the thermal vibrations. In the final step of 
the refinement process, U is modelled with six parameters and the thermal vibrations of 
the  atoms  are  considered  to  vary  by  different  amounts  depending  on  the  different 
directions. This is the anisotropic vibration and the atoms are considered as ellipsoids. 
This last step generally determines a consistent improvement on the fitting between |Fo| 
and |Fc|. The quality of the refinement can measured using the residual factor (R-factor) 
which is a measure of the difference between the calculated pattern and the observed 
one. This can be defined as follow: 
 
Fo Fc
R
Fc



                                                                                          Equation 2.8. 
 
During the refinement the R-factor should decrease to values between 0.02-0.10 (in case 
of good quality data). 
 
Experimental Procedure. 
Single  crystal  diffraction  data  is  nowadays  recorded  using  a  diffractometer.  This 
instrument comprises a goniometer for moving the crystal in many orientations so that 
all possible Bragg “reflections” may be recorded by a photon capture device. Modern 
instruments  now  use  area  detectors  which  have  a  CCD  detector  situated  behind  a 
fluorescent screen. The orientation of the goniometer and the capture of all reflections 
are controlled by a computer, with relevant software modules. For the work reported in 
this thesis, the intensity data were recorded on a Nonius KappaCCD diffractometer 
situated at the window of  a Bruker Nonius FR591 rotating anode generator equipped 
with  a  molybdenum  target  (λ  Mo-kʱ  =  0.71073Å)  and  driven  by  COLLECT
[10], 
DirAx
[11] and DENZO software
[12]. Structures were determined using the direct methods 
procedure  in  SHELXS  97  and  refined  by  full-matrix  least  squares  on  F
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40 
 
SHELXL97
[13] Data were corrected for absorption effects by means of comparison of 
equivalent  reflections  using  the  program  SADABS
[14].    Non-hydrogen  atoms  were 
refined anisotropically, whilst non-carboxylate hydrogen atoms, although located easily 
in difference maps, were fixed in idealised positions with their displacement parameters 
riding on the values of their parent atoms (1.2 Uij). In most cases carboxylate, hydroxo 
and amine hydrogens which were also located in difference maps, were included in the 
refinement with isotropic Uiso values depending on the quality of the data. 
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2.4. XPac Procedure. 
The  XPac  procedure  enables  the  structural  systematic  comparison  of  families  of 
compounds deriving from a common target molecule. The analysis is carried out by 
using the XPac algorithm developed by Dr T. Gelbrich 
[1]. The software identifies any 
geometrically similar assemblies of molecules occurring in two or more structures. The 
recurrent  arrangement,  as  described  in  Chapter  1,  is  defined  as  Supramolecular 
Construct  (SC)  and  may  have  different  dimensionalities:  0-D  (discrete  molecular 
assemblies), 1-D (similar stacks or rows of molecules), 2-D (similar sheets, packed 
differently)  and  3-D  (isostructurality,  isomorphism  and  pseudo-isostructurality).  
Differently  to  the  concept  of  the  supramolecular  synthon 
[15],  which  focuses  on 
intermolecular interactions (directional or non-directional), the SC is a pure geometrical 
arrangement and does not identify any form of connectivity, such as H-bonding or other 
commonly defined form of directed intermolecular interactions. If present, these are 
identified when the results of the calculation are analysed in detail. In this regard the SC 
encompasses the approach originally proposed by Desiraju. 
 
The  identification  of  the  SCs  is  based  on  the  comparison  of  non-conventional 
crystallographic  descriptors.  Each  molecule  in  a  crystal  structure  is  considered  as 
surrounded by closest neighbour molecules to form a cluster. The central molecule is 
the kernel and the surrounding group of molecules is the shell. This model is then 
independent  of  crystal  structure  descriptors  such  as  space  groups  (symmetry 
operations),  unit  cell  parameters  and  atomic  coordinates.  Each  kernel  molecule  is 
typically surrounded by a shell of 14 molecules.  
In  order  to  directly  compare  crystal  structures  of  different  compounds,  the  basic 
geometrical  features  of  any  molecule  must  be  parameterised  by  selecting  a 
representative set of corresponding atoms defined as the corresponding ordered set of 
points (COSP). The consistency or similarity of the COSP from two or more structures 
is given by comparing sufficiently large lists of internal coordinates (distances, angles, 
torsion angle). If N single pairs of corresponding entries xi and xi‟ in two such lists, then 
the mean value  of all N absolute differences | xi - xi‟| is an indicator for the consistency 
of the COSP: 
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1
1 n
ii i xx
N

                                                                                             Equation 2.9. 
 
For  each  structure  the  software  generates  the  coordination  sphere  around  the  kernel 
from the symmetry operations of the space group of each structure.  The kernel is paired 
with  each  of  the  14  molecules  (COSPs)  in  the  shell  leading  to  14  sets  of  parameters 
based on angular, planar and distance relationships. Each of these sets of parameters is 
compared with each of the 14 sets deriving from the other structure (or structures) under 
study. Any matches (within the defined tolerances) of these sets correspond to matches 
in  the  position  of  the  molecules  in  the  cluster  for  each  of  the  structures  under  study. 
Depending on the number of matches the dimension of the similarity can be derived.  
 
Table  2.4  shows  the  dimensionalities  of  the  various  SCs  related  to  the  number  of 
matches.  
 
Number of Matches  Dimensionality  Type of SC 
0  -  - 
1-2  0-D  Discrete assembly (e.g.dimer) 
3-5  1-D  Infinite chain or row of molecules 
6-13  2-D  Layer of molecules 
14  3-D  Isostructurality 
Table 2. 4. Number of  matches/dimensionality  relationships. The type of Supramolecular Constructs 
(SCs) are also reported 
A tolerance criteria consisting of filter parameters can be defined. The filter parameters 
differ depending on the version of the software. XPac1 set limits for intermolecular 
angles (ang), dihedrals (dhd)  and torsion angles (tor)  (all in degrees).  XPac2 use a 
different set of filters which set the limits for angular deviation (a), interplanar angular 
deviation (p) (both in degrees) and corresponding molecular centroid distance deviation 
(d)  (Angstroms).  By  default  there  are  three  different  sets  of  filter  parameters  (low, 
medium and high) but if needed they can be adjusted to more appropriate values.  
For each similarity identified a quantitative dissimilarity index X  is provided 
[16]. This is 
expressed as follow: 
 
 
1
2 22
,, 1
M
a i p i i X 
                                                                                    Equation 2.10. 
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where δa and δp are the mean differences between the comprehensive sets of angles and 
interplanar angles, respectively, between a chosen group of atoms in the core molecule 
and the corresponding atoms in one shell molecule. 
The results are generally represented in a relationship diagram based on Hasse Diagram 
which is a form of “family tree”, in which the SC‟s are ordered in rows vertically in 
terms of dimensionality, and relationships are then indicated by connecting lines. 
Whilst  there  is  some  degree  of  flexibility  in  creating  this  diagram,  the  convention 
generally adopted in our group is to attempt to order the structures at the head of the 
diagram so that the lines indicating the relationships have the least possible crossings. 
 
The experimental procedures adopted for the three families of substituted salicylic acid 
derivatives are described in each chapter in a section dedicated to the XPac analysis. In 
these  sections  the  choice  of  the  COSP  and  the  notation  chosen  to  describe  the 
relationship diagram are also reported. 
 
2.5. Thermal Analysis. 
Differential Scanning Calorimetry (DSC). 
Differential Scanning Calorimetry (DSC) is a useful technique which has a wide range 
of applications. It measures thermodynamic properties such as melting point, boiling 
point,  sublimation  temperature,  glass  transition  temperature,  decomposition 
temperature
[17].  Furthermore  it  is  a  valuable  tool  for  polymorphism  characterization 
often used to determine phase transitions and kinetics of polymorphs. DSC measures the 
amount of energy absorbed or released by a sample under heating, cooling or held at a 
constant temperature in a controlled atmosphere.  
The DSC data are typically expressed as a curve of heat flux versus temperature or 
versus time (Figure 2.7).  
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Figure 2. 7. Typical DSC curve. The extrapolated onset temperature and the peak melting temperature 
are also shown. 
As shown in Figure 2.7, the melting point can be taken from different points of the 
curve: the temperature at which deviation from the base line begin (Tb), the extrapolated 
onset temperature (Tm) the peak temperature (Tp) and the temperature at which the trace 
returns to the base line (Te)
[18]. The extrapolated onset temperature is generally preferred 
since it is not affected by the heating rate. However in case of peak broadening (due to 
impurities) the peak temperature (Tp) should be chosen
[19]. 
The sample is generally prepared by placing approximately 2-5 mg of substance in a 
sample pan. For this thesis work Al pans hermetically sealed were used (see section 
3.2).  
The  analysis  can  be  performed  at  different  heating  rates.  High  heating  rates  (e.g. 
20C/min) result in increasing of the width of the melting peak and so affect resolution 
(for  example  the  ability  to  discriminate  between  thermal  events  close  together). 
However it also results in a decrease of experimental times. Low heating rates (e.g. 3-
5C/min) result in a better resolution but the experimental time is significantly high. A 
heating  rate  about  10C/min  is  generally  a  reasonable  compromise  in  term  of 
resolution/experimental time for most DSC investigations.  
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Hot-Stage Microscopy (HSM). 
Intimately related to the previous technique is the Hot-Stage Microscopy (HSM). This 
technique allows the observation of melting points and in particular phase transitions, 
since these are frequently accompanied by reorganizations of the structure visible as 
changes in optical properties. Furthermore it can be used to analyze cocrystals and in 
general multiple component systems
[20] and solvate forms.  
The HSM is one of the oldest techniques for phase transition analysis. The first example 
of thermo-analysis using an hot-stage equipped with a microscope was performed by 
Otto Lehmann more than a century ago
[21]. Afterwards Kofler developed a simple and 
successful hot-stage which still is used in many laboratories.  
The procedure is quite simple and mainly consists of placing the sample on a suitable 
slide which is afterwards covered with  a cover slip. The analysis is carried out by 
increasing the temperature of the system and observing the eventual phase transitions 
and melting processes by means the microscope.  
The  HSM  also  allows  the  observation  of  desolvation  processes  which  normally 
determine a darkening of the surface of the crystals (pseudomorphosis). Alternatively 
solvate forms can be detected by adding during the sample preparation some silicon oil. 
The desolvation process then determines vigorous bubbles formation in the oil. 
As mentioned above the HSM can also used to investigate two component systems by 
applying the contact preparation method.  
The contact preparation method was first described by Lehmann
[22]. This technique is a 
useful and effective tool to investigate two-component systems. The main advantage is 
the small amount of substance needed, usually less than 5 mg.  
In the contact preparation method, two small portions of different component A and B 
are sequentially melted and recrystallized on a microscope slide so that a zone of mixing 
is created (Figure 2.8).  
 
 
Figure 2. 8. Contact preparation method. Preparation of the two-component slide. 
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By slow heating of that preparation under crossed polar filters on a light microscope, 
two main behaviours can be observed.  
The two components form a eutectic. Under heating process the contact surface melts at 
lower temperature than the two components. When a single eutectic melt is observed, it 
indicates that A and B do not interact to form a molecular compound. 
 
The two components form a molecular compound. Under heating process two eutectics 
are observed and the molecular compound (salt or cocrystal) resides between them. The 
observance of two melting zones separated by solid indicates that a cocrystal or a salt of 
A and B have formed. 
 
Figure 2. 9. a) Eutectic. b) Molecular compound (cocrystal, salt). 
 
Details of the thermal analysis (DSC and HSM) carried out in this thesis work are 
described in Chapter 3 (section 3.2). 
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2.6. Fourier Transform Infrared (FT-IR) Spectroscopy. 
Fourier  Transform  Infrared  (FT-IR)  Spectroscopy  is  a  useful  technique  for  both 
quantitative and qualitative analysis which provides information about the vibrational 
states of a molecule.  It is often used as complementary technique with thermal analysis 
in characterization of polymorphs since it allows the identification of functional groups, 
hydrogen bonding and conformations.  
When a sample is irradiated with infrared radiation the vibrational and rotational status 
of the molecules change and the frequency of the radiation adsorbed is characteristic of 
the particular molecular structure. The energies associated with the vibrational modes of 
organic solids lie in the mid-infrared region (400-5000 cm
-1). 
 
2.7. Materials. 
Salicylic acid derivatives (range of purity 96-99%) and 4-aminopyridine (98 % purity) 
where mainly purchased from Acros. 6-F, 6-MeO, 4-F and 3-NO2 were purchased from 
Aldrich.  
Aspirin  derivatives  were  synthesized  in  our  laboratory  starting  from  the  salicylic 
derivative precursor and acetic anhydride and purified directly by crystallization (for the 
procedure and crystallization methods see Chapter 3, Section 3.2). 
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CHAPTER 3: SUBSTITUTED ACETYLSALICYLIC ACID DERIVATIVES. 
In this chapter the crystal structures of aspirin derivatives and their comparison with 
XPac are described and discussed. A further section is focused on the polymorphism of 
5-chloro aspirin. 
 
3.1. The Family of Substituted Aspirins. 
o-Acetylsalicylic acid, also known as aspirin, has been a world bestselling drug since it 
was first synthesized in 1853 
[1]. In 1964 Wheatley provided the first crystal structure 
determination of this compound 
[2]. Although until recently it was known in only one 
polymorphic form, studies on the polymorphism of this simple analgesic molecule were 
known since 1960s 
[3]. Only in 2005, following on from the projection of its possible 
existence  via  predictive  work 
[4],  a  second  polymorph  of  aspirin  was  accidentally 
isolated by Zaworotko and coworkers 
[5]  during cocrystallizations with levetiracetam 
and acetamide, The two structures show identical layers containing carboxylic dimers, 
which arrange differently (Figure 3.1) through acetyl···acetyl interactions (arrangement 
A: centrosymmetric C-H···O dimers for form I and arrangement B: C-H···O catemers 
for form II).  
 
Figure 3. 1. Different arrangements found in the two polymorphs of aspirin: a) acetyl dimer, b) acetyl 
catemer. 
However, as highlighted by Bond et al. in a paper entitled “On the polymorphism of 
Aspirin” 
[6],  the  structure  as  then  determined  clearly  showed  problems  with  the 
refinement. Furthermore, the very close metric similarity between the unit cells of the 
two forms, induced these authors to prompt the question whether the new polymorph 
“might be an experimental artefact originating from erroneous handling of diffraction 
data collected from a form I crystal” 
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paper by Bond et al. 
[7] which describes form II as an unusual intergrowth structure in 
which both arrangements A and B are present within the same crystal, with a variable 
distribution and ratio. As suggested by these authors 
[7] and thereafter by Desiraju 
[8] this 
also  has  consequences  on  the  definition  of  polymorphism,  and  raises  the  question 
concerning how many polymorphs of aspirin exist. This year Bond et al. isolated the 
pure form II by a crystallization of aspirin in various solvents in presence of aspirin 
anhydride 
[9]. 
Following the considerations reported above, was decided to develop a family of some 
substituted aspirin derivatives 
[10]  and apply the systematic approach developed in our 
laboratory 
[11] in order to see how robust are the packing features in the two phases of 
the parent molecule, which have 2D similarity. Of particular interest were the two types 
of  weaker  acyl···acyl  interactions  which  play  an  important  role  in  determining  the 
differences of the two polymorphs, and whether the additional substituent groups, and 
the associated changes in shape and electrostatics in the aspirin derivatives chosen, 
would introduce additional or alternative intermolecular interactions and /or packing 
patterns. 
The type of compounds chosen for this study are those in which the parent molecule is 
substituted in the phenyl ring by small groups (Cl, Br, I, Me, MeO, etc), and in different 
positions. 
The CSD database showed three main entries corresponding to the desired compound 
type,  the  3-methyl  (ACMEBZ) 
[12]  ,  the  6-methyl  (BEHWOA) 
[13]  and  the  4-
trifluoromethyl (HIRCOB) 
[14]. 
New members of the target compound family, obtained by acylation of pre-substituted 
salicylic acid derivatives as described in the next section, are summarised in Figure 3.1. 
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In  this  chapter  are  thus  reported  the  new  crystal  structures  of  4-methylaspirin  (4-
MeAsp), 5-methylaspirin (5-MeAsp), 5-fluoroaspirin (5-FAsp), polymorphs I and II of 
5-chloroaspirin  (5-ClAsp (I) and 5ClAsp (II)), 5-bromoaspirin (5-BrAsp), 5-iodoaspirin 
(5-IAsp), 5-nitroaspirin (5-NO2Asp), 5-methoxyaspirin (5-MeOAsp), 4-methoxyaspirin 
(4-MeOAsp), 3-methoxyaspirin (3-MeOAsp), 4-fluoroaspirin (4-FAsp), 6-fluoroaspirin 
(6-FAsp). The new structures are compared with the previously reported 3-methyl  and 
6-methyl aspirins (3-MeAsp and 6-MeAsp) 
[12-13], the 4-CF3Asp 
[13]and with the two 
forms of the parent aspirin aspirin I (Asp1 CSD code ACSALA14) 
[6] and aspirin II 
(Asp2  CSD code ACSALA15) 
[7]. Two slightly different derivatives are also described 
5-acetamidoaspirin (5-ACMAsp), and 3-acetamido (3-ACMAsp) aspirin, obtained by 
acylation of the corresponding aminosalicylic acids.  
A  further  section  is  focussed  on  the  polymorphism  of  5-chloroaspirin 
[10a]  which 
currently comprises two anhydrous forms (5-ClAsp I and II where I denotes the highest 
melting form), with a complete characterization by several techniques such as FT-IR, 
Hot-Stage Microscopy, Differential Scanning Calorimetry (DSC) and contains a brief 
discussion of the crystal packing features. 
 
3.2. Experimental. 
Synthesis and Crystallization of Functionalized 2-acetylsalicylic acids. 
The functionalized salicylic acid (10.8 mmol) was mixed with acetic anhydride (2 mL, 
21 mmol) and 1 drop of 85% phosphoric acid solution. The mixture was stirred under 
reflux for 2 hours at 80° C whereupon water (2 mL) was added. The reaction continued 
for 5 minutes and the mixture was cooled with an ice water bath. The precipitate formed 
was filtered off and washed with water. 
Colourless  single  crystals  suitable  for  X-ray  study  were  variously  grown  by  slow 
evaporation from several solvents Table 3.1. 
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  Solvent  Crystal Habit 
4-F  H2O / MeOH  Block 
5-F  H2O / MeOH  Plate 
6-F  From Synthesis*  Block 
5-Cl (I)  H2O / CH3CN  Lath 
5-Cl (II)  2-propanol  Needle 
5-Br  CH3CN  Needle 
5-I  H2O / CH3CN  Needle 
5-NO2  H2O / CH3CN  Rod 
4-Me  H2O / CH3CN  Prism 
5-Me  CH3CN  Plate 
3-MeO  MeOH  Slab 
4-MeO  From Synthesis*  Plate 
5-MeO  MeOH  Lath 
3-ACM  MeOH  Needle 
5-ACM  MeOH  Block 
Table  3.  1.  Summary  of  the  solvents  used  for  crystallizations,  crystal  habits  for  the  aspirin  (ASP) 
derivatives analyzed. (* The solvent deriving from the synthesis is an aqueous solution of acetic acid). 
 
For simplicity, in the remainder of this Chapter, the derivatives of aspirin are labelled 
omitting  the  extension  Asp  and  are  referred  to  using  only  the  abbreviation  of  the 
substituent group (e.g. 5-Cl, 5-Me, 4-CF3 etc.). 
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Thermal Analysis. 
DSC measurements on the two polymorphs of the 5-Cl derivative (5-Cl (I) and 5-Cl 
(II))  were  performed  on  a  Mettler  Toledo  DSC821e  low  temperature  differential 
scanning calorimeter fitted with a 34 place autosampler. The instrument was calibrated 
for temperature accuracy using an indium standard. Approximately 1-5 mg of sample 
was encapsulated in Al-Pans which were hermetically sealed.  
Thermomicroscopic  investigations  were  carried  out  on  a  Mettler  Toledo  FP90  and 
FP82HT Hot Stage Microscope. 
 
Fourier Transform Infrared (FT-IR)Spectroscopy. 
FT-IR spectra were recorded with a Nicolet FT-IR Golden Gate Spectrometer (4000-
400 cm
-1)
 , at an instrument resolution of 4 cm
-1, 32 scans per spectrum).  
 
Crystal Structure Determination. 
A summary of the basic crystal data are given in Table 3.2, in which we have also 
included information on the five previously reported derivatives and the aspirin forms, 
for completeness. Full X-rays experimental data are provided as detailed cif files in the 
Appendix CD. 
  SG  a /Ǻ  b /Ǻ  c /Ǻ  ʱ / º  β / º  γ / º  V /Ǻ
3 
4-F  P21/n  4.90840(10)  10.0101(5)  17.4781(9)  90.00  96.917(3)  90.00  852.51(6) 
5-F  P21/n  9.7655(5)  4.8919(2)  18.3338(10)  90.00  104.739(3)  90.00  847.02(7) 
6-F  P21/c  7.3711(2)  7.09520(10)  16.7141(4)  90.00  100.9190(10)  90.00  858.31(3) 
5-Cl (I)  P21/n  10.1217(4)  4.7359(10)  19.4447(7)  90.00  96.219(2)  90.00  926.60(5) 
5-Cl (II)  P21/c  5.0853(2)  17.8953(10)  10.4472(6)  90.00  98.267(3)  90.00  940.85(8) 
5-Br  P21/n  10.3912(4)  4.72650(10)  19.5116(9)  90.00  96.383(2)  90.00  952.35(6) 
5-I  P21/n  10.7838(5)  4.7168(2)  19.5502(8)  90.00  96.630(2)  90.00  987.77(7) 
5-NO2  P21/n   9.9166(3)  5.04440(10)  18.6808(5)  90.00  99.6860(10)  90.00  921.15(4) 
3-Me
a  P21/c  4.910(1)  11.702(2)  17.233(6)  90.00  98.36(2)  90.00  979.632 
4-Me  P21/n  4.6363(3)  10.3293(9)  19.5855(16)  90.00  93.632(5)  90.00  936.06(13) 
5-Me  P21/n  10.1301(3)  4.88310(10)  18.9682(7)  90.00  100.696(2)  90.00  921.98(5) 
6-Me
b  P21/n  10.164(2)  7.238(2)  13.186(3)  90.00  96.74(2)  90.00  963.351 
Asp1
c  P21/c  11.2776(2)  6.5517(1)  11.2741(2)  90.00  95.837(1)  90.00  828.70(2) 
Asp2
d  P21/c  12.1515(10)  6.5064(5)  11.3637(9)  90.00  111.574(3)  90.00  835.79(12) 
3-MeO  P21/c  9.5451(3)  14.2427(5)  7.3811(2)  90.00  102.716 (2)  90.00  978.83(5) 
4-MeO  P21/n  5.06880(10)  9.4619(3)  20.0281(6)  90.00  94.069(2)  90.00  958.14(5) 
5-MeO  P21/c  5.03850(10)  17.3609(5)  10.8931(3)  90.00  95.402(2)  90.00  948.62(4) 
3-ACM  Pca21  18.379(4)  4.3789(11)  13.658(3)  90.00  90.00  90.00  1099.2(4) 
5-ACM  P-1  7.9457(2)  8.0305(2)  9.6719(2)  110.801(10)  99.754(2)  105.371(2)  531.97(2) 
4-CF3
e  P21/n  14.558(3)  5.7520(12)  26.243(5)  90.00  102.56(3)  90.00  2144.937 
Table 3. 2. Summary of basic crystallographic data. (
a ACMEBZ 
[12], 
b BEHWOA 
[13]  , 
c ACSALA14 
[6] , 
d ACSALA15 
[7] , 
e HIRCOB 
[14])  
 
3. 3. Results and Discussion. 
Diagrams of the twenty structures are given in Figures 3.2. a-l.  Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Interestingly, the family of Asp derivatives do not show any tendency to crystallize as 
solvate forms within the set of solvents used.  
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Figure 3. 3. Crystal packing of the aspirin (Asp) derivatives. 
 
Another interesting feature concerns the tendency of aspirin derivatives to crystallize as 
monoclinic, space group No 14, in the P21/c or P21/n setting. Exception to this trend are 
represented only by the acetamido derivatives, 3-ACM and 5-ACM, which crystallize 
respectively as orthorhombic (Pca21) and triclinic (P-1). Furthermore, the structures in 
the family predominantly crystallize with Z‟= 1. Only the 4-CF3 derivative shows two 
molecules in the asymmetric unit. 
The most interesting result concerns the accidental identification of a polymorphic form 
of the 5-Cl derivative (5-Cl (II)).  As mentioned above, the crystal packing features, 
which are briefly discussed in this section as part of the systematic analysis carried out, 
will be commented on in a further section focussed on the polymorphism screening of 
the 5-Cl derivative (see Chapter 3, Section 3.2).  
 
Conformational Analysis. 
The molecular conformations are very similar in the majority of the structure. Figure 3.3 
shows a typical molecule in the dominant conformational form. Table 3.3 reports the 
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Figure 3. 4. Geometrical parameters: torsion angles τ1, τ2 and τ3 and O∙∙∙O distance d. 
 
  1 /   2 /   3 /   d /  Å 
4-F  12.6(3)  -91.1(2)  -3.1(2)  2.745(2) 
5-F  10.9(3)  -87.8(2)  -6.3(3)  2.741(2) 
6-F  46.3(2)  -101.3(1)  -4.8(2)  2.778(2) 
5-Cl (I)  9.8(2)  -91.5(2)  -3.2(2)  2.695(2) 
5-Cl (II)  5.6(3)  -81.1(2)  -8.9(3)  2.698(2) 
5-Br  8.7(4)  -90.6(3)  -2.8(4)  2.686(3) 
5-I  8.1(6)  -89.1(5)  -3.1(6)  2.692(4) 
5-NO2  9.2(2)  -90.9(1)  -2.8(2)  2.719(1) 
3-Me
a  -11.92  94.92  1.64  2.706 
4-Me  6.9(4)  -89.6(3)  -6.7(4)  2.687(3) 
5-Me  11.4(2)  -90.7(2)  -3.8(2)  2.693(2) 
6-Me
b  44.68  -96.85  -4.49  2.747 
Asp1
c  -1.8(2)  -82.2(1)  -3.9(1)  2.656(1) 
Asp2
d  1.3(2)  83.9(2)  3.7(2)  2.655(2) 
3-MeO  2.1(2)  -83.2(2)  -2.2(2)  2.704(1) 
4-MeO  7.9(3)  -84.9(2)  -1.2(3)  2.746(2) 
5-MeO  6.4(2)  -80.8(1)  -12.2(2)  2.692(1) 
3-ACM  -8(1)  82(1)  12(1)  2.69(1) 
5-ACM  20.1(2)  -89.3(1)  -13.0(2)  2.677(1) 
4-CF3
e  13.3(8)  -94.2(6)  0.7(8)  2.699(5) 
  -6.3(9)  89.0(6)  -0.2(9)  2.701(6) 
Table  3.  3.  Summary  of  the  geometrical  parameters  as  defined  in  Figure  3.3.  (
a  ACMEBZ 
[12], 
b 
BEHWOA 
[13]  , 
c  ACSALA14 
[6]  , 
d  ACSALA15 
[7]  , 
e  HIRCOB 
[14]).  ESD‟s  for  3-Me  and  6-Me 
derivatives are not available. 
The ring-carboxylate torsion angle, τ1 is very close to zero (the majority of the values lie 
between 1
o and 14
o) but for the 6-fluoro and 6-methyl, where the close proximity of the 
6-substituents  generate  a  steric  hindrance;  the  values  for  these  molecules  are 
respectively 46.29
o and 44.7
o. An intermediate value is moreover observed for the 5-
ACM derivative which shows a torsion angle τ1 of 20.06
o.  
In contrast to what is observed for the two 6-derivatives, it is interesting to note here 
that in the other structures, the proximity of the acyl oxygen in the ortho position does 
not  have  an  equivalent  effect,  even  though  the  approximate  co-planarity  of  the 
carboxylate and phenyl groups require an O (carbox)···O (acyl) contact distance of ca. 
2.7Å (Table 3.3). 
Further analysis shows that the acyl group, itself planar (τ3 values lie between 0
o and 
13
o), is very close to orthogonal (τ2 = 90 +/- 11
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structures, with a consistent orientation which places the carbonyl group back towards 
the benzene ring. 
Description of Structures. 
The most significant, but not unexpected, feature of the family of structures is that, as 
shown  in  Figure  3.  2,  the  carboxylic  centrosymmetric  dimer  is  the  most  common 
supramolecular synthon 
[10, 15] adopted by the aspirin derivatives. This is not the case in 
the  6-fluoro  derivative,  however,  which  shows  a  carboxylate  catemer,  in  which  the 
carboxylate groups interact via single hydrogen bonds to form a zig-zag chain (Figure 
3.4).   
 
 
Figure 3. 5. Carboxylate catemer  of 6-fluoroaspirin (6-F).  One representative carboxylate∙∙∙ carboxylate 
catemer is coloured orange, O-H∙∙∙O distances are indicated by dashed lines. 
 
This is the first example of a carboxylate catemer structure in the aspirin family, and is a 
major departure for this group of compounds. However this result is more surprising in 
view of the normal dimer present in the 6-Me structure which, as in the 6-F derivative 
shows a high  value of the torsional angle τ1 (Table 3.3). Close examination of the 
structure shows the presence of other relevant intermolecular interactions in addition to 
the carboxylate catemer link. Figure 3.5 shows C-H∙∙∙F and acetyl C-H∙∙∙O hydrogen 
bonds responsible for the linking of the catemers along the 100 direction (Figure 3.5 a), 
C-H∙∙∙O hydrogen bonds (aromatic C∙∙∙O acetyl) connecting two linked molecules in 
one catemer with three other catemers approximately along the 010 direction (Figure 
3.5  b)  and,  finally  a  C-H∙∙∙O  hydrogen  bond  (acetyl  Me∙∙∙O  acetyl)  connecting  the 
catemers approximately along the 001 direction (Figure 3.5c).  Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Figure  3.  6.  Supplementary  weak  interactions  in  the  6-fluoroaspirin  (6-F).  One  representative 
carboxylate∙∙∙carboxylate catemer is coloured orange, Y-H∙∙∙X distances are indicated as dashed lines. 
 
A second departure from the typical carboxylic dimer is found for the 4-CF3 derivative 
[14], in which the two independent molecules in the asymmetric unit are connected to 
form  a  non-centrosymmetric  carboxylic  dimer  (Figure  3.6),  with  approximate  Cs 
symmetry.  
 
Figure 3. 7. Cis-carboxylate dimer in the 4-trifluoromethylaspirin (4-CF3). 
 
The last departure from the norm is observed for the acetamido derivatives (3-ACM and 
5-ACM), in which, as consequence of the competition between the substituent groups, a 
different synthon involving the carboxylic group and the acetylamino group is adopted. 
However the two structures adopt significantly different geometries. In 3-ACM (Figure 
3.7 a) the two interacting molecules are oriented to form approximately an angle of 90
o 
and  are  connected  via  O-H∙∙∙O  (O∙∙∙O  distance  2.600  Å)  between  the  carboxylate 
oxygen  and  the  C=O  of  the  acetylamino  group,  forming  an  infinite  chain  which Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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develops along the 100 direction. In 5-ACM (Figure 3.7 b) the two molecules adopt a 
co-planar conformation and, as for the 3-ACM, interact via O-H∙∙∙O (O∙∙∙O distance 
2.597 Å) supported by a C-H∙∙∙O hydrogen bond between the methyl of the acetylamino 
group and the other carboxylate oxygen (C∙∙∙O distance 3.381 Å). 
 
Figure  3.  8.  Carboxylate∙∙∙acetylamino  synthon  identified  for  a)  3-ACM  and  b)  5-ACM.  Y-H∙∙∙X 
distances are indicated as dashed lines. 
 
Interestingly  a  check  in  the  CSD  database  reveals  that  these  kinds  of  synthon  are 
common for 3- or 5- acetylaminobenzoic acids (e.g. VIDLUQ) 
[16], conversely to the 4-
acetylamino  derivatives  which  mainly  show  the  carboxylic  dimer  (e.g.  DIXFAR, 
ZAYRIA) 
[17]. The different behaviour of meta-isomers with respect the para-isomers 
might arises from a more efficient packing or an energetically more favourable set of 
interactions. 
 
The analysis of the unit cell parameters (Table 3.2) in conjunction with the similarities 
in  the  conformations  discussed  above  suggests  possible  relationships  between  the 
structures of some of the 5-substituted derivatives, and links between these and some of 
the 4-substituted derivatives. Furthermore, a deep analysis of the crystal packing reveals 
four set of isostructures (set 1: 5-Cl, 5-Br and 5-I; set 2: 5-F, 5-NO2 and 5-Me; set 3: 4-
Me, 4-MeO and 4-F; set 4: 5-MeO and 5-Cl (II)). 
 
XPac Analysis. 
In  order  to  explore  whether  any  other  relationships  exist  outside  the  above  3-D 
similarities, the whole group of structures have been compared using the XPac program, 
developed in our laboratory 
[11d]. The XPac analysis of the twenty ASP derivatives was 
carried  out  using  the  Corresponding  Ordered  Set  of  Points  (COSP)  represented  in Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Figure 3.8. The general procedure for the calculations (see Chapter 2, Section 2.4) is to 
use low filter parameters for identification of similarities, but in selected cases, in order 
to  explore  possible  broader  similarities  the  analysis  is  carried  out  using  more 
“generous” parameters (medium and high). These are highlighted in the relevant cases.  
The  program  generated  a  total  of  190  comparisons  between  all  possible  pairs  of 
structures within the whole family.  
 
Figure 3. 9.  Numbering scheme and Corresponding Ordered Set of Points (COSP) defined for the XPac 
analysis. 
 
The results are displayed in the structural relationship diagram (see Chapter 2, Section 
2.4) reported in Figure 3.9 (For more details see Appendix A1). 
The following notation is used to describe the relationships reported in figure:  
 
The diagram is divided into different regions, each indicating a given dimension (3-D, 
2-D, 1-D, 0-D). Higher similarities are positioned on the top of the diagram and the 
dimensions decrease going downwards. The COSP is labeled as X. 
The different crystal structures are positioned on the top of the diagram. Each structure 
is indicated by a grey circle. Structures in the same position define isostructurality. 
The  SCs  are  indicated  by  letter  followed  by  numbers.  The  first  number  is  used  to 
indicate the dimensionality (e.g. 0, 1, etc.), the second indicates an arbitrary numbering 
scheme.  The  same letter  means  the  same  family  of  SCs  (deriving  from  a  common 
arrangement), this is also indicated using circles having the same colour. Mixed letters 
define  SCs  deriving  from  the  contribution  of  different  arrangements.  This  is  also 
indicated by circles with more than one colour. 
The relationships among the different structures and SCs are indicated by connecting 
lines. Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Dashed lines indicate connections between COSP (X) and those SCs which  directly 
derive from it (e.g. the carboxylic dimer A0 is built by two COSP related by inversion 
symmetry).  
 
Figure  3.  10.  Structural  relationship  diagram  showing  the  relationships  between  supramolecular 
constructs (SCs) identified for the aspirin derivatives under study. 
 
The analysis, as expected, confirms the presence of four isostructural sets. Interestingly 
the 3-Me derivative shows 3-D similarity to the 4-substituted isostructural set: 4-Me, 4-
MeO and 4-F (see below).  
The analysis shows three 0-D SCs labeled respectively A0, B0 and C0. Interestingly all 
these  arrangements  are  centrosymmetric  dimers  but  involving  different  substituent 
groups. This is in agreement with the regular tendency of molecules to pack across 
inversion centres 
[18] which, especially for hydrogen bond ring motifs, play a significant 
role 
[19]. Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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A0 is the carboxylic dimer and, as shown in Figure 3.9, it has a strong influence in the 
crystal packing of the aspirin derivatives since it is precursor of a large number of 
relationships with higher dimensions.   
B0 is a motif present in the isostructural pair 5-Cl (II) and 5-MeO, the isostructural set 
of 5- haloderivatives (Cl (I), Br and I) and in the 5-ACM derivative (Figure 3.10). As 
mentioned above B0 is also a centrosymmetric dimer, in which two molecules in anti-
parallel orientations are connected by interactions involving a carboxylic group oxygen 
and the substituent group in position 5, a halogen in the case of the Cl, Br, I set, a 
methyl hydrogen of the 5-methoxy group in the 5-MeO derivative and the methyl of the 
acetylamino in the 5-ACM structure. B0 in conjunction with the 0-D SC A0, contributes 
to a 1-D arrangement (SC  AB1) which relates the halo derivatives and the 5-MeO 
structure (see below). 
 
Figure 3. 11. Methoxy···carboxylate and halogen···carboxylate interactions in a) the 5-methoxyaspirin 
(5-MeO), b) the 5-halogen aspirin structures and c) the 5-ACM derivative. The additional aromatic C-
H···O contacts shown may also contribute to the association  in the 5-MeO derivative (a). 
 
The third 0-D SC, labeled as C0, is the acetyl-acetyl centrosymmetric dimer which, as 
described above (see Section 3.1), plays a role in defining the differences between the 
two polymorphic forms of aspirin 
[5-7].  
This is identified for the 6-F derivative and Asp1 using low filters (Figure 3.11 a and b). 
However increasing the filter parameters to high values it is also observed in the two 
sets of isostructures (5-F, 5-NO2, 5-Me and 4-Me, 4-MeO, 4-F and 3-Me). Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Figure  3.  12.  The  acetyl···acetyl  dimer  (Supramolucular  Construct  (SC)  C1)  as  found  in:  a)  6-
fluoroaspirin (6-F) and b) aspirin 1 (Asp 1). 
Table 3.4 reports the O∙∙∙H and C∙∙∙O distances for the structures involved in forming 
C0. 
 
  O∙∙∙H (Å)  C∙∙∙O (Å) 
5-F  2.616(2)  3.541(2) 
5-NO2  2.843(2)  3.747(2) 
5-Me  2.793(2)  3.726(2) 
4-Me  2.669(3)  3.614(3) 
3-Me
a  3.056(5)
  4.072(5) 
4-MeO  2.739(3)  3.653(3) 
4-F  2.624(2)  3.561(2) 
Asp1
b  2.620(1)  3.574(1) 
6-F  2.820(2)  3.670(2) 
Table  3.  4.  Acetyl-Acetyl  intermolecular  distances  for  the  set  of  structures  adopting  the  0-D 
Supramolecular Construct (SC) C1. (
a ACMEBZ 
[12], 
bACSALA14 
[6]). ESD‟s  for 3-Me  is  estimated 
considering that C=O bond reported by the authors has value about 4 in the 3
rd decimal place 
 
The acetyl dimer C0 is precursor of two 1-D SCs; the first, C1, relates the 6-F derivative 
and Asp 1; the second, which is in conjuction with A0, labelled as AC1 is common for 
the two sets of isostructures (5-F, 5-NO2, 5-Me and 4-Me, 4-MeO, 4-F and 3-Me).  
The SC C1 consists of a row of acetyl dimers (Figure 3.12 a and b) developing along 
the  shortest  axis  (010  in  both  structures).  It  is  most  interesting  to  note  that  the 
connections between adjacent instances (C1 and C1‟) of the 1-D SC, then involve the 
two most significant synthons, the carboxylate catemer for the 6-F and the carboxylate 
dimer for Asp1, thus generating major differences in the resulting 2D arrangements.  
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Figure  3.  13.    Supramolecular  Construct  (SC)  C1:  a)  6-fluoroaspirin  (6-F)  viewed  along  the  100 
direction; b) aspirin 1(Asp1) viewed approximately along the 001 direction. Instance of SC C1 (C1and 
C1‟)  are  indicated  by  different  colours.  Acetyl-Acetyl  dimer  is  indicated  by  red  dashed  lines;  the 
connectivity between different instances of C1 are indicated with green dashed lines.  
 
Strictly related to the C1 is a second 1-D SC, E1 (Figure 3.13 a-c), which consists of a 
single row of molecules propagating along the 010 axis (i.e. one half of SC C1 in Figure 
3.13 a and b). This is common for the two polymorphic forms of aspirin and for the 6-F 
derivative. Note that the two instances of the arrangement, E1 and E1‟, in Asp1 and the 
6-F derivative are related by a centre of inversion in the acetyl-acetyl dimer, but by 21 
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Figure 3. 14. Supramolecular Construct (SC) E1 viewed along the 010 direction: a) aspirin 1 (Asp 1); b) 
6-fluoroaspirin  (6-F);  c)  aspirin  2  (Asp  2).    Instance  of  SC  E1  (E1  and  E1‟)  are  according  to  the 
orientation of the ring-carboxylate vector: green pointing towards the viewer, blue pointing away from the 
viewer. The SC C1 is also indicated in a) and b). 
As mentioned above, the C0 is precursor of another 1-D SC, AC1, obtained by the 
combination with the carboxylic dimer A0. This is a zig-zag row of molecules, present 
in the 5-F, 5-NO2, 5-Me, 3-Me and 4-Me derivatives (Figure 3.14 a-c). 
 
Figure 3. 15. 1-D Supramolecular Construct (SC) AC1 in aspirin derivatives; a) Asp1, b) 3-Me, c) 5-F.  
SC AC1 is shown in red and hydrogen bonds between constituent molecules are shown in blue.  All other 
hydrogen bonds are omitted for clarity. Each structure is orientated to best show the SC. 
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It is interesting to note that, a part the centrosymmetric acetyl dimer identified, the 
acetyl group might be precursor of other arrangements not identified since they do not 
represent common features within the family under study. In fact, since his approximate 
90
o orientation with respect the aromatic ring (see τ2 values in Table 3.3), it is available 
for  possible  participation  in  supplementary  interactions,  developing  particular 
arrangements (e.g. carboxylic dimers or higher dimensional motifs) along directions 
approximately orthogonal to the aromatic ring (stacking arrangements or diagonal rows 
of molecules) similarly as seen for the dimer C0. An example of this is given by the 3-
Me derivative, in which the acetyl dimer is a packing consequence 
[20] (see Table 3.4) 
and the acetyl group is available for a closer acetyl···acetyl association, in the form of a 
new type of acetyl catemer, linking molecules in a translational stack, as shown in 
Figure 3.15.  
 
Figure 3. 16. Acetyl···Acetyl translation catemer identified in 3-methylaspirin (3-Me) structure. 
 
The next 1-D SC, A11, consists in stacks of tilted carboxylate dimers which develop 
along  the  shortest  axis  (Figure  3.16  a  and  b)  and  is  common  for  the  three  set  of 
isostructures (5-Cl (I), 5-Br, 5-I; 5-F, 5-NO2, 5-Me and 3-Me, 4Me, 4-F, 4-MeO). 
 
Figure 3. 17. 1-D Supramolecular Construct (SC) A11: a) 5-I derivative; b) 4-Me derivative. 
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Strictly linked to A11 is another 1-D SC, D11, which relates the 4-CF3 and the 3-ACM 
derivatives; this is a stacking arrangement built from single molecules of the aspirin 
derivatives. D11 is, essentially, one half of the 1-D SC A11 which is common for the 
three  sets  of  isostructural  compounds  discussed  above  (Figure  3.16).  Note  that  the 
occurrence of different supramolecular synthons (in 3-ACM and 4-CF3) does not affect 
their tendency to adopt similar molecular arrangements. In particular Figure 3.17 shows 
the comparison between the 4-CF3 and 4-F derivatives in which the stacking similarity 
occurs between one half (with the disordered CF3 group) of the cis-dimer in the trifluoro 
structure  and  each  half  of  the  centrosymmetric  dimer  of  the  4-F  derivative.  This 
similarity  was  obtained  using  low  filters  for  some  structures  but  for  a  total 
characterization medium angle filters with an increase in the distance parameter (d = 
2.0) were needed. 
 
Figure 3. 18. 1-D Supramolecular Construct (SC) D1 (yellow): a) 4-trifluoromethylaspirin (4-CF3); b) 4-
fluoroaspirin  (4-F).  1-D  SC  A11  is  also  described  as  formed  by  two  SCs  D1  related  by  inversion 
symmetry (red circle). 
Interestingly, although the stacking of the two halves of the cis dimer appears from the 
diagram to be similar, the D1 similarity only applies to the molecule with the disordered 
CF3. The non-equivalent packing of the two symmetry independent molecules is such 
that the two halves have arrangements which differ by parameters which are higher than 
the filter parameters available for the analysis. 
The next 1-D SC deriving from the carboxylic dimer A0, SC A12, is formed by a row of 
tilted  dimers  (Figure  3.18)  and  relates  the  5-halo  isostructural  set  with  the  6-Me 
derivative.  There are no intermolecular contacts of any significance within  this SC, 
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of the different geometry of the dimer in 6-Me derivative, due to the twist of the ring-
carboxylate bond.  
 
 
Figure  3.  19.  1-D  Supramoleular  Construct  (SC)  A12  in  aspirin  derivatives;  a)  5-Cl,  viewed 
approximately along the 110 direction, b) 6-Me, viewed approximately along the 100 direction.  SC A12 
is shown in green for each structure. 
 
A further 1-D SC, A13, consists of a tilted stacking motif involving carboxylic dimers 
in the 3-MeO derivatives and 6-MeAspirin (Figure 3.19) found with medium filters. 
 
Figure 3. 20. Supramolecular Construct (SC) A13: a) 3-methoxyaspirin (3-MeO) viewed along the 001 
direction; b) 6-methylaspirin (6-Me) viewed along the 010 direction. 
 
As previously observed for the SC A12, it is worth noting that, in spite of the different 
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reflects the fact that the main arrangement in the stack of tilted molecules places the 
carboxylate  groups  in  a  region  where  there  is  enough  space  to  accommodate  the 
different twist without affecting too much the arrangement. Furthermore this last feature 
does not change the separations of the coplanar phenyl rings but only influences the 
stacks,  determining  a  shift  of  the  relative  position  of  the  molecules  along  the  two 
directions at angles to the stacking (Figure 3.29 a and b below). This is also reflected in 
the differences in the associations between the molecules in these constructs Figure 3.20 
a and b). For 3-MeOAsp, SC A13 is built by carboxylic dimers which develop along the 
001 direction, and which are linked by C-H···O hydrogen bonds involving the acetyl 
carbonyl group and the methyl hydrogen H(10) in the methoxy group. In 6-MeAsp, SC 
A13 is arranged along 010 without any hydrogen bond between two adjacent carboxylic 
dimers (the shortest O∙∙∙H distances between two adjacent molecules in the stacking 
arrangement are approximately 5 Å with respect to the aromatic hydrogen H(1).    
 
Figure 3. 21. Intermolecular interactions involved in forming the Supramolecular Construct (SC) A13. a) 
3-methoxyaspirin (3-MeO), b) 6-methylaspirin (6-Me). Short and long contacts distances are respectively 
indicated in blue and red. 
 
A further 1-D SC identified is labelled as AB1. This construct consists of a double chain 
combining A0 and B0, and it is common for the two isostructural sets 5-Cl (I), 5-Br and 
5-I and 5-MeO and 5-Cl (II). The centrosymmetric carboxylic dimer A0 interacts with 
neighbouring  dimers  across  a  further  centre  of  symmetry,  via  SC  B0  through 
reciprocating pairs of X···carboxylate O halogen bonds in the halo structures, and via 
methyl C-H···carboxylate O in the 5-MeO derivative, to form an infinite tape which 
develops respectively along 100 for the isostructural set 5-Cl (I), 5-Br and 5-I, along -
10-1 for the 5-MeO derivative and along 101 for 5-Cl (II) (Figure 3.21). One subtle 
point is that in the halo derivatives this secondary interaction involves the carboxylate 
carbonyl oxygen and in the methoxy derivative the carboxylate hydroxyl oxygen.  Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Figure 3. 22. 1-D Supramolecular Construct (SC) AB1 viewed along the shortest axis in each case: a) 5-
bromoaspirin (5-Br); b) 5-methoxyaspirin (5-MeO). Intermolecular interactions involved in the formation 
SC AB1 are indicated in blue. In 5-MeO C-H···O hydrogen bonds are indicated in red.  
 
An  XPac  calculation  with  medium  filter  parameters  actually  suggests  a  higher  2-D 
similarity  involving  a  stacking  arrangement  of  AB1  constructs,  along  010  for  the 
isostructural set 5-Cl (I), 5-Br and 5-I and along 100 for the set 5-MeO and 5-Cl (II) 
(Figure 3.22).  
 
Figure 3. 23. Approximate 2-D similarity obtained using medium filter parameters: a) 5-bromoaspirin (5-
Br); b) 5-methoxyaspirin (5-MeO). Differences in the corresponding lattice vectors and angles are also 
reported.  
 
The  comparison  of  the  angle  between  the  two  directions  of  propagation  (the  base 
vectors reported in figure 3.22) of the 2-D SC for  the two representative structures 
analyzed,  reveals  a  difference  of  about  20°.  This  value  in  particular,  but  also  the 
distance vectors, is indicative of the slipping of the molecules in the stacks. 
Further examination of the crystal structures reveals the major difference between the 
3D  structures  to  be  the  symmetry  relationships  and  associated  packing  between 
neighbouring 2-D slabs. In the halo derivative the stacks are related by vertical 21 screw 
axes (Figure 3.23 a). In 5-MeO, they are related by c-glide operations (Figure 3.23 b). Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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This  difference  can  also  be  responsible  for  the  shift  in  the  stacking  arrangement 
previously described.   
 
Figure  3.  24.  Packing  arrangements  of  slabs  of  the  Supramolecular  Constructs  (SCs)  AB1:  a)  5-
bromoaspirin  (5-Br);  b)  5-methoxyaspirin  (5-MeO).  Vertical  screw  axis  (green)  and  glide  (red) 
relationships are also reported. The molecules are colour coded according to the orientation of the ring-
carboxylate vector: orange pointing towards the viewer, blue pointing away from the viewer. 
 
The  SC  B0  is  also  precursor  of  the  last  1-D  SC,  B1,  which  is  common  for  the 
isostructural halo derivatives 5-Cl (I), 5-Br, 5-I and the 5-ACM derivative. This is a 
chain of SCs B0 which develops diagonally along 110 for the halo isostructural set and 
101 for the 5-ACM. This arrangement was indentified using medium filter parameters 
and increasing the distance parameter (d = 2.0). However, using less restricted filters 
(high  with  the  distance  parameter  d  =  2)  the  similarity  is  also  extended  to  the 
isostructural set 5-Cl (II) and 5-MeO. This is a further confirmation of the differences in 
the stacking arrangement of the two isostructural sets discussed above (see Figure 3.22). 
Although this similarity was not included in the relationship diagram (Figure 3.9) the 
Figure 3.24 shows the 1-D SC for the 5-MeO (developing along 001) and the 5-ACM 
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Figure 3. 25. Supramolecular Construct (SC) B1 in aspirin derivatives; a) 5-ACM, b) 5-MeO  SC B1 is 
shown in orange and the significant interactions between constituent molecules are shown in black. Each 
structure is orientated to best show the SC. 
 
AE2 is the first of the three 2-D SCs identified within the family of aspirin derivatives. 
It  derives  from  the  combination  of  the  carboxylic  dimer  A0  and  the  1-D  row  of 
molecules E1 related by 21 screw axis to form a layer (Figure 3.25) which is common 
for the two polymorphs of aspirin (Asp 1 and Asp 2).  
 
Figure 3. 26. 2-D Supramolecular Construct (SC) AE2 in the aspirin polymorphs, viewed along the 010 
direction: a) Asp 1; b) Asp 2. Each molecule represents the 1-D SC E1 extending into the page. The 
molecules are colour coded according to the orientation of the ring-carboxylate vector: blue = pointing 
towards the viewer, red = pointing away from the viewer. Individual instances of the SC, AE2 and AE2‟, 
are separated by dashed lines. Symmetry operations are also included: 21 screw axis (green), inversion 
(yellow circles). 
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As previously discussed 
[5-7] (see also Section 3.1), the two polymorphs of aspirin (Asp1 
and Asp2) show differences mainly due to the shift in the relative position of the layers 
AE2 and AE2‟ which is related to the formation of a C-H···O dimer (form I), across a 
centre of inversion (see Figure 3.11), or catemer (ideal form II), spiralling around a 21 
screw axis, each involving the carbonyl and a methyl hydrogen of the acetyl groups.  
 
The two set of isostructures 5-F, 5-NO2, 5-Me, and 3-Me, 4-Me, 4-F, 4-MeO, show a 
common 2-D SC labelled as AC2 (Figure 3.26). This is formed by stacks of tilted, 
parallel dimers, which themselves each constitute a 1D SC, but not identified separately 
since it only exists as part of the higher dimensional 2D SC (AC2), connected via weak 
C-H···O hydrogen bonds (see Table 3.4) between atoms of the acyl groups (cfr the SC 
AC1 in Figure 3.14). Interestingly the stack of dimers is analogous to the 1-D SC A11 
discussed  above  (Figure  3.16),  but  differing  in  tilt  and  spacing.  This  results  in 
significant differences in the cell dimensions related to the stacking directions (4 Å for 
the aspirin derivatives involved in forming A11 and 6 Å for aspirins).  
 
Figure 3. 27. 2D Supramolecular Construct (SC) AC2 in the 5-F aspirin derivative. The colour scheme is 
analogous to that used for Figure 3.25: gold = pointing towards the viewer, black = pointing away from 
the viewer. Hydrogen bonds between acid and acetyl moieties are shown in blue. Instances of SCs AC2 
and AC2‟ are related by a 21 screw axis and are shown separated by dashed lines. The structure is viewed 
along the 010 axis. 
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The last 2-D SC, A2, relates the two isostructural set 5-Cl (I), 5-Br, 5-I and 5-F, 5-NO2, 
5-Me. This consists of a sheet of SCs A11 related by 21 screw axes and connected along 
the  101 direction by C-H···O involving the the acyl carbonyl oxygen and aromatic 
hydrogen in position 4. This is shown in Figure 3.27 for the 5-NO2 and 5-I derivatives 
(C···O distances are respectively 3.10 Å and 3.24 Å).  
 
Figure 3. 28. 2D Supramolecular Construct (SC) A2: a) 5-NO2 derivative; b) 5-I derivative. The colour 
scheme is the same as reported in Figure 3.26. Instances of SCs A2 are shown separated by dashed lines. 
 
As  shown  in  the  figure,  the  two  sets  of  isostructures  show  differences  in  the 
development  of  the  instances  of  the  SC  A2,  which,  as  consequence  of  this,  are 
connected via different interactions. For the 5-Cl (I), 5-Br and 5-I structures, these are 
X···Ocarboxylate (where X= Cl, Br, I) short contacts which have values of 3.12Å, 3.20Å, 
3.37Å for the Cl, Br and I derivatives, respectively. As described above, these contacts 
have a significant role in defining the 0-D SC B0 (see Figure 3.9). For the 5-F, 5-NO2 
and 5-Me  structures, the contacts between the A21 sheets involve weak acyl···acyl 
dimers (see SC C0), which for the 5-F and 5-NO2 derivatives are assisted by additional 
contacts  involving  the  fluoro  and  nitro  substituents.  In  particular  5-F  shows  F···O 
contact to the carboxylate hydroxyl oxygen (F···O distance 2.93 Å) and a C-H···F 
(C···F distance 3.24 Å) contact to the methyl of the acyl group; 5-NO2 shows C-H···O 
hydrogen bonds (C···O distance 3.12Å) between the nitro group and the acyl methyl. 
Interestingly, as consequence of the isostructurality of the two derivatives, the 5-NO2 
structure shows a close approach, presumably non-bonding, between the nitro group and 
the carboxyl hydroxyl oxygen (O···O = 3.03Å). 
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As  mentioned  above,  the  analysis  showed  a  3-D  relationship  between  the  3-Me 
derivative and the 4-substituted isostructural set 4-Me, 4-MeO and 4-F. This is a case of 
approximate isostructurality and derives from the choice of the COSP components (see 
Figure 3.8) which do not include the substituted groups. In fact, though atoms of the 
COSP, have a reasonably close isostructural relationship, the comparison of the two 
methyl structures (3-Me and 4-Me) reveals that the different position of the groups has a 
significant influence on the values of the a and b cell dimensions (see Table 3.2). This is 
also confirmed by the comparison of the “dissimilarity index” 
[21] values calculated by 
the software, which also provides values for the other isostructural sets (see Table 3.5). 
This case can be considered part of the concept “quasi-isostructurality” 
[22] proposed by 
Kalman, which then was changed to “main part isostructurality” 
[23]. In a recent paper 
we proposed the simple term “pseudo-isostructurality” 
[10a] as suitable to cover all such 
cases.  
Structure 1  Structure 2  Dissimilarity Index (χ) 
5-Br  5-Cl (I)  1.1 
5-Br  5-I  1.7 
5-Cl (I)  5-I  2.7 
5-F  5-Me  3.8 
5-F  5-NO2  5.1 
5-Me  5-NO2  4.7 
3-Me  4-Me  8.5 
3-Me  4-MeO  10.9 
3-Me  4-F  6.8 
4-Me  4-MeO  7.4 
4-Me  4-F  7.0 
4-MeO  4-F  6.4 
5-Cl (II)  5-MeO  4.4 
 Table 3. 5. Dissimilarity indices () for groups of structures exhibiting 3D similarity. 
 
The data shows the small influence of changing the size of the substituent in the first 
two isostructural sets, and the greater effect in the 4-substituted isostructural set. This 
last result might be explained by considering that the position para to be more exposed 
to the neighbouring molecules and small variations of the substituent group can increase 
or decrease steric hindrance with the surrounding environment, generating differences 
in the crystal packing. 
 
A  similar  effect  can  also  be  responsible  for  the  small  differences  in  the  stacking 
arrangements observed in the family under study. Although the aspirin derivatives show 
stacking  arrangement  which  can  objectively  be  considered  analogous,  the  structural 
similarity analysis reveals the presence of, at least, three different arrangements. The 
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set, 5-F set and 4-Me set, where these thee derivatives are considered as representative 
for each set) and the 4-CF3 and 3-ACM derivatives, the second is related to the 1-D SC 
A13 and relates the 3-MeO and the 6-Me derivatives and the last is related the 1-D SC 
E1 which relates the two polymorphs of aspirin (Asp1 and Asp2).  
Stacking arrangements are also observed in the other members of the family but not 
discussed  so  far  since  they  do  not  show  any  significant  similarity  within  the  filter 
parameters adopted for the analysis. However, since this is a recurring feature for this 
family of compounds, it is interesting analyze the differences for all member of the 
family. The analysis is carried out using three main parameters (Figure 3.28) 
[24]: a) the 
distances between the molecular planes of two adjacent molecules 1 and 2 (P1 and P2), 
b) the distance between the centroids of 1 and 2 (Cen1 and Cen2) and c) the offset 
angle, defined as the angle formed between the Cen1-Cen2 vector and the perpendicular 
vector to the plane of molecule 2 (). This last parameter defines the shifts occurring 
between  adjacent  molecules  along  the  stacking  direction.  The  angle  between  the 
molecular  planes  of  molecule  1  and  2  is  not  reported  since  is  observed  to  be 
approximately 0 for all the structures.  
 
Figure 3. 29. Geometrical parameters used to describe the stacking arrangement occurring in aspirins. 
Cen = centroid, P = molecular plane,  = offset angle formed between Cen1-Cen2 vector and ring normal 
of molecule 2. 
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Asp Derivative  Cen1-Cen2 (Å)  P1-P2 (Å)   ()  SC 
4-F  4.908  3.127  56.02  D1 
5-F  4.892  3.081  56.63  D1 
6-F  7.095  3.999  61.88  E1 
5-Cl (I)  4.736  3.220  52.40  D1 
5-Cl (II)  5.085  3.223  56.30  - 
5-Br  4.726  3.227  52.15  D1 
5-I  4.717  3.220  52.17  D1 
5-NO2  5.044  3.091  58.01  D1 
3-Me
a  4.910  3.481  49.83  D1 
5-Me  4.883  3.205  54.42  D1 
4-Me  4.636  3.250  50.54  D1 
6-Me
b  7.238  2.701  75.65  A13 
Asp1
c  6.552  3.126  67.96  E1 
Asp2
d  6.506  3.137  67.97  E1 
3-MeO  7.381  3.333  70.17  A13 
4-MeO  5.069  3.257  55.58  D1 
5-MeO  5.038  3.152  56.97  - 
3-ACM  4.379  3.243  46.91  D1 
5-ACM  4.308  3.550  38.34  - 
4-CF3
e
  5.752  3.128  63.40  D1 
Table 3. 6. Geometrical parameters defining  stacking  arrangements observed  in aspirin  structures as 
described in Figure 28. Rows with same colour indicate isostructurality. Structures not involved in any 3-
D similarity are indicated by colourless rows. (
a ACMEBZ 
[12], 
b BEHWOA 
[13]  , 
c ACSALA14 
[6] , 
d 
ACSALA15 
[7] , 
e HIRCOB 
[14]). ESD‟s for these parameters are estimated as <0.01 for distances and 0.1 
for angles, based on values for molecular parameters. 
 
The  values  reported  in  Table  3.6  confirm  that  the  aspirin  derivatives  show  a  quite 
extensive and varied slippage. This is clearly demonstrated in  Figure 3.29 (a-k), in 
which the structures are viewed perpendicular to the planes of the molecules in the 
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Figure 3. 30. Comparison of the stacking arrangements identified in the representative aspirin derivative 
structures viewed along the shortest axis (left) and their orthogonal projections: a) 3-methoxyaspirin (3-
MeO), b) 6-methylaspirin (6-Me), c) 5-methoxyaspirin (5-MeO), d) 5-chloroaspirin form I (5-Cl (I)), e) 
5-fluoroaspirin  (5-F),  f)  4-fluoroaspirin  (4-F),  g)  aspirin  1  (Asp1),  h)  aspirin  2  (Asp2),  i)  4-
trifluoromethylaspirin (4-CF3), j) 6-fluoroaspirin (6-F), k) 3-actylaminoaspirin (3-ACM). 
 
In particular it is worth noting that for the 6-F and 6-Me derivatives the values reported 
in Table 3.6 are higher with respect to the other derivatives. As previously discussed for Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
83 
 
the stacking arrangement identified as the 1-D SC A13, the 6-Me and, for the same 
reason, 6-F derivatives require space in order to accommodate the different twist of the 
carboxylic group due to the steric hindrance of the substituent in position 6. This results 
in an arrangement which can be described as an averaged motif in between the typical 
slipped stacks and a row of molecules. Interestingly a similar behaviour is also observed 
for  the  3-MeO  derivative  which  showed  a  common  arrangement  with  the  6-Me 
derivative (see SC A13) even though the torsion angle value is close to 0. This might 
arise from a steric hindrance involving the methoxy group. However the analysis of the 
Cen1-Cen2 and, in particular, of the  angles reveals that this behaviour is also observed 
in the two polymorphs of aspirin (Asp 1 and Asp 2) in which there are no substituent 
groups at all. 
Interestingly  the  5-ACM  derivative  shows  a  significant  departure  from  the  other 
structures under study. In fact, the stacking arrangement develops with an anti-parallel 
reciprocal orientation of the carboxylate group of adjacent molecules along the  010 
direction (Figure 3.30).  
 
Figure 3. 31. Stacking arrangement of 5-ACM along the 010 direction. 
 
3.4. Polymorphism of 5-chloro aspirin. 
As previously mentioned (see section 3.3), 5-Cl derivative is the only compound within 
the family of aspirin derivatives which showed polymorphism 
[10a]. The structures of 
two forms (5-Cl (I) and 5-Cl (II) where I denotes the highest melting polymorph) have 
been analyzed as part of the structural systematic analysis reported in Section 3.3. In 
this  section,  both,  similarities  and  differences  of  the  crystal  packing  of  the  two 
polymorphs  are  discussed  in  more  detail.  The  two  forms  are  also  characterized  by 
means  several  techniques  such  as  thermal  analysis  using  differential  scanning 
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of a collaboration with Dr. John Kendrick and Dr. Frank Leusen from University of 
Bradford, results of solid state density function (DFT) calculations of lattice energies 
are also provided
[15]. 
The two forms of 5-ClAsp were initially obtained respectively  by slow evaporation 
from,  MeCN/H2O  1:1  and  2-propanol.  However,  a  proper  screening  with  different 
solvent revealed that both forms grow from several solvents and adopt different habits, 
such as needles, laths and prisms (Figure 3.31 a-d).  
Table 3.7 shows the occurrence of the two polymorphs in various solvents.  
 
Solvents  5-Cl (I)  5-Cl (II) 
MeOH  √  √ 
EtOH  √  √ 
MeCN  √  √ 
MeNO2  √  √ 
acetone  √  √ 
MeOH/H2O 1:1  √  - 
EtOH/H2O 1:1  √  - 
MeCN/H2O 1:1  √  √ 
2-propanol  -  √ 
acetone/ H2O 1:1  √  - 
acetone/ MeCN 1:1  √  - 
Toluene  √  - 
CHCl3  √  - 
Table 3. 7. Occurrence (√) of 5-Cl (I) and 5-Cl (II) in various solvents. 
 
Crystals  of  both  5-Cl  (I)  and  5-Cl  (II)  grow  from  pure  MeOH,  EtOH,  MeCN  and 
MeNO2. 5-Cl (I) grows selectively from pure toluene, CHCl3 and mixed solvents (with 
the exception of MeCN/H2O 1:1) such as MeOH/H2O, EtOH/H2O, acetone/H2O and 
acetone/MeCN; on the other hand,  2-propanol is shown to be selective for 5-Cl (II). 
 
Figure 3. 32. Various crystal habits for 5-Cl (I) and 5-Cl (II). 
 
The FT-IR spectra show differences mainly in the region 400-1800 cm
-1 (Figure 3.32). 
The IR frequencies of some of the characteristic bands of 5-chloroaspirin are reported in 
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In the region of the aromatic C-H stretch vibrations (3100-3000 cm
-1) a small difference 
is observed between the two forms (3093 cm
-1 in form I and 3102 cm
-1 in form II). At 
about 1700 cm
-1 the two forms show the carboxylic carbonyl (C=O carb.) stretch (1686 
cm
-1 and 1693 cm
-1 respectively for 5-Cl (I) and 5-Cl (II). The shift at higher values 
observed in 5-Cl (II) suggests that the carbonyl group of this form is involved in weaker 
interactions.  
Small  differences  are  also  found  in  the  C-O  (ester)  stretching  which  is  found 
respectively at 1196 cm
-1 in 5-Cl (I) and 1200 cm
-1 in 5-Cl (II).  
 
 
Figure 3. 33. FT-IR of 5-chloroaspirin form I and II. 
  Form I  Form II 
νCH arom.  3093  3102 
νC=O carb.  1686  1693 
ʴCH CH3  1412  1419 
  -  - 
νC-O-C est.  -  - 
  1196  1200 
Table 3. 8. Characteristic IR bands for 5-chloro-2-acetoxybenzoic acid form I and II. 
 
The thermal properties were investigated by Differential Scanning Calorimetry (DSC) 
and Hot-Stage Microscopy (HSM).  
Problems with the reproducibility were initially noticed in some DSC curves, in which a 
broadening of the  peaks and various melting temperatures were observed. In particular 
some samples showed the presence of an extra peak at approximately 130 °C. This 
behavior was observed for both 5-Cl (I) and 5-Cl (II) and may arise from impurities of 
5-chlorosalicylic acid in the samples.  
A new set of sample was then produced and the thermal analysis shows a good degree 
of purity. The DSC curves were obtained at different heating rates (5, 10 and 20 °C / 
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heating rate 10 °C / min, 5-Cl (I) and  5-Cl (II) melt with an onset temperature of 
respectively 146.4 ± 0.8 °C (ΔHfus= 30.97 ± 0.26 kJ mol
-1) and 141.3 ± 0.3 °C (ΔHfus= 
28.98 ± 0.47 kJ mol
-1) (Table 3.9). On the basis of the DSC data and the density values 
of the two forms (1.538 g/cm
3 for 5-Cl (I) and 1.515 g/cm
3 for 5-Cl (II)) and applying 
the heat of fusion rule and the density rule by Burger and Ramberger 
[25] it follows that 
the two forms are monotropically related. In fact 5-Cl (I) which is the highest melting 
form show the highest enthalpy of fusion (ΔHfus= 30.97 ± 0.26 kJ mol
-1 for form I and 
ΔHfus= 28.98 ± 0.47 kJ mol
-1 for 5-Cl (II))  and the highest density value as well (1.538 
g/cm
3 for 5-Cl (I) and 1.515 g/cm
3 for 5-Cl (II)). However the differences between the 
two forms are small and this fact suggests a high degree of similarity between the two 
structures. 
 
  Form I  Form II 
TM (°C)  144-152  139-147 
DSCOnset(°C)  146.4 ± 0.8  141.3 ± 0.3 
DSCPeak(°C)  151.6 ± 0.8  147.0 ± 0.2 
ΔHfus   30.97 ± 0.26  28.98 ± 0.47 
Table 3. 9. Physicochemical data for the two polymorphs of 5-chloroaspirin (the average of at least three 
measurements at heating rate 10 °C / min is given): TM, thermomicroscopy; ΔHfus, enthalpy of fusion. 
 
Figure 3. 34. DSC curves of 5-chloroaspirin (heating rate: 20 °C/min). 
 
This is also confirmed by DFT calculations (see Table 3.10) which show 5-Cl (I) to 
have a higher stability, with calculated lattice energy 2 kcal mol
-1 of molecule greater 
than that for 5-Cl (II) (-38.8 kcal mol
-1 for 5-Cl (I) and -36.8 kcal mol
-1 for 5-Cl (II)).  
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Energies (kcal mol
-1 of molecule)  5-Cl (I)  5-Cl (II) 
conformation
lattice E    4.5  3.9 
vdw
lattice E    -22.2  -22.3 
electrostatic
lattice E    -21.10  -18.4 
lattice E   -38.8  -36.8 
Table 3. 10. The lattice energies and it components for 5-Cl (I) and 5-Cl (II). 
 
This  mainly  arises  from  differences  in  electrostatic  interactions  (1.6  kcal  mol
-1). 
However the data also show small differences in the contribution coming from the 
conformational  changes  in the  molecule  and  no  changes  deriving  from  the  van  der 
Waals contributions to the lattice energies. 
 
The monotropic relationship between the two forms is also confirmed by HSM analysis 
(heating rate: 10 °C/min) which shows melting process in the range 144-152 °C for 5-Cl 
(I) and 139-147 °C for 5-Cl (II) (Figure 3.34). No solid-solid transitions are observed 
under polarized light (generally recognized by changes in the interference colours of the 
crystals).  
 
Figure 3. 35. Photomicrographs of the Hot-Stage analysis (heating rate: 10 °C/min). 
 
The presence of the impurities in the samples of both polymorphic forms was also 
investigated. In particular a comparison of the FT-IR of some samples of 5-Cl (I) and 5-
Cl  (II)  and  pure  5-chlorosalicylic  acid  (5-ClSA)  revealed  that  the  salicylic  acid 
impurities are present in some of them and might derive from decomposition process or 
directly from the synthesis (Figure 3.35).  Chapter 3                                                                                    Substituted Acetylsalicylic Acid Derivatives 
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Figure 3. 36. Comparison of the FT-IR spectra of 5-chlorosalicylic acid (5-ClSA) and pure and impure 
samples of the two polymorphs. Green circles indicate the peaks deriving from the impurities of 5-ClSA. 
 
This is also confirmed by a HSM analysis using the “contact method” (see Section 2.5) 
procedure aimed to ascertain if 5-ClAsp in presence of 5-ClSA (M.P. = 170°C) forms 
an eutectic mixture which melts at approximately 130°C as observed in some DSC 
curves. Figure 3.36 shows the two components, 5-ClAsp (on the left side) and 5-ClSA 
(on the right side), separated by the contact surface. At 129-130°C in correspondence of 
the contact surface a melting process occurs indicating that the melting point of the 
eutectic mixture lies in this range of temperatures. 
 
 
Figure 3. 37. HSM analysis on the eutectic mixture obtained recrystallizing from the melt 5-ClAsp (left 
side of each image) and 5-ClSA (right side of each image).  
 
The small differences observed in the thermal analysis and in the DFT calculations 
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Cl (I) and 5-Cl (II), crystallize in the monoclinic system with conventionally chosen 
space groups P21/n (5-Cl (I)) and P21/c (5-Cl (II)), each with one independent molecule 
in the asymmetric unit. The two polymorphs, which, as shown in Figure 3.9, are each 
part of two isostructural sets (5-Cl (I), 5-Br, 5-I and 5-Cl (II), 5-MeO), showing a 1-D 
similarity consisting of a chain of centrosymmetric carboxylic dimers connected via 
Cl···O  interactions  (see  Figure  3.21  in  Section  3.3).  However,  a  deeper  analysis 
revealed that the two types of structure also adopt a very close stacking arrangement 
which only differs by a shift of the adjacent molecules propagating along the stacking 
direction. This also generates small differences in the interactions assisting the stacking 
arrangement. In fact, though the stacking arrangement of both polymorphs involves 
weak  C-H···O  hydrogen  bonds,  a  deeper  analysis  reveal  that  in  5-Cl  (I)  these  are 
formed between the acetyl carbonyl group and the acetyl methyl group and in 5-Cl (II) 
these involve the acetyl carbonyl group and the aromatic hydrogen in position 3 with 
respect to the carboxylate group (Figure 3.37). 
 
 
Figure 3. 38. Comparison of the interactions involved in the stacking motif; a) 5-chloroaspirin (I) (5-Cl 
(I)); b) 5-chloroaspirin (II) (5-Cl (II)). Shorter intermolecular distances are indicated as black dashed 
lines, longer as red dashed lines. 
 
The apparent 2-D stacks of molecules, then, develop differently in the two polymorphs. 
In 5-Cl (I) neighbouring 2D stacks are related by rows of vertical 21 screw axes and are 
connected via C-H···O hydrogen bonds between the acetyl carbonyl oxygen and the 
aromatic hydrogen in position 3. In 5-Cl (II), the neighbouring stacks are related by c-
glide operations and connected, by the same C-H···O interactions as observed in 5-Cl 
(I).  
The comparison of the main intermolecular interactions, involved in forming the crystal 
structure  of  the  two  polymorphs,  also  provides  a  further  confirmation  of  the  close 
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Table 3. 11. Distances and angles for the main interactions of the two forms.  
 
As shown in table the two structures adopt the same type of interactions but in general 
5-Cl (I)  shows shorter interactions compared to 5-Cl (II) and this is in agreement with 
the calculated density values for the two forms  (1.538 g/cm
3 for 5-Cl (I) and 1.515 
g/cm
3 for 5-Cl (II). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Interactions  X-H···Y /Ǻ  X···Y /Ǻ  θ /  
5-Cl (I)         
  O-H···O  1.785 (2)  2.623 (2)  176.3 (1) 
  C-H(4)···O(4)  2.352 (2)  3.118 (2)  137.4 (1) 
  C-H(9)···O(4)  2.641 (2)  3.538 (2)  152.3 (1) 
  Cl···O(2)  -  3.121 (1)  - 
5-Cl (II)         
  O-H···O  1.829 (2)  2.668 (2)  176.9 (1) 
  C-H(4)···O(4)  2.389 (3)  3.306 (3)  162.3 (1) 
  C-H(3)···O(4)  2.655 (2)  3.519 (3)  151.5 (1) 
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3.5. Conclusions. 
The family of aspirin derivatives developed for this analysis adopts a range of crystal 
structures types, which show both varying levels of similarity and some differences. In 
most cases these can be related to features which derive from the shape of the target 
molecules, resulting from the different substituents and their positions of attachment, 
and  the  behaviour  of  the  functional  substituents  themselves.  The  most  significant 
example of this compromise between shape and interactions in directing packing modes 
is given by the  set of structures 5-Cl (I),  5-Br and 5-I in which similar shape and 
substituent groups able to form similar interactions result in isostructures. Furthermore, 
significantly  different  substituents  can  also  generate  very  similar  crystal  packing  as 
occur in the other three isostructural sets identified: the first containing 5-NO2, 5-F and 
5-Me, the second 5-Cl (II) and 5-MeO and the last containing 4-F, 4-Me, 4-MeO and 3-
Me. The last set and in particular the 3-Me and 4-Me derivatives demonstrate how 
close,  but  different,  substitutions  can  be  accommodated  within  a  common  structure 
determined by other associations, including packing, which may be dominated by a 
particular part of the molecule. In this  respect it is also worth noting the recurring 
stacking arrangement observed in aspirin derivatives, which may show different shifts 
of adjacent molecules and constitutes different arrangements.  
On the other hand, the analysis showed how important are some functional groups in 
forming robust synthons which may have a significant role in determining particular 
molecular  arrangement.  Of  significant  importance  is  the  carboxylate  groups  which 
showed  preference  for  the  well  known centrosymmetric carboxylic  dimer.  However 
some exceptions are observed; first of all, the carboxylic catemer adopted by the 6-F 
derivative which is the only example of catemer found on aspirin derivatives. Molecular 
shape showed in some cases to have a crucial importance in generating some particular 
interactions. An example is given by the acetylamino derivatives 3-ACM and 5-ACM 
which instead of forming the typical carboxylic dimer adopt a synthon consisting of 
interactions  between  the  carboxylate  group  and  the  acetylamino  group.  However  a 
search in the CSD database showed some preference for the centrosymmetric dimer to 
be adopted if the acetylamino is substituted in the para position. 
The acetyl group, which is one of the recurring features in aspirin derivatives, is shown 
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acetyl-acetyl centrosymmetric dimer is a robust feature which may derive from both 
directional interactions or simply by packing features. 
Of particular relevance is, also, the identification of a polymorphic form of the 5-Cl 
derivative (5-Cl (II)) which is isostructural with 5-MeO. As shown in the discussion the 
small  differences  in  the  crystal  packing  between  the  two  5-Cl  polymorphs  are,  as 
expected, confirmed by similar thermal behaviour. Although this is the only case of 
polymorphism within the family chosen, it does not exclude the possibility of isolate 
polymorphic  forms  for  some  of  the  other  aspirin  derivatives.  In  this  regard,  the 
relationships  diagram  can  be,  in  principle,  useful  to  develop  seeding  experiments 
involving species with high degree of structural similarity (by using the 5-MeO to seed 
5-I or 5-Br). Further work will be devoted to start a proper polymorphism screening. 
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CHAPTER 4: SUBSTITUTED SALICYLIC ACID DERIVATIVES. 
In this chapter the crystal structures of salicylic acid derivatives and their comparison 
with XPac program are described and discussed.  
 
4.1. Introduction. 
o-hydroxybenzoic  acid,  better  known  as  salicylic  acid  (SA)  is  derived  from  the 
metabolism  of  salicin.  Salicylic  acid  was  originally  used  as  drug  for  its  anti-
inflammatory properties, before being replaced by acetylsalicylic acid (aspirin) 
[1].  
SA has been subject to various structural studies, mainly focused on the ability of this 
compound to form an intramolecular hydrogen bond between the beta-hydroxyl group 
and  the  carboxylic  oxygen 
[2].  This  interaction,  described  as  a  six-membered  ring 
formation stabilized by resonance effect 
[2i], is defined as resonance-assisted hydrogen 
bonding (RAHB) 
[3]. This phenomenon, also known as π-bond cooperativity 
[4], occurs 
with  strong  hydrogen  bonds  and  involves  a  significant  covalent  component  (i.e. 
exchange).  
As consequence of this intramolecular interaction, SA has an increased acidity when 
compared to other hydroxybenzoic acids 
[5] and also adopts a co-planar conformation 
between the carboxylic functionality and the aromatic ring.   
As previously described  (Chapter 3), this kind  of hydrogen bond does not occur  in 
aspirin derivatives 
[6] which, however, show a co-planar conformation with torsional 
angles  τ1  close  to  zero  degrees  (values  in  the  range  0-10  in  the  majority  of  the 
structures). However, depending on the steric hindrance of substituted groups, the total 
absence of any intramolecular interaction involving the carboxylic group allows aspirin 
derivatives to adopt different conformations. As described in the previous chapter, 6-
substituted derivatives, in fact, showed higher values of torsional parameter, differences 
in the synthon choice and, consequently, subtle differences in the crystal packing.  
The availability of a series of substituted salicylic acid derivatives, accumulated in order 
to develop the set of aspirin derivatives previously discussed (Chapter 3), provided the 
opportunity for a related investigation. The new family of compounds, based on SA, 
shows  a  fixed  planar  conformation  throughout.  Compared  to the aspirin  derivatives 
previously  discussed  (Chapter  3),  this  new  family  of  compounds  shows  a  reduced 
conformational flexibility and, consequently, higher similarity in molecular shape. As 
for the aspirin derivatives, the choice of members of the family is based on those in Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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which the parent SA molecule is substituted with small groups (Cl, Br, I, Me, MeO, etc) 
and  in  different  positions.  In  this  way  the  only  differences  within  the  family  of 
compounds  defined  arise  from  the  substituent  groups  and  these  should  have  some 
influence in the crystal packing features.  
As for Asp derivatives (see Chapter 3), the derivatives of salicylic acid (SA) are labelled 
omitting  the  extension  SA  and  are  referred  to  using  only  the  abbreviation  of  the 
substituent group (e.g. 5-Cl, 5-Me, 4-ACM, etc.). 
 
 
Figure 4. 1. Set of salicylic acid derivatives chosen for this analysis. 
Although  the  CSD  database  reports  many  crystal  structures  of  salicylic  substituted 
derivatives, no structural systematic analysis of these compounds has been previously 
reported.  
For this purpose a series of different salicylic acid derivatives (Figure 4.1) have been 
crystallized  from  various  solvents  in  order  to  obtain  suitable  crystals  for  X-Ray 
determination.  Some  of  the  crystal  structures  determined  for  this  study  have  been 
previously reported by other authors (3-MeO (PIDJES) 
[7], 3-MeO h (DIWNON) 
[8], 4-
NH2  (AMSALA  and  AMSALA01) 
[9],  5-Me  (BESKEP) 
[10],  5-NO2  (GUTNIS) 
[11]  
derivatives and SA (SALIAC, 01, 03, 12-16)) 
[2b, 12]. In order to define a family which is 
consistent with the analysis previously reported (chapter 3) we included in the study 
some entries from CSD (5-F (ABENEB) 
[13], 5-Br (IYAWIO) 
[14], 5-NO (NTSALA)) 
[15].  As  for  the  aspirin  analysis  (chapter  3)  the  objective  is  to  identify  structural 
similarities in the family, and to see how robust are the packing features and which role 
the different substituted groups have in defining differences in the crystal packing.  
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4.2. Experimental. 
Crystallisation of functionalized 2-hydroxybenzoic acids. 
Single crystals suitable for X-ray analysis were grown by slow evaporation from several 
solvents (Table 4.1).  
  Solvent  Crystal Habit 
3-MeO h  2-propanol  Block 
3-MeO  pyridine   Block 
4-MeO  CH3CN  Block 
5-MeO  CH3OH  Needle 
6-MeO  CH3OH  Block 
3-NO2h  CH3CH2OH  Prism 
5-NO2  H2O / CH3OH  Plate 
4-ACM  2-propanol  Plate 
5-ACM h  acetone  Lath 
4-NH2  CH3OH  Plate 
5-NH2  DMSO  Plate 
4-Cl  pyridine  Plate 
5-Cl h  H2O / CH3CH2OH   Block 
5-Cl  acetone  Lath 
5-I  CH3OH  Block 
SA  pyridine  Needle 
6-F  pyridine  Plate 
4-Me  H2O / CH3OH  Block 
5-Me  H2O / CH3OH  Lath 
Table 4. 1. Summary of the solvents used for crystallizations, crystal habits  for the salicylic acid (SA) 
derivatives under study. 
 
Crystal Structure Determination. 
A  summary  of  the  basic  crystal  data  are  given  in  Table  4.2,  which  also  includes 
information on the three previously reported derivatives (ABENEB
[13] , IYAWIO
[14], 
NTSALA
[15]). Full X-rays experimental data are provided as detailed cif files in the 
Appendix CD. 
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  SG  a /Ǻ  b /Ǻ  c /Ǻ  ʱ / º  β / º  γ / º  V /Ǻ
3 
3-MeO h  P21/c  17.9971(3)  14.3789(2)  6.73370(10)  90.00  91.1210(10)  90.00  1742.20(5) 
3-MeO  P21/n  3.7935(2)  27.8954(16)  7.0172(4)  90.00  94.891(3)  90.00  739.86(7) 
4-MeO  P21/c  4.9629(2)  11.0915(8)  13.6559(9)  90.00  98.788(4)  90.00  742.88(8) 
5-MeO   P21/c  3.97840(10)  16.1049(4)  11.5198(3)  90.00  90.261(2)  90.00  738.09(3) 
6-MeO  P21/n  6.6697(2)  9.3476(4)  12.2016(5)  90.00  104.305(2)  90.00  737.13(5) 
3-NO2h  P21/c  3.5943(2)  21.115(2)  10.7227(10)  90.00  98.950(6)  90.00  803.87(12) 
5-NO2  P-1  5.1246(5)  8.7762(8)  9.2674(9)  62.252(6)  75.292(6)  82.654(7)  356.76(6) 
4-ACM  Pna21  13.5482(8)  5.0245(3)  12.9394(6)  90.00  90.00  90.00  880.82(8) 
5-ACM h  P212121  3.7472(4)  11.5109(17)  21.979(3)  90.00  90.00  90.00  948.0(2) 
4-NH2  P21/n  7.1371(3)  3.7278(2)  24.4465(12)  90.00  94.386(2)  90.00  648.51(5) 
5-NH2  P21/n  3.7239(2)  7.3696(4)  23.3107(11)  90.00  91.806(3)  90.00  639.41(6) 
4-Cl  P21/c  3.7241(2)  14.4178(8)  12.9156(6)  90.00  97.933(3)  90.00  686.84(6) 
5-Cl h  P-1  3.72890(10)  8.2430(4)  13.0565(7)  80.768(2)  87.719(3)  83.755(3)  393.67(3) 
5-Cl  P21/c  23.3708(10)  3.70890(10)  16.5722(7)  90.00  104.853(2)  90.00  1388.48(9) 
5-I  C2/c  38.4671(15)  4.5765(2)  19.9300(7)  90.00  118.789(2)  90.00  3074.9(2) 
SA
  P21/c  4.8894(3)  11.2411(13)  11.3347(13)  90.00  91.919(7)  90.00  622.63(11) 
5-F
a  P21/n  3.8184(8)  21.219(4)  8.2107(17)  90.00  101.172(4)  90.00  652.646 
6-F  P21/n  5.3146(2)  5.2118(2)  22.5378(10)  90.00  91.907(3)  90.00  623.92(4) 
5-Br
b  P-1  4.805(1)  12.047(2)  14.666(3)  114.06(3)  90.40(3)  101.19(3)  756.937 
4-Me  P-1  3.8685(3)  7.2380(9)  13.2142(15)  100.756(5)  93.271(7)  90.788(7)  362.80(7) 
5-Me  P21/n  7.2810(3)  5.0146(2)  20.2789(7)  90.00  95.498(2)  90.00  737.00(5) 
5-NO
c  P21/n  22.829(2)  8.028(1)  3.6669(4)  90.00  91.07(1)  90.00  671.920 
Table 4. 2. Summary of basic crystallographic data. (a: ABENEB
[13] , b: IYAWIO
[14], c: NTSALA
[15]) 
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4.3. Results and Discussion. 
The  crystal  structures  of  the  SA  substituted  derivatives  studied,  and  the  unit  cell 
parameters are reported in figure 4.2. in contrast to what has been observed for aspirin 
derivatives 
[6] (Chapter 3, Section 3.2 and 3.3), as shown in Table 4.2 and Figure 4.2, 
some SA derivatives have shown the tendency to crystallize as hydrate forms. 3-MeO, 
3-NO2, 5-ACM and 5-Cl, indeed, include water molecules in the crystal packing. For 3-
MeO and 5-Cl, however, the anhydrous structures have also been isolated. The majority 
of the structures crystallize with Z‟= 1; exceptions are observed for 3-MeO h, 5-Cl, 5-I 
and 5-Br which show Z‟= 2. As observed in aspirin derivatives 
[6] (Chapter 3), the 
carboxylic centrosymmetric dimer occurs in the majority of the structures. However the 
6-MeO  derivative  and  the  hydrate  forms  adopt  different  choices  (see  below). 
Surprisingly no isostructures are identified in this family of compounds, in contrast to 
what  was  found  for  the  Asp  derivatives,  which  showed  three  different  set  of 
isostructures. 
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Figure 4. 2. Crystal Packing of the SA derivatives. 
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Conformational Analysis. 
The  analysis  of  molecular  conformations  of  salicylic  acid  derivatives  reveals  the 
expected high similarity in all structures. The values of the ring-carboxylate torsion 
angle τ (Figure 4.3) lie in the range 0-6.5 (Table 4.3). This particular geometry arises 
from the intra-molecular hydrogen bond between carboxylic and the hydroxyl group.  
 
Figure 4. 3. Geometrical parameters: carboxylic torsional angle (). 
 
SA subst   /   D / Å  d / Å 
3-MeO h  2.7 (2)  2.611 (1)  1.887 (1) 
  1.1 (2)  2.596 (1)  1.865 (1) 
3-MeO  2.9 (2)  2.619 (2)  1.74 (2) 
4-MeO  2.5 (2)  2.602 (1)  1.79 (2) 
5-MeO  3.4 (2)  2.643 (2)  1.920 (1) 
6-MeO  2.5 (2)  2.549 (2)  1.67 (4) 
3-NO2h  6.34 (1)  2.551 (1)  1.801 (1) 
5-NO2  5.2 (3)  2.642 (2)  1.914 (1) 
4-ACM  1.7 (2)  2.636 (1)  1.813 (1) 
5-ACM h  1.9 (7)  2.564 (5)  1.820 (3) 
4-NH2  0.8 (2)  2.611 (2)  1.79 (3) 
5-NH2  4.6 (2)  2.557 (2)  1.67 (2) 
4-Cl  1.0 (3)  2.615 (3)  1.888 (2) 
5-Cl h  1.0 (2)  2.585 (2)  1.81 (2) 
5-Cl  5.2 (4)  2.607 (3)  1.877 (2) 
  -0.2 (4)  2.608 (3)  1.875 (2) 
5-I  3.9 (6)  2.595 (5)  1.85 (7) 
  4.0 (6)  2.641 (5)  2.05 (7) 
salic
  0.4 (4)  2.620 (3)  1.891 (2) 
5-F
a  4.0 (1)  2.615 (2)  1.83 (3) 
6-F  3.3 (2)  2.573 (2)  1.96 (3) 
5-Br
b  0.60 (1)  2.614 (5)   1.87 (5) 
  1.64 (1)  2.633 (5)  1.90 (5) 
4-Me  1.4 (3)  2.626 (2)  1.750 (4) 
5-Me  0.6 (2)  2.604 (2)  1.75 (3) 
5-NO
c  -4.50  2.653  1.989 
Table 4. 3. Summary of the geometrical parameters as defined in Figure 4.3. ESD‟s for 5-NO SA not 
available. 
The distances O(2)∙∙∙O(3) are within the range 2.55-2.65 Å, and these values suggest 
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(2.549 Å), 4-ACM (2.549 Å), 3-NO2 (2.551 Å) and 5-NH2 (2.557 Å) derivatives and the 
highest value for 5-NO derivative (2.653 Å).  
The  carboxylic  group  mainly  adopts  the  syn-planar  conformation  (Figure  4.4  a). 
However the 6-MeO derivative shows a anti-planar conformation (Figure 4.4b),  due to 
a secondary IMHB occurring between the carboxylic OH group and the oxygen of the 
methoxy group (O(1)∙∙∙O(4) 2.538 Å) 
[16].  
 
Figure 4. 4. Conformation of the carboxylic group in the set of structures analyzed: a) Syn-planar; b) 
anti-planar. 
This last feature also explains the departure of 6-MeO derivative in the synthon choice 
with respect to the general tendency to form the typical carboxylic dimer. As shown in 
Figure 4.5, the 6-MeO derivative adopts a catemer motif built by C=O∙∙∙H-O hydrogen 
bonds (2.328 Å) between carboxylic groups of adjacent molecules. This arrangement is 
also  assisted  by  weak  C-H∙∙∙O  interactions  between  a  methoxy  hydrogen  and  the 
hydroxyl group (2.699 Å). 
 
 
Figure 4. 5. Chain of 6-MeO molecules assembled via catemeric supramolecular synthon. 
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Further  departures  from  the  common  carboxylic  dimer  are  observed  in  the  ACM 
derivatives:  4-ACM  adopts  a  O-H∙∙∙O=C  hetero-synthon  involving  the  carboxylic 
hydroxo group and the carbonyl of the acetylamino group (Figure 4.6 a); in the 5-ACM 
hydrate derivative the water molecule is interposed between the two functional groups, 
resulting in a different supramolecular synthon. A similar situation is observed in the 
case of the remaining hydrate forms, in which the water molecules interact by hydrogen 
bonds with the carboxylic groups of two molecules, preventing the carboxylic dimer 
formation (Figure 4.6 c-e). As mentioned above, it is worth noting that in contrast to 
what was observed in chapter 3 for the Asp derivatives 
[6], some SA derivatives show 
the  tendency  to  crystallize  as  hydrates,  adopting  different  supramolecular  synthons. 
However, in terms of geometry, the resulting shape of the motifs derived from the two 
different synthons remains essentially unchanged. In fact, due to their small size and to 
fact that they can behave as both donor and acceptor in forming hydrogen bonds, the 
molecules of water act as a efficient spacers and the resulting motif in solvate forms has 
similar shape with respect to the dimers observed in anhydrous forms.  
 
Figure  4.  6.  Alternative  supramolecular  synthons  identified  in  the  structure  in  study:  a)  5-
acetamidosalicylic  acid  monohydrate  (5-ACM  h),    b)  4-acetamidosalicylic  acid  (4-ACM),  c)  3-
methoxysalicylic acid monohydrate (3-MeO h), d) 5-chlorosalicylic acid monohydrate (5-Cl h), e) 3-
nitrosalicylic acid monohydrate (3-NO2 h). 
 
The most significant departure is found in the 5-NH2 derivative which occurs in its 
zwitterionic form, deriving from a local proton transfer from the carboxylic group to the 
amino group. This assignment of 5-NH2SA as a zwitterion is based on the results of the Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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refinement, which gave a smaller R-factor (4.6% for the zwitterion form and 6.18% for 
the  non-zwitterionic  form)  and  is  supported  by  the  similar  C-O  distances  of  the 
carboxylic group which are respectively 1.257 Å and 1.277 Å. 
The carboxylate group interacts via a hydrogen bond with the quaternary amine (O∙∙∙N 
2.734  Å) as shown in figure 4.7  a and  c. Further interactions (Figure 4.7  b and  c) 
involve the second carboxylate oxygen with the hydrogens of three adjacent quaternary 
amine groups (O∙∙∙N: 2.778 Å, 2.930 Å, 3.022 Å). 
 
Figure  4.  7. Relevant  interactions  involving  the  carboxylate  oxygens  of  the  zwitterionic  form  of  5-
aminosalicylic acid (5-NH2): a) main supramolecular carboxylate-quaternary amine synthon, b) further 
interactions  involving  carboxylate  oxygen  and  quaternary  amine  of  three  neighbour  molecules,  c) 
representation of both set of interactions reported in a and b. The neighbouring molecules are represented 
in different colours (green, yellow and red). 
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XPac Analysis. 
The  XPac  analysis  of  the  twenty-two  SA  derivatives  was  carried  out  using  the 
Corresponding Ordered Set of Points (COSP) 
[17] represented in Figure 4.8 and low 
filter parameters (see Chapter 2, Section 2.4). The program generated a total of 231 
comparisons between all possible pairs of structures within the whole family.  
 
Figure 4. 8. Corresponding Ordered Set of Points (COSP) defined for the XPac analysis. 
A diagram of the structural relationships is reported in Figure 4.9 (For more details see 
Appendix A2). The term Supramolecular Construct (SC) 
[17], described in Chapter 1, is 
used  to  define  the  common  geometrical  arrangement  occurring  in  two  or  more 
structures.  
 
 
Figure 4. 9. Structural relationship diagram showing the relationships between supramolecular constructs 
(SCs) A11-A22. 
 Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
112 
 
 
The following notation is used to describe the relationships reported in Figure 4.9:  
The diagram is divided in different regions, each indicating a given dimension (3-D, 2-
D, 1-D, 0-D).  Higher  similarities are positioned on the top of the diagram and the 
dimensions decrease going downwards. The COSP is labeled as X. 
The different crystal structures are positioned on the top of the diagram. Each structure 
is indicated by a coloured circle. The colour represents the substituted groups (same 
colour means same substituent). 
SCs, indicated by circles, are labelled by letters followed by two numbers. The first 
number  defines  the  dimension  of  the  SC  and  the  second  indicates  an  arbitrary 
numbering scheme.  
Anm SCs derive from the 0-D SC A0 (carboxylic dimer) Xnm is used to define SCs 
deriving directly from the COSP.  
The relationships among the different structures and SCs are indicated by connecting 
lines. 
Dashed lines indicate relationships between COSP (X) and those SCs which directly 
derive from it (e.g. the carboxylic dimer A0 is built by two COSP related by inversion 
symmetry).  
 
Although,  as  described  in  the  previous  section,  SA  derivatives  adopt  various 
supramolecular synthons, and the only 0-D SC found is the carboxylic dimer. The 1-D 
SCs observed mainly involve stacking arrangements. These arrangements are generally 
observed in aromatic systems and in general for flat molecules 
[18]. The stacking motifs 
develop  along  the  shortest  axis  for  all  the  structures.  However  the  stacking 
arrangements observed show small differences (see below) and this is consistent with 
the differences observed in the unit cell parameters for the shortest axis (Table 4. 2).  
The  most  significant  feature  observed  in  the  structures  in  study  is  the  absence  of 
isostructural sets. This is a surprising result if close molecular similarity is considered, 
and  especially  when  compared  to  what  observed  in  the  family  previously  analyzed 
(Chapter  3,  Section  3.3).  However  lower  similarities  (2-D)  involve  significantly 
different substituted derivatives which form two 2-D SCs (5-Cl and 5-NO for the first 
set and 5-NO, 4-Me, 4-NH2, 5-F and 3-MeO for the second set). 
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A11 is a 1-D similarity common to the derivatives: 4-Cl, 5-MeO, 5-Cl, 5-NO, 4-Me, 4-
NH2, 5-F and 3-MeO (Figure 4.10). It consists of a stacking arrangement of carboxylic 
dimers developing along the shortest axis (the values determined for the shortest axis 
for the substituted derivatives involved (Table 4. 2) lie in the range 3.67-3.97 Å). Apart 
from the 3-MeO and 5-MeO derivatives which connect via weak C-H∙∙∙O hydrogen 
bonds  between  the  methoxy  groups  of  adjacent  molecules  (C∙∙∙O  distances  are 
respectively 2.657 Å and 2.688 Å), there are no significant intermolecular interactions 
within this SC. 
 
Figure 4. 10. 1-D Supramolecular Construct (SC) A11 in salicylic acid (SA) derivatives: a) 4-Cl viewed 
approximately along the 001 direction and b) 5-F (ABENEB
ref) viewed approximately along the 001 
direction. A11 is shown in yellow for each structure. 
 
A similar stacking arrangement is also observed for 5-Cl h and 5-ACM h which showed 
the common 1-D SC X11 (Figure 4.11). Although X11 is treated as a distinct motif, 
because the different synthon involved, it is worth noting that the stacking arrangement 
is analogous to A11. This is confirmed by comparison of the values of the shortest axis 
which are in the range observed for the structures involved in forming A11 (3.747 Å for 
5-ACM h and 3.729 Å for 5-Cl h). The only difference derives from the fact that A11 is 
built from the carboxylic dimer and X11 derives directly from the COSP structure. It is 
implicit that this SC is also common to all the structures involved in forming A11. 
Again,  as  already  observed  in  the  previous  chapter,  the  occurrence  of  different 
supramolecular sythons does not affect the tendency of SA derivatives to stack forming 
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Figure  4.  11.  1-D  Supramolecular  Construct (SC)  X11  in  salicylic  acid  (SA)  derivatives:  a)  5-Cl  h 
viewed aproximately along the 0-11 direction and b) 5-ACM h   viewed approximately along the 010 
direction. X11 is shown in yellow for each structure. 
 
Strictly related to X11 is a second 1-D SC labeled as X12, common to 3-NO2 h, 5-NH2, 
and  the  set  of  structures  5-NO,  4-Me,  4-NH2,  5-F  and  3-MeO.  This  arrangement 
consists of two SC X11 related by centres of inversion (Figure 4.12). As observed for 
the  previous  SCs,  no  particular  directed  interactions  are  involved  in  building  this 
molecular arrangement. 
 
 
Figure 4. 12. 1-D Supramolecular Construct (SC) X12 (blue). 5-NO2 viewed approximately along the 
100 direction. As described in the text, X12 consists of two SC X11, related by center of inversion. 
 
A further 1-D SC, A12, is common to 5-Me and 5-NO2. This arrangement consists of a 
chain  of  carboxylic  dimers  each  connected  by  a  different  set  of  intermolecular 
interactions (Figure 4.13). In the 5-Me structure the carboxylic dimers build along 100 
via C-H∙∙∙O weak hydrogen bonds (C∙∙∙O 3.358 Å) between the methyl in position 5 and 
the  hydroxyl  group.  In  5-NO2  SCA12  develops  along  001  and  involves  O-H∙∙∙O 
hydrogen  bonds  (O∙∙∙O  2.904  Å)  between  the  carboxylic  hydroxyl  and  one  of  the Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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oxygen of the nitro group. Note that this 1-D SC is analogous to the 1-D SC (AB1) 
discussed in the previous chapter (Chapter 3 Figure 3.21).  
 
 
Figure 4. 13. 1-D Supramolecular Construct (SC) A12 (green). a) 5-Me viewed along the 010 direction; 
b) 5-NO2 viewed along the 010 direction. 
 
5-NO, 4-Me, 4-NH2, 5-F and 3-MeO also show a common 1-D SC with 3-MeO h, 
labeled as X13. This arrangement consists of a row of single molecules (Figure 4.14).  
In 4-Me and 4-NH2, the motif involves hydrogen bonds between the hydroxyl oxygen 
and the hydrogen of the 4-substituted group (O∙∙∙N and O∙∙∙C distances are respectively 
3.337 Å and 3.602 Å).    
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Figure 4. 14. 1-D Supramolecular Construct (SC) X13 (orange). a) 5-MeO h along the 010 (left) and 100 
(right) directions b) 4-NH2 along the 010 (left) and approximately the 001 (right) directions. N-H∙∙∙O 
hydrogen bonds are indicated by dashed lines. (+) is used to indicate the axis pointing towards the viewer 
and (-) for axis pointing away from the viewer. 
 
A further 1-D SC, A13, consists of a steps row of carboxylic dimers (Figure 4.15 d). 
This is common for SA, 4-Cl and 5-NO2 structures. The dimers are not connected by 
any significant intermolecular interactions.  
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Figure 4. 15. 1-D Supramolecular Construct (SC) A13. a) A13 reported for 5-NO2 viewed approximately 
along the 100 direction; b) 5-NO2 viewed approximately along the 011 direction; c) SA viewed along the 
100 direction d) 4-Cl  viewed  along the  100 direction. O-H∙∙∙O hydrogen  bonds are  indicated  by red 
dashed lines. The molecules are colour-coded according to the orientation of the ring–carboxylate vector; 
grey = pointing towards the viewer, green = pointing away from the viewer. Instances of the SC, A13 and 
A13‟, separated by dashed lines, are related by 21 screw axis and are separated by dashed lines. (+) is 
used to indicate the axis pointing towards the viewer and (-) for axis pointing away from the viewer. 
 
A deep analysis of the crystal structures of 4-Cl and SA acid reveals that, though the 
unit cell parameters for these two structures are significantly different (Table 4.2), the 
two structures adopt a very similar crystal packing. As described below, A13 stacks in 
both  structures  along  the  shortest  axis  100  adopting  a  slightly  different  stacking 
arrangement. Along the 001 axis each A13 is related to the adjacent A13‟ (Figure 4.15 a 
and b) by a 21 screw axis. This similarity is confirmed by an XPac analysis using very 
high filters which gives an approximate 3-D similarity (Figure 4.16) between the two 
structures (Dissimilarity Index (): 21.2) 
[19].  
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Figure  4.  16.  Crystal  packing  representation  along  the  three  axis  a,  b  and  c.  a)  SA;  b)  4-Cl. 
Intermolecular interactions are indicated by dashed lines. (+) is used to indicate the axis pointing towards 
the viewer and (-) for axis pointing away from the viewer. 
 
The analysis of the interactions also reveals that in both structures the hydroxyl group is 
involved in forming a hydrogen bond with the group para to the carboxylate function. In 
4-Cl SA this consists of a O-H∙∙∙Cl hydrogen bond (3.270 Å) and in SA is a C-H∙∙∙O 
hydrogen bond (O∙∙∙C is 3.645 Å). However the calculated dissimilarity index for this 
comparison is higher in respect to the calculation performed with low filters and the two 
structures are better described as having a 1-D similarity. It is worth noting that even if 
the unit cells parameters are different (a and c differ approximately by 1 Å and c by 3 
Å), the two structures adopt analogous choices in the crystal packing formation (Figure 
4.15)  and  these  choices  involve  interactions  occurring  in  the  same  positions  of  the 
aromatic ring In this situation, it is difficult to say whether  the similar packing is a 
consequence  of  the  similar  interactions  or  the  interactions  assist  similar  choices  in 
crystal packing. 
 
A14 is a further 1-D SC which simply involves stacks of carboxylic dimers (Figure 
4.17) and is common to 6-F, 5-Br, 4-MeO and SA. This arrangement is analogous to 
A11, however, as described later, there are some subtle differences involving shifting of 
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Figure 4. 17. 1-D Supramolecular Construct (SC) A14. a) SA along the 101direction; b) 5-Me along the 
100 direction. O-H∙∙∙O hydrogen bonds are indicated by red dashed lines. 
 
As seen before for A11 and X11, related to A14 is a further 1-D SC labelled as X14. 
This arrangement consists of stacks of single molecules along the shortest axis (Figure 
4.18) and is found in 4-ACM and the set of structures involved in the formation of A14.  
 
 
Figure 4. 18. 4-ACM: 1-D Supramolecular Construct (SC) X14 viewed approximately along the 110 
direction. O-H∙∙∙O hydrogen bonds are indicated by red dashed lines. 
 
The final 1-D SC, A15 is present in the structures of 5-I and 6-F and consists of a stack 
of a pairs of carboxylic dimers, related by inversion symmetry (Figure 4.19).  Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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Figure  4.  19.  1-D  Supramolecular  Construct  (SC)  A15.  a)  5-I  viewed  approximately  along  the  010 
direction. SC A15 and A15‟ are related by 2-fold (green) and 21 screw axis (red).  b) 6-F viewed along the 
100 direction. SCs A15 and A15‟ are related by simple translation and 21 screw axis (red arrow). The 
molecules are colour-coded as in Figure 4.15; gold = pointing away from the viewer, black = pointing 
towards the viewer. Hydrogen bonds between the acid and acetyl moieties are shown in blue. Individual 
instances of SC A15 are separated with dashed lines. 
 
It is worth noting that the 6-F derivative adopts two distinct stacking arrangements (A14 
and A15 SCs) developing along two different axis. This result is consistent with the unit 
cell parameters of 6-F structure which show two very similar axes (a = 5.31 Å and b = 
5.21 Å).  
 
The last two SCs, A21 and A22 are 2-D arrangements both constructed from SC A11. 
A21 is present in the structures 5-NO, 4-Me, 4-NH2, 5-F and 3-MeO. This SC consists 
of a row of SC A11 stacks (Figure 4.20 a-e). This arrangement also contains the 1-D SC 
X12 which, as previously described, is formed by two SCs X11 related by a center of 
inversion (Figure 4.12). Note that SC A21 can also be considered as to be formed by 
stacks of a chain of carboxylic dimers. This constitutes a proper 1-D SC, but has not 
been identified separately since it only exists as part of A21.  
Apart from the 5-F and 5-NO derivatives, no intermolecular interactions of particular 
significance are involved in the formation of SC A21. In 5-F and 5-NO structures SC 
A11 built into SC A21 via a different set of interactions (Figure 4.20 a and b): in 5-F 
adjacent stacks of carboxylic dimers are linked by F∙∙∙O interactions (F∙∙∙O 2.844 Å); 5-Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
121 
 
NO involves a N=O∙∙∙O interaction with the carboxylic oxygen (O∙∙∙O 3.032 Å) and a 
N=O∙∙∙H-O hydrogen bond with the hydroxyl group (O∙∙∙O 2.744 Å).  
 
Figure  4.  20.  2-D  Supramolecular  Construct  (SC)  A21.  Each  molecule  represents  a  1D  stack  of 
molecules extending into the page and are colour-coded as in Figure 4.15: red = pointing towards the 
viewer, blue = pointing away from the viewer. Instances of SC A21 are indicated as separated by dashed 
lines. a) 5-F viewed along the 100 direction. b) 5-NO viewed along the 001 direction. c) 4-Me viewed 
along  the  100  direction.  d)  4-NH2  viewed  along the  010  direction.  e)  3-MeO  viewed  along  the  100 
direction. 
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The  five  structures  show  differences  along  the  longest  axis  corresponding  to  the 
different development of SC A21 along this direction (Figure 4.20). In 5-F and 3-MeO 
two adjacent SCs A21 (A21 and A21‟) are related by a glide plane perpendicular to the 
sheet. In 3-MeO the adjacent SCs are connected by weak C-H∙∙∙O hydrogen bond (C∙∙∙O 
3.047  Å)  between  the  methoxy  methyl  and  the  hydroxo  group;  in  5-NO  the  two 
subsequent SCs are related by 21 screw axes parallel to the plane; in 4-NH2 the instances 
are related by 21 screw axes perpendicular to the plane; 4-Me develops along the longest 
axis by translation symmetry (A21 = A21‟).  
 
The final 2-D SC A22 is present in 5-Cl and 5-NO. This is formed by a tilted zig-zag 
chain of SC A11 developing in both structures along 100 (Figure 4.21 a and b).  
 
 
Figure  4.  21.  2-D  Supramolecular  Construct  (SC)  A22.  Each  molecule  represents  a  1D  stack  of 
molecules extending into the page and are colour-coded as in Figure 4.19 orange = pointing towards the 
viewer, blue = pointing away from the viewer. Instances of SC A22 are related by glide planes and shown 
separated by grey dashed lines.  a) 5-Cl viewed along the 010 direction. The two symmetry independent 
molecules are indicated respectively as 1 and 2; the two different set of hydrogen bonds are indicated by 
different colours (red for the O∙∙∙Cl and black for O-H∙∙∙Cl) b) 5-NO viewed along the 00-1 direction; 
hydrogen bonds are indicated by black dashed lines, the 21 screw axis is shown by green arrows. 
 
In the 5-Cl structure the 2-D arrangement arises from the reciprocal orientation of the 
two independent molecules in the asymmetric unit. A22 develops along 001 along the 
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carboxylic dimers 1 interact with each other by O-H∙∙∙Cl hydrogen bonds (Cl∙∙∙O 3.217 
Å) between the hydroxyl group and the chloro substituent,  stacks of the type 2 are 
instead connected in one case via O-H∙∙∙Cl (Cl∙∙∙O 3.422 Å) hydrogen bonds between 
the hydroxyl group and the chloro and in another case by O∙∙∙Cl interactions involving 
the carboxylic oxygen (Cl∙∙∙O 3.114 Å). In 5-NO structure A22 is formed by adjacent 
SC A11 related by 21 screw axes parallel to the plane 110 (Figure 4.21 b). As observed 
for  5-Cl,  A22  propagates  along  010  by  glide  planes  via  O-H∙∙∙O  (O∙∙∙O  2.744  Å) 
hydrogen bonds between the hydroxyl group and the nitroso group. 
 
As  described  in  Figure  4.9,  the  6-MeO  derivative  has  no  similarity  with  the  other 
structures  in  the  crystal  packing.  This  is  a  direct  consequence  of  the  different 
supramolecular synthon adopted.  
As previously discussed, the 6-MeO derivative adopts a carboxylic catemer due to the 
anti-planar  conformation  of  the  carboxylic  group  (Figure  4.5).  The  analysis  of  the 
crystal  packing  shows  a  different  stacking  arrangement  which  develops  along  the 
shortest axis (100) with an anti-parallel orientation between two adjacent molecules. 
This is shown in Figure 4.22, with the crystal packing along the three directions.  
 
 
Figure 4. 22. 6-MeOSA: a) anti-parallel stacking of 6-MeO along the 100 direction; b) crystal packing of 
6-MeO viewed along the 100 direction; c) crystal packing of 6-MeO viewed along the 010 direction; d) 
crystal packing of 6-MeO viewed along the 001 direction. Different colours are used according to the 
orientation of molecules. Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
124 
 
A similar behavior is also observed for the 3-MeO h structure (Figure 4.23) in which the 
pair  of  molecules  stack  taking  a  90  orientation  along  001.  Interestingly  this 
arrangement is observed only for one of the two independent molecules of the Z‟= 2 
structure. The other molecule forms stacks of pairs of molecules oriented anti-parallel. 
 
Figure 4. 23. Stacking arrangement observed in 3-methoxysalicylic acid monohydrate (3-MeO h). The 
number 1 and 2 are used to indicate the two symmetry independent molecules. The molecules of the type 
1 are coloured coded according to the orientation of ring–carboxylate vector. A pair molecules of the type 
2 stack adopting an anti-parallel orientation and are indicated as yellow and grey. 
 
The XPac analysis clearly shows the predominance of the stacking motifs in the crystal 
packing of salicylic acid derivatives. It is interesting to note that the main differences 
between these arrangements consist in a different shifting of the adjacent molecules.  
Figure 4.24 shows the differences observed for the three main SCs identified. 
 
 
Figure 4. 24. Different stacking arrangements observed within the set of salicylic acid derivatives. The 
Supramolecular Constructs (SCs) are viewed along the shortest axis (left), after a 90 rotation (center) and 
by a further 90 degrees rotation (right). The direction of the stacking arrangement is indicated by black 
arrows. a) 4-Cl as representative of the set of structures adopting the 1-D Supramolecular Construct (SC) 
A11. b) 5-F as representative for the 1-D Supramolecular Construct (SC) A14; c) 5-I as representative of 
the 1-D Supramolecular Construct (SC) A15. SCs X11, X12 and X14 are not included since they are part 
or strongly related to the SCs represented in figure. Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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Although some analogies can be observed between the three stacking arrangements 
described and therefore, these arrangements can be objectively considered similar, it is 
important to note that the term “similarity” used in this analysis is strictly related to the 
set of tolerance parameters adopted (see Chapter 2, Section 2.4).  
Table 4.4 reports the results of the analysis of the geometrical parameters (see also 
Chapter 3, Section 3.3) used to define the stacking arrangements: interplanar distances, 
aromatic ring centroid-centroid vector and the angle of “slippage” (Figure 4.25) 
[20]. The 
angle  between  the  molecular  planes  of  molecule  1  and  2  is  not  reported  since  is 
observed to be approximately 0 for all the structures.  
 
Figure 4. 25. Stacking descriptors: molecular planes 1 and 2 (P1 and P2), centroids 1 and 2 (Cen 1 and 
Cen  2),  centroid-centroid  distance  (Cen1-Cen2),  plane1-plane2  distance  (P1-P2)  and  angle  formed 
between the Cen1-Cen2 vector and the perpendicular vector to the plane of molecule 2 ()  
SA subst  Cen1-Cen2 (Å)  P1-P2 (Å)   ()  SC 
3-MeO h  4.287  3.210  46.12  - 
  3.577  3.370  21.76  - 
3-MeO  3.793  3.452  17.20  A11 
4-MeO  4.963  3.353  52.77  A14 
5-MeO  3.978  3.387  35.14  A11 
6-MeO  3.696  3.348  25.06  - 
3-NO2  3.594  3.376  20.06  X11 
5-NO2  5.125  3.093  52.88  - 
4-ACM  5.024  3.443  46.74  X14 
5-ACM h  3.747  3.385  25.39  X11 
4-NH2  3.728  3.442  22.59  A11 
5-NH2  3.724  3.469  21.32  X11 
4-Cl  3.724  3.414  23.54  A11 
5-Cl h  3.729  3.402  24.17  X11 
5-Cl  3.709  3.399  23.59  A11 
  3.709  3.402  23.47  A11 
5-I  4.576  3.231  45.08  A15 
  4.576  3.280  44.21  A15 
salic
  4.889  3.316  52.55  A14 
5-F
a  3.818  3.403  29.96  A11 
6-F  5.512  3.270  56.82  A14 
  5.315  2.998  61.85  A15 
5-Br
b  4.805  3.420  49.58  A14 
  4.805  3.320  51.44  A14 
4-Me  3.868  3.567  25.28  A11 
5-Me  5.015  3.300  54.28  A14 
5-NO
c  3.667  3.346  26.83  A11 
Table 4. 4. Stacking descriptor parameter as described in Figure 4.25. Supramolecular Construct (SC) 
(where involved) is also reported for completeness. ESD‟s for these parameters are estimated as <0.01 for 
distances and 0.1 for angles, based on values for molecular parameters. Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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As reported in table 4.4 all the inter-planar distances approximately lie in the range 3-
3.8 Å. Differences are observed in the values of the cen1-cen2 distances and in the  
values. As expected, three different behaviors, correspondent to the three main families 
of SCs, can be defined. SC A11 and the related X11 show values of Cen1-Cen2 in the 
range 3.5- 4 Å and  values in the range 17-35. SCs A14 and X14 both lie in the range 
4.8-5.5 Å for the Cen1-Cen2 distance and in the range 46-57 for the  angle. The last 
SC A15 shows Cen1-Cen2 values between 4.5-5.3 Å and  angles in the range 45-62. 
Interestingly  A14  and  A15  show  close  values.  However  a  detailed  analysis  reveals 
differences in the stacking direction, which lie along the carboxylic-carboxylic vector 
for A14 and along its perpendicular direction for A15.  This latter feature is confirmed 
by the comparison of the two structures with the 6-F structure which, as previously 
discussed, is involved in forming both A14 and A15 SC and, as consequence shows two 
closely related unit cell axis with values of respectively 5.315 Å (along 010) and 5.212 
Å (along 100).  
The Cen1-Cen2 distance and the  angles indicate that SC A11 is constructed by stacks 
of molecules which adopt a more parallel geometry than both SC A14 and SC A15. The 
reasons of the different displacement are still not clear since they cannot be ascribed to 
the substituent effect (the distribution of withdrawing and electron-donor substituent is 
quite uniform in the three SCs) or to particular steric hindrance and/or particular stable 
interaction promoting a higher shifting. 
A similar tendency was previously observed in aspirin derivatives (Chapter 3, Section 
3.3) where the formation of offset stacks of molecules was a recurring feature. However 
the comparison of the geometrical parameters reveals that aspirin derivatives adopt a 
more shifted arrangement with Cen1-Cen2 distance within the range 4.7-7.4 Å and  
values in the range 50-75.  
 
In  contrast  with  what  is  observed  in  aspirin  derivatives,  in  which  the  derivatives 
substituted  in  the  same  site  showed  3-D  or  at  least  2-D  similarities  (indicating  an 
importance of the shape in generate the crystal packing), SA derivatives showed 1-D 
similarities mainly arising from the tendency to form stacking arrangements. This can 
arise from two different and concomitant factors. 
The  acetyl  group  in  aspirin  derivatives  surely  has  an  involvement  in  generate 
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showed a common 0-D SC consisting in acetyl dimers) and it could have an influence in 
determining particular molecular arrangements.  
The higher structural flexibility of aspirin derivatives could also allow, if needed, small 
variation in the conformation of the molecule in order to build some preferred molecular 
arrangements (an example of this latter feature is given by the comparison of 6MeAsp 
and 6-MeOSA structures in which the steric hindrance of the substituent groups affect 
differently the synthon choice: carboxylic dimer for the aspirin derivative and catemer 
for the salicylic acid derivative).  
 
4.3. Conclusions. 
Though the set of molecules chosen for this analysis show close shape similarity, the 
structures here analyzed clearly shown strong differences in the crystal packing. The 
most  surprising  feature  is  the  absence  of  any  isostructurality  within  the  family  of 
structures analyzed. The highest similarity occur in 2-D (SCs A21 and A22) and involve 
derivatives substituted at different sites and/or substituted by different groups. This is in 
contrast to what is observed in the aspirin derivatives (Chapter 3) in which molecules 
with similar substituents and/or similar site of substitution showed high similarities (3-D 
or 2-D). In this regard, geometrical features do not have a strong impact in generating 
crystal  packing  of  SA  derivatives.  However  the  various  stacking  arrangements 
observed, which differ only in the slippage of the adjacent molecules, derive from the 
flat  shape  and  the  rigid  conformations  of  SA  molecules.  Accordingly  to  the  XPac 
analysis, the parameters which quantify, both the interplanar distances plus the aromatic 
ring centroid-centroid vector and the angle of “slippage” identify three main stacking 
arrangements which involve different substituted derivatives.  
Another interesting feature of the family of molecules here analyzed is related to their 
tendency  to  crystallize  as  solvate  forms.  For  these  structures  the  synthon  choice  is 
affected by the water molecules. However, as previously described, the water molecules 
only  behave  as  spacer  maintaining  unchanged  the  shape  of  the  0-D  arrangement 
deriving from the alternative supramolecular synthon. The rigid conformation of the 
carboxylic group, due to the intramolecular O-H∙∙∙O with the hydroxyl in position 2, 
also affects the synthon choice as observed for 6-MeO SA which adopts a catemeric 
motif. However, where possible, the carboxylic dimer remains the preferred choice. Chapter 4                                                                                             Substituted Salicylic Acid Derivatives 
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At this point of the analysis would be interesting to verify how the molecules pack 
together if they are forced to adopt a different supramolecular synthon, crystallizing 
these SA derivatives as multiple component  systems with a cocrystallizing agent, as 
described in the next chapter (Chapter 5).   
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CHAPTER 5: MOLECULAR SALTS BASED ON 4-AMINOPYRIDINE-SALICYLIC 
ACID DERIVATIVES. 
In this chapter the crystal structures of a family of 4-aminopyridinium salts of salicylic 
acid  derivatives  and  their  comparison  with  the  XPac  program  are  described  and 
discussed.  
 
5.1. Introduction. 
As previously described (Section 1.5), cocrystals, salts and multiple component systems 
in  general  have  recently  gained  importance  in  many  fields  such  as  supramolecular 
chemistry and pharmaceutical solid forms. The Journal Crystal Growth and Design has 
recently dedicated to this topic a virtual issue entitled “Pharmaceutical Cocrystals” in 
which  the  most  relevant  papers  on  this  topic  published  in  2009  are  collected 
[1]. 
Interestingly some papers focussed on salts or molecular salts 
[2] have been included in 
this issue and this is a consequence of the recent debate on the semantics of the terms 
cocrystal 
[3] and if molecular salts and cocrystals are really so different 
[4]. In fact it is 
generally  recognized  that  cocrystals  and  molecular  salts  can  adopt  very  similar 
supramolecular synthons and the only difference is related to the proton location. The 
resulting  supramolecular  synthons  are  generally  defined  as  neutral  or  ionic.  Ionic 
synthons are more robust and easily predicted than the neutral synthons 
[5]. However, as 
pointed  out  by  Aakeroy  in  a  survey  of  85  salts  and  cocrystals 
[4b],  molecular  salt 
formation often results in unpredictable chemical or stoichiometric composition  and 
structure prediction and targeted supramolecular synthesis is much more difficult for 
this  class of compounds.  
In a recent paper Nangia 
[2a] analyzed the hydrogen bond motifs of a series of multi-
component systems based on hydroxobenzoic acid and aminopyridine. In this paper 
Nangia analyzed the synthon competition occurring among the four functional groups 
simultaneously  present  in  the  multiple component  system  and also  showed  that  the 
presence of the hydroxyl and amino groups promote the formation of ionic PyNH
+···
-
OOC synthon.  
Following the systematic approach described in the previous chapters (Chapters 3 and 
4) and bearing in mind the growing importance of salts or cocrystals, a new family of 
multicomponent systems has been studied. The analysis is carried out on  structures 
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the competition of different hydrogen bond donors (NH2 groups for amino pyridine and 
OH groups for salicylic units) and acceptors can affect the robustness of the typical 
carboxylate···pyridine synthon. Furthermore, in order to analyse if the close molecular 
similarity can be in some way extended to the crystal packing, generating, as described 
in the previous chapters, 1-D, 2-D or eventually 3-D similarities, a structural similarity 
analysis using the XPac approach 
[6] has been performed.  
The molecules selected for this study are those obtained by mixing in the ratio 1:1 4-
aminopyridine (4-AP) and some 3, 5 and 6 substituted salicylic acids (SA) as shown in 
figure 5.1. 
 
Figure 5. 1. Molecules selected for the study: 3,5 and 6-salicylic derivatives (SA); 4-aminopyridine (4-
AP). 
 
As for the previous families (Chapter 3 and 4) the derivatives are labelled referring only 
the abbreviation for the substituent in the salicylic moiety (e.g. 5-Cl, 5-ACM etc.) and 
indicating the eventual presence of the solvent (H2O = h, pyridine = Py) 
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5.2. Experimental Procedures. 
Crystallizations.  
The starting materials (see Chapter 2, Section 2.7) were mixed in 1:1 ratio and dissolved 
in various solvents to obtain co-crystal or salted forms (Table 5.1). Crystals suitable for 
X-ray study were obtained by slow evaporation from saturated solutions.  
 
  Solvent  Crystal Habit 
5-Cl  CH3OH  Block 
5-F  CH3CN  Slab 
5-I  CH3OH  Slab 
5-I Py  pyridine  Plate 
5-I h  H2O/CH3OH  Plate 
5-Br h  CH3OH  Block 
5-NH2 Py  pyridine  Block 
5-ACM  pyridine  Block 
5-MeO h  CH3OH  Lath 
5-Me  CH3OH  Block 
5-NO2  CH3OH  Prism 
3- NO2  pyridine  needles 
6-F  pyridine  Block 
Table 5. 1. Summary of the solvents used for crystallizations, crystal habits for the 4-aminopyridinium 
salicylates (4-APSA) derivatives under study. 
 
Crystal Structure Determination. 
A summary of the basic crystal data are given in Table 5.2. Full X-ray experimental 
data are provided as detailed cif files in the Appendix CD. 
 
Table 5. 2. Summary of the basic crystallographic data. 
  SG  a / Ǻ  b / Ǻ  c / Ǻ  ʱ / º  β / º  γ / º  V / Ǻ
3 
5-Cl  P21/c  11.9815(5)  7.9626(2)  12.4836(5)  90  100.400(2)  90  1171.42(7) 
5-F  P21/c  10.7838(4)  8.5407(2)  12.1504(5)  90  95.099(2)  90  1114.64(7) 
5-I  P21/c  13.6431(3)  8.1006(2)  12.4428(2)  90  112.279(1)  90  1272.49(5) 
5-I Py  P21/c  18.6570(10)  8.6657(5)  10.9293(5)  90  102.573(4)  90  1724.63(16) 
5-I h  P21  4.400(5)  18.068(5)  8.581(5)  90  96.077(5)  90  678.3(9) 
5-Br h  Pca21  17.1666(5)  3.8501(1)  19.5610(4)  90  90  90  1292.85(6) 
5-NH2 Py  C2c  23.3169(11)  8.1015(4)  18.0588(8)  90  110.986(2)  90  3185.1(3) 
5-ACM  P21/n  15.1705(7)  4.6669(2)  19.6506(8)  90  104.734(2)  90  1345.50(10) 
5-MeO h  Pna21  21.8619(15)  15.0658(9)  3.9918(3)  90  90  90  1314.77(16) 
5-Me  P21/c  13.5414(3)  15.0598(2)  13.0106(2)  90  108.6450(10)  90  2514.01(8) 
5-NO2  P212121  3.77770(10)  12.5991(5)  25.0825(10)  90  90  90  1193.82(7) 
3- NO2  P21  10.9737(5)  4.5752(2)  11.9808(5)  90  96.809(3)  90  597.28(5) 
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5.3. Results and Discussion. 
Description of the Structures. 
Diagrams of the representative packing for the thirteen structures analyzed are reported 
in  Figure  5.2.  These  comprise  eight  simple  binary  products,  three  binary  product 
hydrates and two binary product pyridine solvates. 
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Figure 5. 2. Crystal Packing of the 4-APy
+SA
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As expected, considering the high value of pKa 
[7] (pKa values of SA derivatives lie in 
the range 2-3, pKa 4-AP: 9.17), all the compounds crystallized as molecular salts. This 
is not only confirmed by the identification of the pyridinium hydrogen, but also by the 
analysis of C-O distances for the carboxylic group and the values of the C-N-C angle of 
aminopyridine (Table 5.2). In fact, the typical C-O distances are approximately 1.30 Ǻ 
and 1.22 Ǻ for carboxylic acids (r > 0.08 Ǻ) and in the range 1.23-1.29 Ǻ in case of 
deprotonated  carboxylate  groups.  Protonation  also  affects  the  values  of  the  C-N-C 
angles of pyridines which are approximately 116-117 for neutral pyridines and in the 
range 120-121 for protonated pyridines 
[2a, 8]. As reported in table 5.2 all the structures 
show values consistent with a proton transfer between the salicylic acid and the pyridine 
moiety (the difference between the C-O lengths r < 0.08 Ǻ and C-N-C angles are in 
the range 119.8-121.0). 
It  is  also  interesting  to  note  the  tendency  of  some  of  the  systems  under  study  to 
crystallize as solvate forms. In particular 5-MeO, 5-Br and 5-I crystallized as hydrate 
forms and 5-NH2 and, again, 5-I crystallized as pyridine solvates. This tendency was 
also  observed  in  the  family  of  salicylic  acid  derivatives  discussed  in  the  previous 
chapter (Chapter 4, Section 4.3). 
Furthermore,  the  structures  predominantly  crystallize  with  Z‟=1,  the  only  exception 
from this common behaviour is represented by the 5-Me derivative which crystallizes 
with two independent molecules in the asymmetric unit. One of the two molecules 
shows positional disorder of the methyl group. The disorder, as described later, also 
affects the structure of the 5-Cl derivative, in which the pyridine moiety adopts two 
different orientations. 
 
Conformational Analysis. 
As in the salicylic acid derivatives discussed in the previous chapter (Chapter 4, Section 
4.3), the family of salts show the intramolecular hydrogen bond formation between the 
hydroxyl group and one of the carboxylic oxygens (Figure 5.3) of the salicylic moiety. 
This is a typical feature of 2-hydroxycarboxylic acid (Chapter 4) and it is responsible 
for  the  rigid  conformation  adopted  by  the  carboxylic  group  of  salicylic  acids. 
Furthermore, the intramolecular hydrogen bond is also recognized to have a key role in 
determining their acidity stabilizing the anion by resonance 
[9].  Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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Figure  5.  3.  Torsional  angle  τ1  and  intramolecular  O-H···O  hydrogen  bond  for  a  generic  4-
aminopyridinium salicylate. 
 
The torsion angles τ1, which refers to the rotation of the carboxylate group (Figure 5.3), 
are close to 0 (Table 5.2) for all the structures.  
 
 
Table 5. 3. C-O distances, C-N-C angles, O-H···O and O···O distances, torsional angle τ1 for the 4-
aminopyridinium salicylate derivatives under study (* Refers to a different supramolecular synthon). 
 
However  the  O···O  distances  observed  in  the  salted  forms  are  slightly  shorter  if 
compared to what was observed for pure salicylic acid derivatives (O···O distances lie 
in the range 2.4-2.5 Å for salicylates and in the range 2.5-2.6 Å for salicylic acids). This 
can be ascribed to the ionic character of the salicylic unit. 
The most significant feature is provided by the supramolecular synthon 
[10] adopted by 
the  structures  under  study.  In  fact,  as  expected,  the  COO
-···H
+NPy  supramolecular 
synthon  is  a  very  robust  feature  in  the  majority  of  the  structures  (Figure  5.2). 
Furthermore the supramolecular synthon also involves an additional C-H···O hydrogen 
  C-O HN (Å)  C-OCH (Å)  C-N-C (°)  D (Å)  d(Å)  τ1 (°) 
5-Cl  1.276 (3)  1.244 (2)  121.0 (1)  2.512 (2)  1.58 (2)  1.2 (3) 
5-F  1.281 (2)  1.243 (2)  120.3 (1)  2.531 (2)  1.79 (2)  2.3 (2) 
5-I  1.285 (2)  1.241 (3)  120.8 (2)  2.520 (2)  1.77 (2)  -2.2 (3) 
5-I Py  1.281 (5)  1.246 (5)  120.4 (4)  2.517 (5)  1.73 (5)  -1.7 (5) 
5-I h  1.275 (3)  1.252 (3)  120.0 (2)  2.525 (2)  1.78 (2)  0.8 (3) 
5-Br h  1.285 (4)  1.253 (4)  120.7 (3)  2.530 (3)  1.79 (3)  -4.0 (4) 
5-NH2 Py    1.278 (4)*  1.250 (4)*  120.8 (3)  2.505 (3)  1.61 (3)  7.9 (5) 
5-ACM  1.261 (2)  1.273 (2)  120.1 (1)  2.475 (2)  1.72 (2)  4.8 (2) 
5-MeO h  1.277 (3)  1.263 (3)  120.7 (3)  2.514 (3)  1.77 (3)  6.9 (4) 
5-Me  1.261 (2)  1.271 (2)  120.6 (1)  2.470 (1)  1.71 (1)  1.9 (2) 
  1.287 (2)  1.250 (2)  121.0 (1)  2.572 (1)  1.83 (1)  -1.2 (2) 
5-NO2  1.279 (4)  1.236 (3)  120.8 (3)  2.497 (3)  1.75 (3)  -1.9 (4) 
3- NO2  1.247 (4)  1.290 (4)  119.8 (3)  2.437 (3)  1.67 (3)  2.1 (5) 
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bond between one carboxylate oxygen and the aromatic hydrogen in ortho position to 
the  charged  pyridine  nitrogen.  The  term  “two  point  synthon”  is  generally  used  to 
distinguish  this  situation  from  the  normal  single  COO
-···H
+NPy  supramolecular 
synthon which is described as “single point synthon” 
[2a].  
Table  5.3  gives  a  summary  of  the  main  parameters  used  to  describe  the  synthon 
occurring in the structures under study (see also Figure 5.4) 
 
Figure 5. 4. Supramolecular Synthon descriptors  for a generic  multiple component system  involving 
salicylic acid and aminopyridine. 
 
  N···O (Å)  N-H···O (Å)  C···O (Å)  C-H···O (Å)  τ2 (°) 
5-Cl  2.793 (3)  1.968 (1)  3.122 (5)  2.533 (1)  -2.0 (3) 
5-F  2.738 (2)  1.87 (2)  3.191 (2)  2.584 (1)  8.0 (2) 
5-I  2.711 (2)  1.84 (2)  3.316 (3)  2.712 (2)  2.47 (3) 
5-I Py  2.820 (5)  2.04 (5)  3.214 (5)  2.66 (4)  -4.38 (5) 
5-I h  2.694 (3)  1.84 (3)  -  -  3.79 (3) 
5-Br h  2.692 (3)  1.84 (3)  -  -  52.29 (4) 
5-NH2 Py   -  -  -  -  - 
5-ACM  2.665 (2)  1.68 (2)  3.195 (2)  2.555 (1)  6.26 (2) 
5-MeO h  2.802 (3)  1.92 (3)  3.187 (4)  2.590 (2)  6.82 (4) 
5-Me  2.640 (1)  1.77 (1)  3.322 (2)  2.709 (1)  0.07 (2) 
  2.861 (2)  2.00 (2)  3.179 (2)  2.665 (1)  10.65 (2) 
5-NO2  2.696 (3)  1.86 (3)  3.510 (4)  2.978 (2)  16.15 (4) 
3-NO2  2.647 (4)  1.64 (4)  3.436 (4)  2.859 (2)  -1.48 (5) 
6-F  2.747 (2)  1.87 (2)  3.187 (2)  2.602 (1)  -3.93 (2) 
Table 5. 4. Supramolecular synthon descriptors as shown in Figure 5.4.  
 
The N-H···O distances (Table 5.3) are considerably shorter than the van der Waals 
radius (2.6 Å), indicating a strong interaction, as expected for ionic compounds. The C-
H···O hydrogen bonds show C···O distances which lie the range of 3.122-3.322 Å.  
Interestingly  the  N-H···O  hydrogen  bond  generally  involves  the  carboxylic  oxygen 
lying in the same side of the hydroxyl group of the salicylic moiety (Figure 5.5 a). This 
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opposite side with respect the hydroxyl group (Figure 5.5 b). Furthermore the 5-Me 
derivative, which crystallizes with Z‟=2, shows both cases.  
The terms syn and anti are respectively used to describe the previous two cases (Figure 
5.5). 
 
Figure 5. 5. Syn and anti conformation for the 4-aminopyridinium-salicylate supramolecular synthon. a) 
4-aminopyridinium-6-fluorosalicylate (6-F); b) 4-aminopyridinium-3-nitrosalicylate (3-NO2). 
 
Departures  from  the  general  tendency  to  form  the  two  point  synthon  are  mainly 
observed  in  the  hydrate  structures  in  which  the  solvent  molecules  are  interposed 
between  the carboxylic  oxygen  and  the  aromatic  hydrogen  in  ortho  position  to  the 
heteroatom of the pyridinium component (Figure 5.6 a-c) in a similar manner to that 
observed in the previous chapter (Chapter 4, Section 4.3) for the hydrates of salicylic 
acid derivatives (in which the typical carboxylic dimer was disrupted by interposition of 
water molecules).  
 
Figure 5. 6. . Supramolecular synthon of hydrate forms. a) 4-aminopyridinium-5-bromosalicylate (5-Br 
h); b) 4-aminopyridinium-5-methoxysalicylate (5-MeO h); c) 4-aminopyridinium-5-iodosalicylate (5-I h). Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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In the 5-Br derivative, the presence of water affects the torsional angle value (τ2 = 
52.29°) and the association involves a single point synthon in which the pyridine moiety 
is slightly tilted (Figure 5.6 a). Interestingly, even though the torsion angle is close to 0 
(τ2 = 3.79°) the 5-I h shows C-H···O distances (C···O 4.224 Å and O···O 3.753 Å) 
consistent with a single point synthon (Figure 5.6  c). This is a consequence of the 
presence of the water molecule which induces a bending of the N-H···O interaction, as 
shown in figure 5.7 a. 
 
 
Figure 5. 7. Influence of the water molecule in the typical pyridine-carboxylic supramolecular synthon: 
a)  4-aminopyridinium-5-iodosalicylate  (5-I  h);  b)  4-aminopyridinium-5-nitrosalicylate  (5-NO2).  The 
direction and the entity of the bending is indicated by black arrows. 
 
This is not the case for the 5-MeO derivative in which the water molecule interacts by a 
hydrogen bond  with the carboxylic oxygen involved in forming the COO
-···H
+NPy 
interaction without affecting the ability of the two components to form the two point 
synthon (Figure 5.6 b).  
The  major  departure  from  the  expected  synthon  choice  is  observed  in  the  5-NH2 
derivative  which  crystallizes  as  pyridine  solvate  and  in  which  a  PyN···H
+NPy 
interaction  between  the  4-aminopyridinium  component  and  a  molecule  of  pyridine 
replace the COO
-···H
+NPy synthon (Figure 5.8 a).  
Interestingly this is not observed for the pyridine solvate form of the 5-I derivative 
which crystallizes adopting the expected two point supramolecular synthon (Figure 5.8 
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Figure 5. 8. Supramolecular differences in the two pyridine solvate structures: a) 4-aminopyridinium-5-
aminosalicylate (5-NH2 Py); b) 4-aminopyridinium-5-bromosalicylate (5-Br Py). 
 
It is in some way surprising the fact that the 5-NH2 derivative adopts this alternative 
supramolecular synthon. In fact as shown in figure 5.6 there is a proper exchange of the 
positions  of  the  solvent  molecule  and  the  salicylate  moiety  which  results  in  a 
PyN
+H···NPy  hydrogen  bond  extremely  similar  to  the  COO
-···H
+NPy  interactions 
generally observed for the other structures (N···N
+ 2.793 Å is very similar to the lengths 
observed for the COO
-···H
+NPy synthon). This is a good demonstration of the recent 
suggestion  that  salts  often  crystallize  with  unpredictable  chemical  or  stoichiometric 
composition 
[4b]. However, these differences may arise from the competition between 
PyN
+H and the amino group in para position in interacting with the carboxylate group 
of the salicylic moiety. One can argue that the  COO
-···H
+NPy interaction should be 
more favourable with respect to the COO
-···H2NPy because the positive charge in the 
aromatic nitrogen increases his ability as hydrogen bond donor. However the positive 
charge in the 4-aminopyridinium can be considered as delocalized between these two 
positions. 
 
The  synthon  competition  described  above  is  even  more  pronounced  if  the  5-Cl 
derivative  is  considered  (Figure  5.9).  In  this  structure  a  disorder  consisting  of  two 
different orientations of the aminopyridine ring are observed in a ratio 63-37%.  
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Figure 5. 9. Disorder observed in 4-aminopyridinium-5-chlorosalicylate (5-Cl). 63% of the molecules 
are oriented as the red molecule and the remaining 37% are oriented as the yellow molecule. 
 
This  results  in  two  different  supramolecular  synthons:  COO
-···H
+NPy  and  COO
-
···H2NPy (Figure 5.10 a and b)   
 
Figure  5.  10.  General  interaction  for  the  two  different  orientations  of  4-aminopyridinium-5-
chlorosalicylate (5-Cl). 
 
As described in figure 5.9 the carboxylate group can interact adopting the typical two 
points  COO
-···H
+NPy  and  the  COO
-···H2NPy  assisted  by  a  C-H···O  interaction 
between one of the carboxylic oxygen and the aromatic hydrogen in the ortho position 
with respect to the amino group (N···O, C···O distances respectively 2.840 Å and 3.564 
Å). 
A  different  situation  is  observed  in  the  nitro-derivatives  in  which  the  nitro  group 
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results in a NOO···H2NPy interaction reinforced by a weak PyC-H···O2N hydrogen 
bond (Figure 5.11). 
However this is a secondary interaction since both nitro derivatives form the typical 
COO
-···H
+NPy synthon observed in the majority of the structures. 
 
 
Figure  5.  11.  PyC-H···O2N  hydrogen  bond  for  the  two  nitro  derivatives:  a)  4-aminopyridinium-3-
nitrosalicylate (3-NO2). b) 4-aminopyridinium-5-nitrosalicylate (5-NO2). 
 
The N···O and C···O distances are respectively 3.152 Å, 3.388 Å for 5-NO2 and 3.093 
Å,  3.441  Å  for  3-NO2.  The  small  difference  could  be  ascribed  to  the  different 
conformation of the nitro group observed for 3-NO2 which is slightly tilted. In fact the 
torsion angle for 5-NO2 and 3-NO2 are respectively -1.68° and 19.84°. The higher value 
for 3-NO2 could depend on the steric hindrance between the nitro group and the OH 
group.  
Interestingly no isostructurality was observed among the thirteen structures under study. 
However partial similarity of the unit cell of some derivatives, mainly concerning the 
halo derivatives, is indicative of possible high dimensional structural relationships. For 
this purpose an X-Pac 
[6] analysis was carried out as described in the next section. 
 
XPac Analysis. 
In contrast to the previous analysis (see Chapter 3 and 4), in which the target systems 
are single component, the choice of the COSP for this new family should, in principle, 
include both components. Furthermore, the COSP, by definition, must be representative 
for the whole set of structures. However, as described above, the structures under study 
shown differences in the supramolecular synthon deriving from the inclusion of solvent 
molecules in the crystal structure or from differences in the associations (e.g. N-H···O 
interactions syn or anti with respect the hydroxyl group). These differences affect the 
relative  positioning  of  the  two  components.  In  particular  the  3-NO2  and  5-ACM 
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oxygen involved in forming the N-H···O hydrogen bond which is anti with respect to 
the hydroxyl group.  
Furthermore, since the software only permits a COSP choice on single molecules (e.g. 
choice of COSP in molecules with Z‟ > 1 can carried out  separately in each of the 
symmetry  independent  molecules  but  not  simultaneously)  a  simultaneous  choice  of 
atoms located in both components is not possible. To obviate this last problem a new 
procedure has been developed which allows consideration of the two components as a 
single “molecule”. For this purpose a new set of CIF files have been created in which 
the two components are connected by a “dummy” covalent bond which replace the N-
H···O hydrogen bond.  
The analysis was carried out using high filters (XPac 1) and the Corresponding Ordered 
Set of Points (COSP) as defined in figure 5.12. 
 
 
Figure 5. 12. COSP defined for the XPac analysis: a) Syn derivatives, b) Anti derivatives. 
 
The two COSPs in Figure 5.12 take into account the syn and anti conformation adopted 
by the two components.  
In order to analyze the 5-NH2 derivative, which adopts a different synthon, and those 
hydrate  forms  which  showed  major  differences  in  the  relative  position  of  the  two 
components a parallel analysis was carried out using the salicylic moiety only, as the 
COSP. However the results reported in the relationship diagram (see Figure 5.13) are 
related to the COSP shown in Figure 5.12 and if a new relationship is identified with the 
second set of COSP (salicylic), it will be commented on (For more details see Appendix 
A3). 
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As for the previous analysis (Chapter 3 and 4) the diagram is divided in four regions, 
each indicating a given dimension (3-D, 2-D, 1-D, 0-D). The dimensions increase from 
the bottom of the diagram going through to the top.  
The thirteen crystal structures are identified at the top of the diagram. Each structure is 
indicated  by  a  coloured  circle. The  colour  represents  the  substitutuent  group  (same 
colour  means  same  substituent).  Two  structures  in  the  same  position  mean  3-D 
similarity (e.g. 5-Cl and 5-F derivatives). 
SCs, indicated by circles, are labelled by letters (the same letter means the same family 
of SCs) followed a number which is an arbitrary numbering scheme. When more than 
one SC deriving from the same family and having the same dimension is present, the 
letter is followed by two numbers (the first defines the dimension of the SC and the 
second indicates an arbitrary numbering scheme).  
Instances  of  the  0-D  Supramolecular  Constructs  are  also  reported,  to  show  the 
differences between the two families of arrangements isolated. Different colours are 
used to differentiate the two components of the salts: yellow for the salicylate moiety 
and red for the aminopyridinium. 
All the relationships among the different structures and SCs are indicated by connecting 
lines. 
 
 
Figure 5. 13. Structural similarities identified among the structures in study. 
 
The most significant feature concerns the two different behaviours observed for the 
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identified, labelled respectively M (monomer) and D (dimer). The family M derives 
directly from the 0-D SC M0, which can be considered as the primary SC. This is not 
observed in the hydrate forms 5-I and 5-Br, which showed some differences in the 
geometry of the supramolecular synthon, due to the presence of the water molecules and 
in the pyridine solvate of 5-NH2 derivatives which adopts a different supramolecular 
synthon.  
The  family  D  derives  from  the  0-D  SCs  labelled  as  D01  (Figure  5.13)  which  is  a 
dimeric arrangement obtained from M0 by additional inversion symmetry. 
 
Interestingly the 5-MeO h, 5-ACM, 5-NO2 and 3-NO2 derivatives show relationships 
within the family M and the halo-derivatives 5-Cl, 5-F, 5-I, 5-I Py, 6-F and the 5-Me 
derivatives show preferentially relationships within family D.  
Only one 3-D similarity has been observed, which relates the 5-Cl and 5-F derivatives. 
However, as described below the two structures show some small differences in the 
packing arrangements.  
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 Supramolecular Constructs M. 
The family of SCs  M, directly obtained from M0, contains three 1-D SCs labelled 
respectively as M11, M12, M13 and one 2-D SC labelled as M2.   
M11 is the first 1-D SC which consists of a stacking arrangement of the salicylate-
aminopyridinium pair (Figure 5.14 a and b) which develops along the shorter axis. This 
arrangement is common for the 5-MeO h, 5-ACM, 5-NO2 and 3-NO2 derivatives. No 
significant  intermolecular  interactions  are  systematically  involved  in  generating  the 
stack of molecules. The only exception is presented by the 5-ACM derivative in which 
the salicylic moieties are connected via N-H···O and C-H···O hydrogen bonds between 
the acetamido groups of adjacent molecules (N···O and C···O respectively 2.904 Å and 
3.176 Å). 
 
Figure 5. 14. 1-D Supramolecular Construct (SC) M11: a) 4-aminopyridinium-3-nitrosalicylate (3-NO2) 
derivative  viewed  along  the  00-1  direction;  b)  4-aminopyridinium-5-acetylaminosalicylate  (5-ACM) 
viewed along the -10-1 direction.  
 
Table 5.4 summarizes the geometrical parameters used to characterize the stacking as 
previously described for aspirins and salicylic acid derivatives (Chapters 3 and 4).  
 
  Cen1-Cen2 (Å)  P1-P2 (Å)   ()  Axis directions 
5-MeO Hyd  3.992  3.477  32.63  001 
5-ACM  4.667  3.455  46.93  010 
5-NO2  3.378  3.244  17.99  100 
3-NO2  4.575  3.385  46.97  010 
Table 5. 5. Molecular stacking descriptors as previously described in Chapter 3 and 4. ESD‟s for these 
parameters  are  estimated  as  <0.01  for  distances  and  0.1  for  angles,  based  on  values  for  molecular 
parameters. 
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Interestingly the four structures show some differences in the stacking arrangements; in 
particular in 5-ACM and 3-NO2 the values of Cen1-Cen2 distances are higher with 
respect the other two derivatives involved in the common SC M11 (Cen1-Cen2 in the 
range 4.5 - 4.7 Å for 5-ACM and 3-NO2 and in the range 3.3 - 4.0 Å for 5-MeO h and 5-
NO2). However an analysis using more restricted filter parameters (medium 10-18-18 
XPac 1) confirms the relationship as found.  
 
A similar stacking arrangement is also observed in 5-Br h, and 5-I h but not included in 
the analysis since the differences in the supramolecular synthon are not compatible with 
the COSP chosen for this analysis. However, as previously described, a parallel analysis 
using the salicylic moiety as COSP reveals a 1-D similarity very close to M11 (Figure 
5.15 a and b). 
 
 
Figure 5. 15. 1-D stack as found in the two hydrates of the halo derivatives: a) 4-aminopyridinium-5-
iodosalicylate (5-I) derivative viewed approximately along the 001 direction; b) 4-aminopyridinium-5-
bromosalicylate (5-Br) viewed along the 10-1 direction. The salicylic moieties are coloured as orange, 4-
aminopyridine moieties as yellow. 
 
The second 1-D SC, M12, is closely related to M11 and is common to 3-NO2, 5-ACM 
and 5-MeO h (Figure 5.16 a - d). 
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Figure 5. 16. 1-D Supramolecular Construct (SC) M12: a) 4-aminopyridinium-3-nitrosalicylate (3-NO2) 
derivative  viewed  along  the  010  direction;  b)  4-aminopyridinium-5-acetylaminosalicylate  (5-ACM) 
viewed along the 010 direction. c) 4-aminopyridinium-5-methoxysalicylate (5-MeO) viewed along the 
001 direction. Instances of the 1-D SC M11 are also indicated. 
 
M12 consists of two adjacent SCs M11 related by a 21 screw axis and connected via N-
H···O hydrogen bonds between the amino group of the pyridinium and the hydroxyl 
group for 5-ACM and 5-MeO h (N···O distance respectively 2.917 Å and 2.932 Å) and 
the  nitro  group  for  the  3-NO2  derivative  (N···O  distance  2.950  Å).  The  3-NO2 
derivative also shows a C-H···O hydrogen bond involving the hydroxyl group and the 
aromatic hydrogen in position meta to the pyridinium nitrogen (Figure 5.16 a). 
 
The  5-NO2  derivative,  which  is  not  involved  in  forming  M12,  shows  a  similar 
arrangement differing in the relative shifting of the two stacks M11 (Figure 5.17 a and 
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Figure 5. 17. a) 4-aminopyridinium-5-nitrosalicylate (5-NO2); a) 4-aminopyridinium-3-nitrosalicylate (3-
NO2). 
 
Note that, similarly to the 3-NO2 derivative, the arrangement for the 5-NO2 derivative is 
linked  by  weak  C-H···O  hydrogen  bond  but  involving  in  this  case  the  aromatic 
hydrogen in the  position ortho to the pyridinium nitrogen, and the hydroxyl group of 
the salicylate (C···O distance 3.349 Å). 
 
The third 1-D SC, M13 (Figure 5.18 a - c), is common to 5-NO2, 3-NO2, 5-F and 5-Cl 
derivatives  and  consists  in  a  zig-zag  infinite  chain  of  M0  SCs  which  develops 
diagonally along the [2-10] direction for the 5-NO2 derivative, 1-20 for the 3-NO2, and 
respectively -1-10 and 110 for the 5-F and 5-Cl derivatives.  
 
 
Figure 5. 18. 1-D Supramolecular Construct (SC) M13: a) 4-aminopyridinium-5-nitrosalicylate (5-NO2) 
derivative viewed along the 001 direction; b) 4-aminopyridinium-3-nitrosalicylate (3-NO2) viewed along 
the 001 direction; c) 4-aminopyridinium-5-fluorosalicylate (5-F) viewed along the 001 direction. 
 
Figure 5.19 a - d shows instances of the SC M13 and the interactions involved.  Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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Figure  5.  19.  Instances  of  the  Supramolecular  Construct  (SC)  M13:  a)  4-aminopyridinium-5-
nitrosalicylate (5-NO2) viewed along the 100 direction; b) 4-aminopyridinium-3-nitrosalicylate (3-NO2) 
viewed along the 010 direction; c) 4-aminopyridinium-5-fluorosalicylate (5-F) viewed along the  0-10 
direction; d) 4-aminopyridinium-5-chlorosalicylate (5-Cl) viewed approximately along the 010 direction. 
The pyridinium···carboxylate synthon is indicated by blue dashed lines, other interactions by red dashed 
lines. 
 
Note that, as consequence of the carboxylate-pyridinium anti configuration (see Figure 
5.5), the 3-NO2 derivative shows a departure from the group of structures involved in 
forming M13 which consists of a different orientation of the salicylic moiety (Figure 
5.19 b). In particular, the comparison of the nitro derivatives emphasizes this difference 
but  also  highlights  the  importance  of  the  directional  interactions  in  generating  the 
common arrangement. In fact, as shown in figure, the nitro group of both derivatives 
interacts  via  N-H···O  hydrogen  bond  with  the  amino  group  of  the  pyridine  moiety 
(N···O  distances  for  3-NO2  and  5-NO2  respectively  3.093  Å  and  3.152  Å).  This 
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meta to the PyN
+ (C···O distances for 3-NO2 and 5-NO2 respectively 3.441 Å and 3.388 
Å). 
A similar behaviour is also observed for the 5-F derivative in which the amino group 
interacts with the fluoro (F···N 3.015 Å) determining a similar geometry (Figure 5.19 
c). However, no analogous significant interactions are found for the 5-Cl derivative 
(apart a C-H···Cl contact involving the aromatic hydrogen in position meta with respect 
the  pyridinium  nitrogen  with  a  C-H···Cl  3.268  Å)  in  which  the  Cl···N  distance  is 
approximately 5 Å (Figure 5.19 d). This last observation suggests that this molecular 
arrangement is the result of both directional interactions and close packing features.  
It is also worth noting how important is the correct choice of the COSP (see comparison 
reported in Figure 5. 19) in order to obtain relationships between systems which may 
have significant differences. In this case, in fact, the selection of two set of COSPs (see 
Figure 5.12) permits comparison of the two nitro derivatives which in other case would 
be difficult.  
 
Strictly related to A13 is the 2-D SC M2 common to the nitro derivatives. This is built 
by the combination of the two 1-D SCs M11 and M13 (Figure 5.20).  
 
 
Figure 5. 20. 2-D Supramolecular Construct (SC) M2 reported for 4-aminopyridinium-3-nitrosalicylate 
(3-NO2): a) viewed along the 010 direction; b) viewed approximately along the 001 direction. 
 
The two nitro derivatives show significant differences along the 001 direction. 
Figure 5.21 shows the crystal packing of the two derivatives viewed along the shortest 
axis. Instances of the SC M2 are also shown. The two nitro derivatives show a different 
development of M2 along the 001direction.  
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Figure 5. 21. 2-D Supramolecular Construct (SC) M2: a) 4-aminopyridinium-3-nitrosalicylate (3-NO2) 
viewed along the 010 direction. SCs M2-M2‟ are related by 21 screw axis perpendicular to the sheet 
(green); b) 4-aminopyridinium-5-nitrosalicylate (5-NO2) viewed along the 100 direction. SCs M2 - M2‟ 
and M2‟‟- M2‟‟‟are related vertical 21 screw axis perpendicular to the sheet (green), SCs M2‟ - M2‟‟ and 
M2‟‟‟-  M2  by  l  21  screw  axis  parallel  to the  sheet  (green  arrows).  The  molecules  are  colour-coded 
according to the orientation of the ring–carboxylate vector; red = pointing away from the viewer, blue = 
pointing towards the viewer. 
 
In  the  3-NO2  derivative  the  SC  M2  adopts  two  different  orientations,  labeled 
respectively as M2 and M2‟, which are related by vertical 21 screw axes. M2 and M2‟ 
are connected by N-H···O hydrogen bonds between the amino group of the pyridinium 
and the nitro group assisted by a C-H···O hydrogen bond involving the hydroxyl group 
and the aromatic hydrogen in position meta to the pyridinium nitrogen (Figure 5.16 b).  
In  the  5-NO2  derivative  one  more  21  screw  axis  operates  along  the  010  direction, 
generating two more orientations labeled as M2‟‟ and M2‟‟‟ (indicated as blue in Figure 
5.21 b). M2 and M2‟ are related, as in the 3-NO2 derivative, by the vertical 21 screw 
axis. The same operation relates M2‟‟ and M2‟‟‟. These instances of the SC M2 are 
connected by C-H···O hydrogen bond involving the hydroxyl group and the aromatic 
hydrogen in position ortho to the pyridinium nitrogen (Figure 5.16 a). 
M2‟ and M2‟‟ and M2‟‟‟ and M2 are instead related by a 21 screw axis lying in the 011 
plane  and  connected  by  N-H···O  hydrogen  bonds  between  the  amino  group  of  the 
pyridinium and the oxygen of the carboxylic group (N···O distances 2.796 Å). Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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Supramolecular Constructs D. 
The second family of SCs, labelled as D, includes the halo derivatives 5-Cl, 5-F, 5-I, 5-I 
Py and 6-F and the 5-Me derivative. As previously described, this is not the case for the 
two hydrate forms 5-Br h and 5-I h, which adopt molecular arrangements close to the 
family M.  
The group D contains a 0-D SCs D01 and a 2-D SC D2. The SCs D01, which is the 
precursors  of  the  molecular  arrangement  of  the  type  D,  is  a  dimeric  arrangements 
obtained from M0 by inversion symmetry. This is common for 5-Cl, 5-F, 5-I, 5-I Py, 6-
F and the 5-Me derivative. No significant interactions are involved in forming this SC.  
Interestingly the arrangement observed for the 5-I Py derivative shows some significant 
differences with the other derivatives related to the relative shifting of the 0-D SCs M0 
and M0‟ (Figure 5.22 a and b). This can arises from the steric hindrance of the pyridine 
molecules which interact via a N-H···N hydrogen bond with the amino group of the 4-
aminopyridinium (N···N 3.058 Å). 
 
 
Figure 5. 22. 0-D Supramolecular Construct (SC) D01: a) 4-aminopyridinium-5-chlorosalicylate (5-Cl) 
b)  4-aminopyridinium-5-iodosalicylate  (5-I  Py).  Centre  of  inversion  is  indicated  by  a  yellow  circle; 
instances of the 0-D SC M0 are also indicated. 
 
The  SC  D01  contributes  in  generating  a  1-D  arrangement,  common  to  the  halo 
derivatives (5-Cl, 5-F, 5-I, and 5-I Py) and not included in the analysis since it is part of 
the higher dimension SC D2. This can be considered as a stack of SC D01 which 
develops along the shortest axis (Figure 5.23 a and b).  Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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Figure 5. 23. 1-D stack arrangement reported for 4-aminopyridinium-5-chlorosalicylate (5-Cl): a) viewed 
approximately along the 001 axis; b) viewed along the 010 axis. 
 
The 5-Cl, 5-F, 5-I and 5-I Py derivatives show a common 2-D SC labelled as D2. This 
is formed by a combination of the 1-D arrangements described above, related by 21 
screw axes (Figure 5.24 a - c). 
Figure 5.24 shows a comparison of the crystal packing of 5-Cl and 5-I and 5-I Py 
derivatives, viewed along the 010 axis.  
 Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
159 
 
 
Figure 5. 24. 2-D Supramolecular Construct (SC) D2: a) 4-aminopyridinium-5-chlorosalicylate (5-Cl) 
viewed along the 010 direction. SCs D2-D2‟ are related by 21 screw axis perpendicular to the sheet 
(green); b) 4-aminopyridinium-5-iodosalicylate (5-I) viewed along the 010 direction. SCs D2 - D2‟ are 
related by centre of inversion (yellow); c) 4-aminopyridinium-5-iodosalicylate (5-I Py) viewed along the 
010 direction. SCs D2 - D2‟ are related by 21 screw axis perpendicular to the sheet (green) and centre of 
inversion (yellow). The molecules are colour-coded according to the orientation of the ring–carboxylate 
vector; dark blue = pointing towards from the viewer, blue = pointing away the viewer. 
 
The three structures mainly differ in the development of D2 along the 100 axis. In the 5-
Cl and 5-I Py derivatives (Figure 5.24 a and c) the instances of the 2-D SC (D2 and 
D2‟) are related by 21 screw axes and connected by N-H···Cl hydrogen bonds for 5-Cl 
(N··Cl distance 3.214 Å) and I···I contacts for the 5-I Py derivative (I···I distance 3.807 
Å), this not the case for the 5-I derivative (Figure 5.24 b) in which D2 and D2‟ are Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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related  by  inversion  symmetry  and  connected  by  C-H···I  interactions  involving  the 
aromatic hydrogen in position ortho to the carboxylate. 
However it is interesting to note the differences related to the 5-I Py structure in which 
the instances of the SC D2 are more spaced. This is also confirmed by the comparison 
of the unit cell parameters for the four structures involved in this arrangements which 
show similar values for the 010 (in the range 7.9-8.6 Å) and 001 axis (in the range 10-
12.5 Å) and a very different value for the 100 axis (approximately 18 Å for the 5-I Py 
and in the range 10-13 Å for the other halo derivatives). This is, again (see SC D01), the 
effect of the steric hindrance of the solvent molecules which act as spacers. However it 
is  interesting  to  note  that  though  the  presence  of  the  solvent  molecules  influence 
significantly the dimensions of the unit cell parameters, the 5-I Py derivatives adopts a 
crystal packing very close to the 5-Cl and 5-F derivatives (see Figure 5.24 a and c).  
 
As shown in the relationships diagram (see Figure 5.13), 5-Cl and 5-F derivatives are 
related by a 3-D similarity. However, the analysis of the unit cell parameters reveals 
some differences along all three axes. In particular the two structures show differences 
of about 1 Å, 0.5 Å and 0.3 Å respectively along the 100, 010 and 001 axes. Figure 5.25 
a and b show the crystal packing of the two halo derivatives viewed along the 010 axis.  
 
 
Figure 5. 25. Crystal packing of: a) 4-aminopyridinium-5-chlorosalicylate (5-Cl); b) 4-aminopyridinium-
5-fluorosalicylate (5-F) both viewed along the 010 axis. 
In particular the two derivatives show a different shift of the two adjacent SCs D2 and 
D2‟ along the 001 and -100 direction. This also influences the interactions involved in 
connecting  the  two  adjacent  SCs  D2  and  D2‟,  which  are  in  both  cases  N-H···X 
interactions (X = halogen) between the amino group of the pyridinium and the halogen 
in position meta of the salicylate but involving different positions (Figure 5.26 a and b). Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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Figure 5. 26. Relative shifting of instances of the Supramolecular Construct (SC) D2 and interactions 
involved; a) 4-aminopyridinium-5-chlorosalicylate (5-Cl); b) 4-aminopyridinium-5-fluorosalicylate (5-F). 
Shorter intermolecular distances are indicated as black dashed lines, longer as red dashed lines. 
 
In the 5-Cl derivative (Figure 5.26 a) the shortest contact (indicated in black) occurs 
between two adjacent molecules along the 100 direction (N···Cl distance 3.214 Å), in 5-
F  (Figure  5.26  b)  this  involves  adjacent  molecules  along  the  001  direction  (N···F 
distance 3.015 Å). 
 
5.4. Conclusions. 
The  robustness  of  the  COO
-···H
+NPy  supramolecular  synthon  is  the  main  common 
feature of this set of structures. In general the salicylate and the 4-aminopyridinium 
moieties interact by a strong N-H···O hydrogen bond assisted by a secondary C-H···O 
weak hydrogen bond, forming a “two point synthon”. This definition is ambiguous for 
the  two  nitro  derivatives  which,  even  if  they  adopt  a  conformation  suitable  for  the 
formation of the “two point synthon” (low torsional angle τ2), the C-H···O interactions 
are significantly longer with respect those observed for the majority of the structures 
(C···O distances 3.510 Å for the 5-NO2 and 3.436 Å for the 3-NO2).  
However, the simultaneous presence of different substituent groups or the presence of 
solvent  molecules  in  the  solvate  forms  can  affect  the  predictability  of  the 
supramolecular  synthon  of  some  structures.  In  particular  the  amino  group  of  the 
aminopyridine moiety competes with the aromatic nitrogen in forming the typical COO
-
···H
+NPy. This is mainly observed in the 5-NH2 Py derivative, in which the COO
-···H-
NH interaction replace the COO
-···H
+NPy synthon and in the 5-Cl derivative, in which Chapter 5                                         Molecular Salts Based on 4-Aminopyridine-Salicylic Acid Derivatives 
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the two different orientations of the aminopyridine ring, observed in a ratio 63-37%, 
show both possibilities.  
The  complex  structural  behaviour  of  the  molecular  salts  is  more  emphasized 
considering  the  crystal  packing  differences  observed  within  the  family.  The  XPac 
analysis clearly shows two different tendencies to pack. The main difference concerns 
the identification of two families of SCs labelled as M and D. The family of SCs M 
derives from the 0-D SC D0, a monomer which is formed by the two components 
assembled  together  trough  the  COO
-···H-NH  supramolecular  synthon.  This  family 
contains the 5-NO2 and 3-NO2, 5-MeO, 5-ACM derivatives.  
The second family of SCs, D, derives from the 0-D SC D0 which is a dimer formed by 
two SCs M0 related by inversion symmetry. This family contains the halo derivatives 5-
Cl, 5-F, 5-I, 5-I Py, 6-F and the 5-Me derivative. 
In contrast to the family of salicylic acid derivatives discussed in the previous chapter 
(Chapter 4), the set of salts analyzed here shows high degree of structural similarity 
within derivatives with similar substituted groups. This is observed for the two nitro 
derivatives  3-NO2  and  5-NO2  which  show  a  2-D  similarity.  The  most  significant 
example is given by the halo derivatives substituted in position 5 which show 3-D and 
2-D  similarities.  Surprisingly  the  hydrate  forms  show  significant  differences  in  the 
crystal packing adopted and in particular 5-Br h and 5-I h adopt a crystal packing which 
shows closeness to the family of structures M. 
Surprisingly the 5-I Py, which includes in the crystal structure molecule of the pyridine 
solvent, adopts a crystal packing close to the other 5-halo derivatives. The difference is 
mainly ascribed to the molecule of the solvent which acts as spacer, increasing some of 
the unit cell parameters. 
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CHAPTER 6: CONCLUSION AND FURTHER WORK. 
 
6.1. Conclusions. 
This  thesis  work  has  shown  quite  clearly  that,  as  described  in  Section  1.5,  crystal 
structure assembly is a trade-off between close packing (and in general geometrical 
features) and intermolecular interactions. In particular, the observation of recurring 1-D 
or  2-D  fragments  held  together  by  different  sets  of  directional  and  non-directional 
interactions indicates that close packing has a significant role in determining the crystal 
structure  of  a  given  compound.  This  scenario  is  consistent  with  the  related  ideas 
proposed  by  Dunitz  and  Schweitzer 
[1],  in  relation  to  recent  studies  of  the  alloxan 
structure (which, though rich in hydrogen bond donors and acceptors, does not form any 
strong directional intermolecurar interaction),  that the structure  is “held together by 
whatever factors contribute to the cohesive energies” of specified pairs of molecules. 
This view has received further comment by Desiraju 
[2], and by Boese, Desiraju et al 
[3] 
in their report of an extended analysis of structures of further fluoroaromatics. 
 
The analysis of the three families of salicylic acid derivatives has also shown how the 
type  of  substituents  and  the  position  of  attachment  can  have  a  significant  role  in 
determining particular molecular arrangements.  
In  particular  the  family  of  substituted  aspirin  derivatives  showed  a  wide  range  of 
common  molecular  arrangements  which  might  be  explained  considering  both  the 
similar shape (resulting from the substituents and their positions of attachment) and the 
directional interactions. In this regard it is worth mentioning the high similarities (3-D 
and 2-D) involving the 5- and 4-substituted derivatives.  On the contrary, the substituted 
salicylic  acid  derivatives  (Chapter  4)  mainly  showed  1-D  similarities  consisting  on 
different  types  of  stacking  arrangements.  This  is  an  unexpected  result  if  the  rigid 
molecular conformation and the close shape of the molecule are considered. In this 
regard,  the  absence  of  the  acetyl  group  seems  to  be  one  possible  reason  for  such 
different behaviour. In particular the acetyl centrosymmetric dimer is a robust synthon 
observed in the majority of the aspirin derivatives, which might have an important role 
in defining similarities within the family.  
As expected, the family of salts (Chapter 5) obtained by proton transfer between the 
substituted salicylic acid derivatives and the 4-aminopyridine, shown significant crystal Chapter 6                                                                                                        Conclusions and Further Work 
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packing differences if compared with the previous two families. However, as in aspirin 
derivatives, compounds with similar substituent groups adopt similar crystal packing.  
In the other hand, the analysis showed the importance of particular functional group in 
defining robust supramolecular synthons.  
The three families studied showed, apart from a small number of exceptions, predictable 
synthons (carboxylic dimers for the aspirins and the salicylic acids and the well known 
pyridine-carboxylate synthon for the salts) observed in the majority of the structures.  
A further consideration concerns the occurrence of solvate forms. In particular, and 
differently to the other two families studied, the aspirin derivatives showed the tendency 
to crystallize as anhydrous or generally non-solvate forms. It is also interesting that 
hydrate or solvate formation in the other two families is not dominant. The combined 
results  from  this  work  clearly  indicate  that  further  study,  particularly  using  the 
systematic approach of this present work, would be very useful. 
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6.2. Further Work. 
Future work can thus be addressed in many directions. First of all would be of interest 
to increase the number of the family members by synthesizing and crystallizing more 
derivatives.  Additionally  new  families  might  also  be  defined  by  varying  the  target 
molecules.  An  example could  be  the  preparation  of trifluoroacetylsalicylic  acids,  to 
study the influence of the trifluoro substituent in generating the crystal packing and 
eventually  in  disrupting  the  centrosymmetric  acetyl  dimer  which  hasproved  to be  a 
strong feature in the aspirin derivatives. 
The  family  of  salts  could  be  increased  using  more  salicylic  acid  derivatives.  Of 
particular  interest  could  also  be  the  preparation  of  more  hydrate  forms  in  order  to 
identify  the  differences  with  the  anhydrous  form  in  the crystal  packing.  In  fact,  as 
described in Chapter 5, the hydrate forms so far analyzed showed the tendency to pack 
adopting molecular arrangemets deriving from the monomer. The salt screening could 
also  be  extendend  to  molecular  salts  prepared  using  other  pyridine  derivatives.  An 
example can be represented by the 3,4-diaminopyridine which can also be deprotonated 
in position 3, determining a family of deprotonated salts. Other relevant molecules can 
be represented by quinoline substituted derivatives (amino or hydroxy). 
A further direction concerns the systematic search of potential polymorphs for both the 
aspirin  and  the  substituted  salicylic  acid  derivatives.  The  XPac  procedure  and  in 
particular  the  relationships  diagram,  can  be  a  useful  guide  in  developing  the 
experiments. The aim is to develop a protocol for polymorphism screening based on the 
XPac  results.  The  screening  could  be  based  on  seeding  experiments  involving 
derivatives  which  showed  similar  molecular  arrangements.  Computational  studies, 
aimed at providing information on the stability of all the forms studied, and specifically 
the  relative  energies  in  all  the  intermolecular  interactions  identifiedwould  be  of 
particular importance in selecting derivatives for seeding experiments. 
For example, following from the isolation of the polymorphic form of 5-chloroaspirin 
(5-Cl (II)) it would be interesting try to isolate polymorphic forms of the other member 
of the halo isostructural set (5-iodo and 5-bromoaspirin). This could be carried out by 
seeding the halo derivatives with crystals of 5-Cl (II).  
Further work can also be addressed on the development of other families of related 
compounds  based  on  molecules  of  pharmaceutical  interest.  An  example  can  be 
represented by 2-(2,6-dichloranilino) phenylacetic acid, generally known as diclofenac. Chapter 6                                                                                                        Conclusions and Further Work 
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The analysis can also be extended to flexible molecules such as aliphatic carboxylic 
acids, in order to investigate the influence of the flexibility of the chains in determining 
the crystal packing.  
Finally, it is obvious to point to the great value of the kind of systematic studies so far 
made in helping to understand the factors operative in the assembly of organic crystal 
structures,  and  that  these  methods,  and  the  tools  and  procedures  which  have  been 
developed, can, in general, enable an expansion into an almost unlimited variety of 
similar projects.  
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Table A1. 1. Supramolecular Construct descriptions. SC = Supramolecular Construct; D = dimensionality; Description, „>‟ = is related by; # = Number of structures in which 
construct occurs; Base = base vector of SC (see Table 2); Dependencies show lower dimensionality SCs present in given SC. 
 
 
 
 
 
 
 
SC  D  Description  Figs  #  Base  Dependencies 
A0  0  Centrosymm. carboxylic acid dimer  -  16  -  - 
B0  0  Centrosymm. carboxylic O···5-R dimer  3.10  6  -  - 
C0  0  Centrosymm.acetyl dimer  3.11  9  -  - 
A11  1  Stack of A0 dimers > translation  3.16  10  t1  A0 → A11 
A12  1  Row of tilted A0 dimers > translation  3.18  4  t2  A0 → A12 
A13  1  Stack of A0 dimers > translation  3.19  2  t3  A0 → A13 
B1  1  Diagonal chain of B0 dimers > translation  3.24  4  t4  B0 → B1 
C1  1  Row of C0 dimers > translation  3.12  2  t5  C0 → C1 
D1  1  Stack of single molecules > translation  3.17  12  t1  X→ D1 
E1  1  Row of single molecules > translation  3.13  3  t6  X→ E1 
AB1  1  Tape- chain of A0 and B0 dimers > translation  3.21  5  t7  A0·B0 → AB1 
AC1  1  Zig-zag row of acetyl H-bonded A0 dimers > translation  3.14  8  t8  A0·C0 → AC1 
A2  2  Sheet – A11 dimer stacks > 21 screw axes  3.27  6  t1, t9  A0·A11 → A2 
AC2  2  Sheet – A11 dimer stacks > 21 screw axes  3.26  7  t1, t10  A0·A11·AC1 → AC2 
AE2  2  Sheet – A0 dimer stacks > 2-fold rotation  3.25  2  t11, t12  A0·E1 → AE2 
             
Isostructural  5-Cl (I)/5-Br/5-I,    5-Me/5-NO2/5-F,    5-Cl (II)/5-MeO,   4-Me/3-Me/4-F/4-MeO  
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  t1  d1  t2  d2  t3  d3  t4  d4  t5  d5  t6  d6  t7  d7  t8  d8  t9  d9  t10  d10  t11  d11  t12  d12 
4-F  100  4.908                          1-10  11.149      010  10.010         
5-F  0-10  4.892                          -110  10.922  10-1  22.860  -100  9.766         
6-F                  010  7.095  010  7.095                         
5-Cl I  010  4.714  110  11.134      110  11.134          100  10.086      -101  22.804             
5-Cl II                          -10-1  10.942                     
5-Br  010  4.727  110  11.416      110  11.416          100  10.391      -101  23.103             
5-I  010  4.717  1-10  11.770      110  11.770          -100  10.784      -101  23.392             
5-NO2  0-10  5.044                          -110  11.126  10-1  22.575  -100  9.917         
3-Me  100  4.910                          -110  12.690      0-10  11.702         
4-Me  100  4.636                          -1-10  11.322      010  10.329         
5-Me  0-10  4.883                          1-10  11.246  10-1  23.103  -100  10.130         
6-Me      -100  10.164  010  7.238                                     
Asp1                  0-10  6.552  0-10  6.552      -100  11.278          010  6.552  001  11.274 
Asp2                      0-10  6.506                  010  6.506  001  11.368 
3-MeO          001  7.381                                     
4-MeO  100  5.069                          110  10.734      010  9.462         
5-MeO                          -10-1  11.563                     
3-ACM  010  4.379                                             
5-ACM              10-1  13.517                                 
4-CF3  0-10  5.752                                             
Table A1. 2. Translation vectors with lengths (Å) (angles in the 2-D arrangements are all 90) 
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Table A2. 1. Supramolecular Construct descriptions. SC = Supramolecular Construct; D = dimensionality; Description, „>‟ = is related by; # = Number of structures in which 
construct occurs; Base = base vector of SC (see Table 2); Dependencies show lower dimensionality SCs present in given SC. 
 
 
. 
 
 
 
 
 
SC  D  Description  Figs  #  Base  Dependencies 
A0  0  Centrosymm. carboxylic acid dimer  -  16  -  - 
A11  0  Stack of A0 dimers > translation  4.10  8  t1  A0 → A11 
A12  0  Tape of  A0 dimers > translation  4.13  2  t2  A0 → A12 
A13  1  Steps row A0 dimers > translation  4.15  3  t3  A0 → A13 
A14  1  Stack of A0 dimers > translation  4.17  5  t4  A0 → A14 
A15  1  Stack of pairs of  A0 dimers  > inversion, translation  4.19  2  t5  A0 → A15 
X11  1  Stack of single molecules > translation  4.11  12  t1  X0→X11 
X12  1  Stack of pairs of X11 > inversion  4.12  7  t1  X0→X11→ X12 
X13  1  Row of single molecules > translation  4.14  6  t6  X0→X13 
X14  1  Stack of single molecules > translation  4.18  6  t4  X0→X14 
A21  2  Row of A11 stacks > translation  4.20  5  t1, t7  A0·A11 → A21 
A22  2  Row of Zig-zag chains of A0 dimers > translation  4.21  2  t1, t8  A0·A11→ A22 
             
Isostructural  -  
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  t1  d1  t2  d2  t3  d3  t4  d4  t5  d5  t6  d6  t7  d7  t8  d8   
t1, t7 
 
t1, t8 
3-MeO h                      001  6.734             
3-MeO  100  3.793                  10-1  8.257  001  7.017      94.89   
4-MeO              100  4.963                     
5-MeO  100  3.978                                 
6-MeO                                     
3-NO2h  100  3.594                                 
5-NO2      001  9.267  -111  15.142                         
4-ACM                                     
5-ACMh  100  3.747                                 
4-NH2  0-10  3.728                  -100  7.137  100  7.137      90   
5-NH2  -100  3.724                                 
4-Cl  100  3.724      110  14.891                         
5-Clh  100  3.729                                 
5-Cl  010  3.709                          101  24.945    90 
5-I                  010  4.576                 
SA          -2-10  14.899  -100  4.889                     
5-F  -100  3.818                  -10-1  8.357  001  8.211      78.83   
6-F              0-10  5.212  -100  5.315                 
5-Br              100  4.805                     
4-Me  -100  3.868                  0-10  7.238  010  7.238      89.21   
5-Me      110  8.841      010  5.015                     
5-NO  00-1  3.667                  0-10  8.028  010  8.028  1-11  24.412  90  97.63 
Table A2. 2. Translation vectors with lengths (Å) and angles  (). 
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Table A3. 1. Supramolecular Construct descriptions. SC = Supramolecular Construct; D = dimensionality; Description, „>‟ = is related by; # = Number of structures in which 
construct occurs; Base = base vector of SC (see Table 2); Dependencies show lower dimensionality SCs present in given SC. 
 
 
 
 
 
 
   
 
 
SC  D  Description  Figs  #  Base  Dependencies 
M0  0  Hydrogen bonded pyridinium-carboxylate   -  10  -  - 
D01  0  Dimer of M0 > inversion  5.22  6  -  M0 → D0 
M11  0  Stack of M0 > translation  5.14  4  t1  M0→  M11 
M12  1  Pair of M11 > 21 screw axes  5.16  3  t1  M11 →  M12 
M13  1  Zig-zag chain of M0 > translation  5.18  4  t2  M0 → M13 
M2  1  Stack of M13  > translation  5.21  2  t1, t3  M11·M13 → M2 
D2  1  Tape of stacks of D0> translation, 21 screw axes  5.24  4  t4, t5  D01→D2 
             
Isostructural  5-Cl, 5-F  
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  t1  d1  t2  d2  t3  d3  t4  d4  t5  d5   
t1, t3 
 
t4, t5 
5-Cl      -1-10  14.386      00-1  12.484  0-10  7.963    90 
5-F      110  13.756      00-1  12.150  0-10  8.541    90 
5-I              00-1  12.443  010  8.101    90 
5-I Py              00-1  10.929  0-10  8.666    90 
5-I h                         
5-Br h                         
5-NH2 Py                         
5-ACM  010  4.667                     
5-MeO h  00-1  3.992                     
5-Me                         
5-NO2  -100  3.778  -210  14.691  1-10  13.153          106.691   
3-NO2  0-10  4.575  1-20  14.288  -110  11.889          112.632   
6-F                         
Table A3. 2. Translation vectors with lengths (Å) and angles  (). 
  
 
 
 